1	Available	JJ	O	available	amod	2	SENT_1	[p1l1015t81r1168b110],
2	online	NN	O	online	_	0	SENT_1	[p1l1180t81r1279b110],
3	at	IN	O	at	_	0	SENT_1	[p1l1292t82r1322b110],
4	wvvw.sciencedirect.com	NNP	O	wvvw.sciencedirect.com	prep_at	2	SENT_1	[p1l1333t81r1726b110],

1	--	:	O	--	_	0	SENT_2	[p1l1108t129r1224b155],
2	at	IN	O	at	prep	4	SENT_2	[p1l1108t129r1224b155],
3	"	``	O	"	punct	4	SENT_2	[p1l1082t154r1190b223],
4	3	CD	NUMBER	3	_	0	SENT_2	[p1l1082t154r1190b223],
5	'	''	O	'	_	0	SENT_2	[p1l1082t154r1190b223],
6	ScienceDirect	NNP	O	ScienceDirect	dep	4	SENT_2	[p1l1228t160r1660b220],

1	Pmsm	NN	O	pmsm	_	0	SENT_3	[p1l110t334r250b375],

1	Neuro-Psychopharmacology	NNP	O	Neuro-Psychopharmacology	nn	6	SENT_4	[p1l9t393r352b434],
2	&	CC	O	&	_	0	SENT_4	[p1l42t451r62b486],
3	Biological	NNP	O	Biological	nn	6	SENT_4	[p1l70t451r190b492],
4	Psychiatly	NNP	O	Psychiatly	nn	6	SENT_4	[p1l200t451r327b492],
5	P	NN	O	p	nn	6	SENT_4	[p1l6t503r225b537],
6	Q	NNP	O	Q	dep	16	SENT_4	[p1l6t503r225b537],
7	+	CC	O	+	_	0	SENT_4	[p1l6t503r225b537],
8	Progress	NNP	O	Progress	dep	16	SENT_4	[p1l474t511r586b541],
9	in	IN	O	in	_	0	SENT_4	[p1l643t510r668b534],
10	Neuro-Psychopharmacology	NNP	ORGANIZATION	Neuro-Psychopharmacology	nn	13	SENT_4	[p1l723t510r1099b541],
11	&	CC	ORGANIZATION	&	_	0	SENT_4	[p1l1156t511r1180b534],
12	Biological	NNP	ORGANIZATION	Biological	conj_and	10	SENT_4	[p1l1237t510r1373b541],
13	Psychiatry	NNP	ORGANIZATION	Psychiatry	prep_in	6	SENT_4	[p1l1429t510r1567b541],
14	30	CD	NUMBER	30	dep	16	SENT_4	[p1l1624t511r1655b534],
15	(	CD	NUMBER	(	num	16	SENT_4	[p1l1713t510r1798b541],
16	2006	CD	DATE	2006	dep	20	SENT_4	[p1l1713t510r1798b541],
17	)	CD	DATE	)	num	18	SENT_4	[p1l1713t510r1798b541],
18	1356	CD	DATE	1356	dep	16	SENT_4	[p1l1859t511r1944b534],
19	-	:	DATE	-	_	0	SENT_4	[p1l1859t511r1944b534],
20	1358	CD	DATE	1358	_	0	SENT_4	[p1l1953t511r2014b534],

1	www.elsevier.com/locate/pnpbp	NN	O	www.elsevier.com/locate/pnpbp	_	0	SENT_5	[p1l1734t643r2154b674],

1	Case	NNP	O	Case	_	0	SENT_6	[p1l967t738r1060b773],
2	report	NN	O	report	dep	1	SENT_6	[p1l1078t742r1195b783],

1	Response	NN	O	response	amod	12	SENT_7	[p1l354t823r621b886],
2	to	TO	O	to	_	0	SENT_7	[p1l647t828r698b872],
3	hydrocodone	NN	O	hydrocodone	prep_to	1	SENT_7	[p1l724t821r1105b886],
4	,	,	O	,	_	0	SENT_7	[p1l724t821r1105b886],
5	codeine	NN	O	codeine	prep_to	1	SENT_7	[p1l1134t821r1348b872],
6	and	CC	O	and	_	0	SENT_7	[p1l1376t821r1475b872],
7	oxycodone	NN	O	oxycodone	prep_to	1	SENT_7	[p1l1500t821r1805b886],
8	in	IN	O	in	_	0	SENT_7	[p1l635t904r687b953],
9	a	DT	O	a	det	10	SENT_7	[p1l713t920r742b954],
10	CYP2D6	NN	O	cyp2d6	prep_in	1	SENT_7	[p1l768t905r1020b954],
11	poor	JJ	O	poor	amod	12	SENT_7	[p1l1046t920r1177b968],
12	metabolizer	NN	O	metabolizer	_	0	SENT_7	[p1l1199t904r1528b954],

1	Margaret	NNP	PERSON	Margaret	nn	3	SENT_8	[p1l399t1040r593b1088],
2	T.	NNP	PERSON	T.	nn	3	SENT_8	[p1l612t1040r649b1077],
3	Susce	NNP	PERSON	Susce	_	0	SENT_8	[p1l674t1040r806b1085],
4	,	,	O	,	_	0	SENT_8	[p1l674t1040r806b1085],
5	Elaina	NNP	PERSON	Elaina	nn	6	SENT_8	[p1l828t1039r963b1077],
6	Murray	NNP	PERSON	Murray	appos	3	SENT_8	[p1l982t1039r1415b1088],
7	.	.	O	.	_	0	SENT_8	[p1l982t1039r1415b1088],

1	—	NN	O	—	_	0	SENT_9	[p1l982t1039r1415b1088],
2	.	.	O	.	_	0	SENT_9	[p1l982t1039r1415b1088],

1	Carmichael	NNP	PERSON	Carmichael	nn	5	SENT_10	[p1l982t1039r1415b1088],
2	,	,	O	,	_	0	SENT_10	[p1l982t1039r1415b1088],
3	Jose	NNP	PERSON	Jose	appos	5	SENT_10	[p1l1437t1040r1527b1077],
4	de	IN	PERSON	de	amod	5	SENT_10	[p1l1548t1039r1596b1077],
5	Leon	NNP	PERSON	Leon	_	0	SENT_10	[p1l1616t1040r1725b1077],
6	*	NNP	O	*	nn	7	SENT_10	[p1l1741t1033r1759b1054],
7	University	NNP	ORGANIZATION	University	dep	5	SENT_10	[p1l390t1136r523b1166],
8	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l534t1135r566b1166],
9	Kentucky	NNP	ORGANIZATION	Kentucky	nn	14	SENT_10	[p1l569t1135r695b1166],
10	,	,	O	,	_	0	SENT_10	[p1l569t1135r695b1166],
11	Mental	NNP	ORGANIZATION	Mental	appos	14	SENT_10	[p1l709t1135r804b1159],
12	Health	NNP	ORGANIZATION	Health	nn	14	SENT_10	[p1l813t1135r902b1159],
13	Research	NNP	ORGANIZATION	Research	nn	14	SENT_10	[p1l914t1135r1034b1159],
14	Center	NNP	ORGANIZATION	Center	prep_of	7	SENT_10	[p1l1049t1135r1137b1159],
15	at	IN	O	at	_	0	SENT_10	[p1l1148t1139r1173b1159],
16	Eastern	NNP	ORGANIZATION	Eastern	nn	17	SENT_10	[p1l1183t1136r1284b1159],
17	State	NNP	ORGANIZATION	State	prep_at	14	SENT_10	[p1l1297t1135r1362b1159],
18	Hospital	NNP	ORGANIZATION	Hospital	nn	24	SENT_10	[p1l1372t1135r1491b1166],
19	,	,	O	,	_	0	SENT_10	[p1l1372t1135r1491b1166],
20	Lexington	NNP	LOCATION	Lexington	appos	24	SENT_10	[p1l1505t1136r1642b1166],
21	,	,	O	,	_	0	SENT_10	[p1l1505t1136r1642b1166],
22	KY	NNP	O	KY	appos	24	SENT_10	[p1l1656t1136r1701b1163],
23	,	,	O	,	_	0	SENT_10	[p1l1656t1136r1701b1163],
24	USA	NNP	LOCATION	USA	dep	5	SENT_10	[p1l1717t1135r1772b1159],

1	Available	JJ	O	available	amod	2	SENT_11	[p1l870t1202r995b1226],
2	online	NN	O	online	_	0	SENT_11	[p1l1007t1202r1088b1226],
3	24	CD	DATE	24	dep	2	SENT_11	[p1l1100t1202r1132b1225],
4	April	NNP	DATE	April	tmod	3	SENT_11	[p1l1144t1202r1212b1232],
5	2006	CD	DATE	2006	num	4	SENT_11	[p1l1224t1202r1289b1226],

1	Abstract	JJ	O	abstract	_	0	SENT_12	[p1l6t1348r145b1374],

1	Codeine	NNP	O	Codeine	nsubjpass	3	SENT_13	[p1l57t1439r179b1466],
2	is	VBZ	O	be	auxpass	3	SENT_13	[p1l195t1439r217b1466],
3	metabolized	VBN	O	metabolize	_	0	SENT_13	[p1l233t1439r413b1466],
4	by	IN	O	by	_	0	SENT_13	[p1l428t1439r465b1473],
5	the	DT	O	the	det	11	SENT_13	[p1l481t1439r525b1466],
6	cytochrome	NN	O	cytochrome	nn	11	SENT_13	[p1l541t1439r714b1473],
7	P450	NN	O	p450	nn	11	SENT_13	[p1l729t1439r804b1465],
8	2D6	NN	O	2d6	nn	11	SENT_13	[p1l821t1439r883b1465],
9	(	CD	NUMBER	(	num	11	SENT_13	[p1l901t1439r1059b1473],
10	CYPZD6	NN	O	cypzd6	nn	11	SENT_13	[p1l901t1439r1059b1473],
11	)	NN	O	)	agent	3	SENT_13	[p1l901t1439r1059b1473],
12	to	TO	O	to	_	0	SENT_13	[p1l1075t1443r1103b1466],
13	morphine	NN	O	morphine	prep_to	11	SENT_13	[p1l1119t1439r1267b1473],
14	.	.	O	.	_	0	SENT_13	[p1l1119t1439r1267b1473],

1	Codeine	NNP	O	Codeine	nsubj	6	SENT_14	[p1l1285t1439r1407b1466],
2	is	VBZ	O	be	cop	6	SENT_14	[p1l1424t1439r1446b1466],
3	a	DT	O	a	det	6	SENT_14	[p1l1463t1448r1479b1465],
4	much	JJ	O	much	amod	6	SENT_14	[p1l1493t1439r1575b1466],
5	weaker	JJR	O	weaker	dep	4	SENT_14	[p1l1590t1439r1698b1466],
6	agonist	NN	O	agonist	_	0	SENT_14	[p1l1712t1439r1818b1473],
7	at	IN	O	at	_	0	SENT_14	[p1l1834t1443r1860b1465],
8	[	CD	NUMBER	[	number	9	SENT_14	[p1l1876t1448r1894b1472],
9	.1	CD	NUMBER	.1	num	11	SENT_14	[p1l1876t1448r1894b1472],
10	opioid	NN	O	opioid	nn	11	SENT_14	[p1l1911t1439r2005b1473],
11	receptors	NNS	O	receptor	prep_at	6	SENT_14	[p1l2020t1443r2154b1473],
12	than	IN	O	than	_	0	SENT_14	[p1l6t1484r70b1510],
13	morphine	NN	O	morphine	prep_than	11	SENT_14	[p1l84t1484r232b1518],
14	.	.	O	.	_	0	SENT_14	[p1l84t1484r232b1518],

1	Therefore	RB	O	therefore	advmod	7	SENT_15	[p1l249t1484r401b1516],
2	,	,	O	,	_	0	SENT_15	[p1l249t1484r401b1516],
3	codeine	NN	O	codeine	nn	4	SENT_15	[p1l418t1484r531b1511],
4	analgesia	NN	O	analgesia	nsubj	7	SENT_15	[p1l547t1484r683b1518],
5	is	VBZ	O	be	cop	7	SENT_15	[p1l698t1484r720b1511],
6	highly	RB	O	highly	advmod	7	SENT_15	[p1l735t1484r830b1518],
7	dependent	JJ	O	dependent	_	0	SENT_15	[p1l845t1484r997b1518],
8	on	IN	O	on	_	0	SENT_15	[p1l1011t1493r1048b1511],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_15	[p1l1062t1485r1196b1511],
10	activity	NN	O	activity	prep_on	7	SENT_15	[p1l1213t1484r1327b1518],
11	.	.	O	.	_	0	SENT_15	[p1l1213t1484r1327b1518],

1	Large	JJ	O	large	amod	3	SENT_16	[p1l1344t1485r1428b1518],
2	prospective	JJ	O	prospective	amod	3	SENT_16	[p1l1442t1484r1612b1518],
3	studies	NNS	O	study	nsubj	10	SENT_16	[p1l1628t1484r1728b1511],
4	in	IN	O	in	_	0	SENT_16	[p1l1744t1484r1772b1510],
5	the	DT	O	the	det	7	SENT_16	[p1l1786t1484r1830b1511],
6	clinical	JJ	O	clinical	amod	7	SENT_16	[p1l1846t1484r1952b1511],
7	environment	NN	O	environment	prep_in	3	SENT_16	[p1l1968t1484r2154b1511],
8	do	VBP	O	do	aux	10	SENT_16	[p1l6t1529r41b1556],
9	not	RB	O	not	neg	10	SENT_16	[p1l58t1533r105b1556],
10	exist	VB	O	exist	dep	24	SENT_16	[p1l122t1529r198b1561],
11	,	,	O	,	_	0	SENT_16	[p1l122t1529r198b1561],
12	but	CC	O	but	_	0	SENT_16	[p1l219t1529r267b1556],
13	it	PRP	O	it	nsubj	15	SENT_16	[p1l287t1529r307b1556],
14	appears	VBZ	O	appear	cop	15	SENT_16	[p1l327t1538r438b1563],
15	reasonable	JJ	O	reasonable	dep	24	SENT_16	[p1l458t1529r615b1556],
16	to	TO	O	to	aux	17	SENT_16	[p1l636t1533r664b1556],
17	avoid	VB	O	avoid	xcomp	15	SENT_16	[p1l686t1529r767b1556],
18	codeine	NN	O	codeine	nn	19	SENT_16	[p1l787t1529r901b1556],
19	use	NN	O	use	dobj	17	SENT_16	[p1l921t1538r970b1556],
20	in	IN	O	in	_	0	SENT_16	[p1l991t1529r1019b1555],
21	CYPZD6	NN	O	cypzd6	nn	23	SENT_16	[p1l1039t1530r1173b1556],
22	poor	JJ	O	poor	amod	23	SENT_16	[p1l1195t1538r1264b1563],
23	metabolizers	NNS	O	metabolizer	prep_in	17	SENT_16	[p1l1283t1529r1470b1556],
24	(	VBP	O	(	_	0	SENT_16	[p1l1492t1529r1589b1563],
25	PMs	NNS	O	pm	dobj	24	SENT_16	[p1l1492t1529r1589b1563],
26	)	CD	NUMBER	)	nsubj	24	SENT_16	[p1l1492t1529r1589b1563],
27	.	.	O	.	_	0	SENT_16	[p1l1492t1529r1589b1563],

1	CYPZD6	NN	O	cypzd6	nsubj	2	SENT_17	[p1l1612t1530r1746b1556],
2	metabolizes	VBZ	O	metabolize	_	0	SENT_17	[p1l1768t1529r1942b1556],
3	other	JJ	O	other	amod	5	SENT_17	[p1l1964t1529r2040b1556],
4	opioid	JJ	O	opioid	amod	5	SENT_17	[p1l2060t1529r2154b1563],
5	analgesics	NNS	O	analgesic	dobj	2	SENT_17	[p1l6t1574r164b1608],
6	,	,	O	,	_	0	SENT_17	[p1l6t1574r164b1608],
7	including	VBG	O	include	_	0	SENT_17	[p1l179t1574r317b1608],
8	tramadol	NN	O	tramadol	prep_including	5	SENT_17	[p1l329t1574r467b1606],
9	,	,	O	,	_	0	SENT_17	[p1l329t1574r467b1606],
10	dihydrocodeine	NN	O	dihydrocodeine	prep_including	5	SENT_17	[p1l481t1574r718b1608],
11	,	,	O	,	_	0	SENT_17	[p1l481t1574r718b1608],
12	oxycodone	NN	O	oxycodone	prep_including	5	SENT_17	[p1l732t1574r894b1608],
13	and	CC	O	and	_	0	SENT_17	[p1l906t1574r959b1601],
14	hydrocodone	NN	O	hydrocodone	prep_including	5	SENT_17	[p1l970t1574r1172b1608],
15	,	,	O	,	_	0	SENT_17	[p1l970t1574r1172b1608],
16	although	IN	O	although	mark	22	SENT_17	[p1l1185t1574r1314b1608],
17	they	PRP	O	they	nsubjpass	22	SENT_17	[p1l1326t1574r1389b1608],
18	have	VBP	O	have	aux	22	SENT_17	[p1l1400t1574r1469b1601],
19	been	VBN	O	be	auxpass	22	SENT_17	[p1l1480t1574r1550b1601],
20	less	JJR	O	less	advmod	22	SENT_17	[p1l1562t1574r1615b1601],
21	systematically	RB	O	systematically	advmod	22	SENT_17	[p1l1629t1574r1838b1608],
22	studied	VBN	O	study	advcl	2	SENT_17	[p1l1851t1574r1963b1601],
23	.	.	O	.	_	0	SENT_17	[p1l1851t1574r1963b1601],

1	It	PRP	O	it	nsubj	3	SENT_18	[p1l1977t1575r1999b1600],
2	is	VBZ	O	be	cop	3	SENT_18	[p1l2011t1574r2033b1601],
3	unclear	JJ	O	unclear	_	0	SENT_18	[p1l2045t1574r2154b1601],
4	whether	IN	O	whether	complm	12	SENT_18	[p1l6t1619r125b1646],
5	these	DT	O	these	det	7	SENT_18	[p1l135t1619r209b1646],
6	other	JJ	O	other	amod	7	SENT_18	[p1l223t1619r299b1646],
7	pro-drugs	NNS	O	pro-drug	nsubj	12	SENT_18	[p1l310t1619r453b1653],
8	may	MD	O	may	aux	12	SENT_18	[p1l467t1628r530b1653],
9	be	VB	O	be	cop	12	SENT_18	[p1l542t1619r576b1646],
10	as	IN	O	as	dep	12	SENT_18	[p1l590t1628r619b1646],
11	completely	RB	O	completely	advmod	12	SENT_18	[p1l633t1619r796b1653],
12	dependent	JJ	O	dependent	ccomp	3	SENT_18	[p1l809t1619r961b1653],
13	on	IN	O	on	_	0	SENT_18	[p1l974t1628r1010b1646],
14	CYPZD6	NN	O	cypzd6	prep_on	12	SENT_18	[p1l1023t1620r1157b1646],
15	for	IN	O	for	_	0	SENT_18	[p1l1172t1619r1215b1646],
16	their	PRP$	O	they	poss	17	SENT_18	[p1l1226t1619r1294b1646],
17	analgesia	NN	O	analgesia	prep_for	14	SENT_18	[p1l1306t1619r1443b1653],
18	as	IN	O	as	_	0	SENT_18	[p1l1456t1628r1484b1646],
19	codeine	NN	O	codeine	prep_as	12	SENT_18	[p1l1499t1619r1619b1646],
20	.	.	O	.	_	0	SENT_18	[p1l1499t1619r1619b1646],

1	We	PRP	O	we	nsubj	2	SENT_19	[p1l1634t1620r1682b1646],
2	describe	VBP	O	describe	_	0	SENT_19	[p1l1695t1619r1817b1646],
3	a	DT	O	a	det	4	SENT_19	[p1l1831t1628r1846b1645],
4	patient	NN	O	patient	nsubj	5	SENT_19	[p1l1858t1619r1959b1653],
5	identified	VBD	O	identify	ccomp	2	SENT_19	[p1l1972t1619r2112b1646],
6	as	IN	O	as	_	0	SENT_19	[p1l2125t1628r2154b1646],
7	a	DT	O	a	det	9	SENT_19	[p1l6t1673r22b1690],
8	CYPZD6	NN	O	cypzd6	nn	9	SENT_19	[p1l34t1665r168b1691],
9	PM	NN	O	pm	prep_as	5	SENT_19	[p1l182t1665r235b1690],
10	with	IN	O	with	_	0	SENT_19	[p1l248t1664r313b1691],
11	a	DT	O	a	det	12	SENT_19	[p1l327t1673r343b1691],
12	history	NN	O	history	prep_with	5	SENT_19	[p1l355t1664r457b1698],
13	of	IN	O	of	_	0	SENT_19	[p1l471t1664r505b1691],
14	problems	NNS	O	problem	prep_of	12	SENT_19	[p1l513t1664r650b1698],
15	with	IN	O	with	_	0	SENT_19	[p1l664t1664r729b1691],
16	opioid	JJ	O	opioid	amod	17	SENT_19	[p1l743t1664r837b1698],
17	analgesics	NNS	O	analgesic	prep_with	14	SENT_19	[p1l850t1664r1008b1698],
18	.	.	O	.	_	0	SENT_19	[p1l850t1664r1008b1698],

1	The	DT	O	the	det	2	SENT_20	[p1l57t1708r112b1735],
2	patient	NN	O	patient	nsubj	6	SENT_20	[p1l128t1708r229b1743],
3	was	VBD	O	be	cop	6	SENT_20	[p1l245t1717r301b1735],
4	an	DT	O	a	det	6	SENT_20	[p1l319t1717r353b1735],
5	85-year-old	JJ	DURATION	85-year-old	amod	6	SENT_20	[p1l370t1708r541b1743],
6	female	JJ	O	female	_	0	SENT_20	[p1l558t1708r656b1735],
7	Caucasian	JJ	MISC	caucasian	amod	6	SENT_20	[p1l673t1708r824b1735],
8	who	WP	O	who	nsubj	9	SENT_20	[p1l840t1708r903b1735],
9	had	VBD	O	have	rcmod	6	SENT_20	[p1l919t1708r973b1735],
10	hip	NN	O	hip	nn	11	SENT_20	[p1l989t1708r1035b1743],
11	surgery	NN	O	surgery	dobj	9	SENT_20	[p1l1054t1717r1167b1743],
12	.	.	O	.	_	0	SENT_20	[p1l1054t1717r1167b1743],

1	The	DT	O	the	det	2	SENT_21	[p1l1186t1708r1242b1735],
2	patient	NN	O	patient	nsubj	3	SENT_21	[p1l1258t1708r1359b1743],
3	had	VBD	O	have	_	0	SENT_21	[p1l1375t1708r1428b1735],
4	a	DT	O	a	det	8	SENT_21	[p1l1445t1717r1460b1735],
5	long	JJ	O	long	amod	8	SENT_21	[p1l1477t1708r1679b1743],
6	—	NN	O	—	nn	8	SENT_21	[p1l1477t1708r1679b1743],
7	standing	NN	O	standing	nn	8	SENT_21	[p1l1477t1708r1679b1743],
8	intolerance	NN	O	intolerance	dobj	3	SENT_21	[p1l1697t1708r1859b1735],
9	to	TO	O	to	_	0	SENT_21	[p1l1875t1712r1903b1735],
10	codeine	NN	O	codeine	prep_to	8	SENT_21	[p1l1920t1708r2041b1735],
11	.	.	O	.	_	0	SENT_21	[p1l1920t1708r2041b1735],

1	In	IN	O	in	_	0	SENT_22	[p1l2060t1709r2090b1735],
2	her	PRP$	O	she	poss	4	SENT_22	[p1l2106t1708r2154b1735],
3	ﬁrst	NN	O	ﬁrst	nn	4	SENT_22	[p1l6t1753r64b1780],
4	admission	NN	O	admission	prep_in	9	SENT_22	[p1l79t1753r235b1786],
5	,	,	O	,	_	0	SENT_22	[p1l79t1753r235b1786],
6	she	PRP	O	she	nsubj	9	SENT_22	[p1l252t1753r299b1781],
7	could	MD	O	could	aux	9	SENT_22	[p1l314t1753r436b1781],
8	n’t	RB	O	n’t	advmod	9	SENT_22	[p1l314t1753r436b1781],
9	tolerate	VB	O	tolerate	_	0	SENT_22	[p1l449t1753r558b1781],
10	the	DT	O	the	det	11	SENT_22	[p1l572t1753r617b1781],
11	regimen	NN	O	regimen	dobj	9	SENT_22	[p1l630t1753r751b1788],
12	of	IN	O	of	_	0	SENT_22	[p1l765t1753r799b1781],
13	oxycodone	NN	O	oxycodone	prep_of	11	SENT_22	[p1l809t1753r970b1788],
14	combined	VBN	O	combine	partmod	13	SENT_22	[p1l985t1753r1130b1781],
15	with	IN	O	with	_	0	SENT_22	[p1l1144t1753r1209b1780],
16	tramadol	NN	O	tramadol	nn	17	SENT_22	[p1l1223t1753r1353b1781],
17	pms	NNS	O	pm	prep_with	14	SENT_22	[p1l1366t1762r1429b1788],
18	(	RB	O	(	advmod	14	SENT_22	[p1l1444t1754r1485b1788],
19	as	IN	O	as	_	0	SENT_22	[p1l1444t1754r1485b1788],
20	needed	VBN	O	need	amod	21	SENT_22	[p1l1499t1753r1623b1788],
21	)	NN	O	)	prep_as	14	SENT_22	[p1l1499t1753r1623b1788],
22	.	.	O	.	_	0	SENT_22	[p1l1499t1753r1623b1788],

1	She	PRP	O	she	nsubjpass	3	SENT_23	[p1l1641t1753r1694b1781],
2	was	VBD	O	be	auxpass	3	SENT_23	[p1l1707t1762r1764b1781],
3	genotyped	VBN	O	genotype	_	0	SENT_23	[p1l1779t1753r1933b1788],
4	as	IN	O	as	_	0	SENT_23	[p1l1946t1762r1975b1781],
5	a	DT	O	a	det	7	SENT_23	[p1l1990t1762r2006b1780],
6	CYPZD6	NN	O	cypzd6	nn	7	SENT_23	[p1l2020t1754r2154b1781],
7	PM	NN	O	pm	prep_as	3	SENT_23	[p1l6t1800r59b1825],
8	and	CC	O	and	_	0	SENT_23	[p1l79t1799r131b1826],
9	after	IN	O	after	mark	13	SENT_23	[p1l152t1799r218b1826],
10	the	DT	O	the	det	11	SENT_23	[p1l235t1799r279b1826],
11	information	NN	O	information	nsubjpass	13	SENT_23	[p1l298t1799r471b1826],
12	was	VBD	O	be	auxpass	13	SENT_23	[p1l489t1808r545b1826],
13	provided	VBN	O	provide	advcl	24	SENT_23	[p1l563t1799r695b1833],
14	to	TO	O	to	_	0	SENT_23	[p1l713t1803r740b1826],
15	the	DT	O	the	det	17	SENT_23	[p1l759t1799r803b1826],
16	treating	VBG	O	treat	amod	17	SENT_23	[p1l821t1799r932b1833],
17	physician	NN	O	physician	prep_to	13	SENT_23	[p1l950t1799r1092b1833],
18	in	IN	O	in	_	0	SENT_23	[p1l1111t1799r1139b1825],
19	her	PRP$	O	she	poss	21	SENT_23	[p1l1156t1799r1203b1826],
20	second	JJ	ORDINAL	second	amod	21	SENT_23	[p1l1222t1799r1323b1826],
21	admission	NN	O	admission	prep_in	17	SENT_23	[p1l1341t1799r1498b1831],
22	,	,	O	,	_	0	SENT_23	[p1l1341t1799r1498b1831],
23	she	PRP	O	she	nsubj	24	SENT_23	[p1l1519t1799r1566b1826],
24	seemed	VBD	O	seem	conj_and	3	SENT_23	[p1l1585t1799r1695b1826],
25	to	TO	O	to	aux	26	SENT_23	[p1l1712t1803r1739b1826],
26	have	VB	O	have	xcomp	24	SENT_23	[p1l1758t1799r1827b1826],
27	a	DT	O	a	det	29	SENT_23	[p1l1846t1808r1862b1826],
28	better	JJR	O	better	amod	29	SENT_23	[p1l1878t1799r1963b1826],
29	response	NN	O	response	dobj	26	SENT_23	[p1l1980t1808r2108b1833],
30	to	TO	O	to	_	0	SENT_23	[p1l2127t1803r2154b1826],
31	hydrocodone	NN	O	hydrocodone	prep_to	26	SENT_23	[p1l6t1843r207b1878],
32	.	.	O	.	_	0	SENT_23	[p1l6t1843r207b1878],

1	Large	JJ	O	large	amod	2	SENT_24	[p1l224t1845r308b1878],
2	case	NN	O	case	nsubj	25	SENT_24	[p1l325t1843r503b1870],
3	—	CD	NUMBER	—	num	6	SENT_24	[p1l325t1843r503b1870],
4	control	NN	O	control	nn	6	SENT_24	[p1l325t1843r503b1870],
5	naturalistic	JJ	O	naturalistic	amod	6	SENT_24	[p1l521t1843r683b1870],
6	studies	NNS	O	study	nsubjpass	18	SENT_24	[p1l702t1843r802b1870],
7	followed	VBN	O	follow	partmod	6	SENT_24	[p1l822t1843r952b1870],
8	by	IN	O	by	_	0	SENT_24	[p1l969t1843r1006b1878],
9	randomized	VBN	O	randomize	agent	7	SENT_24	[p1l1023t1843r1198b1870],
10	trials	NNS	O	trial	dobj	9	SENT_24	[p1l1215t1843r1287b1870],
11	in	IN	O	in	_	0	SENT_24	[p1l1305t1843r1333b1870],
12	patients	NNS	O	patient	prep_in	10	SENT_24	[p1l1350t1843r1464b1878],
13	taking	VBG	O	take	partmod	12	SENT_24	[p1l1482t1843r1574b1878],
14	opioid	JJ	O	opioid	amod	15	SENT_24	[p1l1592t1843r1686b1878],
15	analgesics	NNS	O	analgesic	dobj	13	SENT_24	[p1l1704t1843r1854b1878],
16	may	MD	O	may	aux	18	SENT_24	[p1l1872t1852r1935b1878],
17	be	VB	O	be	auxpass	18	SENT_24	[p1l1952t1843r1987b1870],
18	needed	VBN	O	need	rcmod	2	SENT_24	[p1l2004t1843r2109b1870],
19	to	TO	O	to	aux	21	SENT_24	[p1l2127t1847r2154b1870],
20	deﬁnitively	RB	O	deﬁnitively	advmod	21	SENT_24	[p1l6t1888r174b1923],
21	establish	VB	O	establish	xcomp	18	SENT_24	[p1l189t1888r317b1915],
22	that	DT	O	that	det	24	SENT_24	[p1l331t1888r386b1915],
23	CYPZD6	NN	O	cypzd6	nn	24	SENT_24	[p1l399t1889r533b1916],
24	genotyping	NN	O	genotyping	dobj	21	SENT_24	[p1l548t1888r714b1923],
25	has	VBZ	O	have	_	0	SENT_24	[p1l727t1888r775b1916],
26	clinical	JJ	O	clinical	amod	27	SENT_24	[p1l790t1888r896b1916],
27	relevance	NN	O	relevance	dobj	25	SENT_24	[p1l909t1888r1049b1916],
28	in	IN	O	in	_	0	SENT_24	[p1l1064t1888r1091b1915],
29	the	DT	O	the	det	30	SENT_24	[p1l1104t1888r1148b1916],
30	use	NN	O	use	prep_in	27	SENT_24	[p1l1161t1897r1210b1916],
31	of	IN	O	of	_	0	SENT_24	[p1l1224t1888r1258b1916],
32	several	JJ	O	several	amod	34	SENT_24	[p1l1268t1888r1370b1916],
33	opioid	JJ	O	opioid	amod	34	SENT_24	[p1l1384t1888r1478b1923],
34	analgesics	NNS	O	analgesic	prep_of	30	SENT_24	[p1l1492t1888r1649b1923],
35	.	.	O	.	_	0	SENT_24	[p1l1492t1888r1649b1923],

1	©	RB	O	©	advmod	2	SENT_25	[p1l6t1935r32b1961],
2	2006	CD	DATE	2006	_	0	SENT_25	[p1l46t1935r119b1961],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_25	[p1l133t1934r254b1961],
4	Inc.	NNP	ORGANIZATION	Inc.	dep	2	SENT_25	[p1l266t1935r319b1961],
5	.	.	O	.	_	0	SENT_25	[p1l266t1935r319b1961],

1	All	DT	O	all	det	2	SENT_26	[p1l334t1934r381b1960],
2	rights	NNS	O	rights	nsubj	3	SENT_26	[p1l394t1934r477b1968],
3	reserved	VBN	O	reserve	_	0	SENT_26	[p1l491t1934r622b1961],
4	.	.	O	.	_	0	SENT_26	[p1l491t1934r622b1961],

1	Keywords	NNS	O	keyword	_	0	SENT_27	[p1l6t2028r146b2058],
2	:	:	O	:	_	0	SENT_27	[p1l6t2028r146b2058],
3	Analgesia	NN	O	analgesia	dep	1	SENT_27	[p1l159t2028r298b2058],
4	;	:	O	;	_	0	SENT_27	[p1l159t2028r298b2058],
5	Codeine	NNP	O	Codeine	nsubj	11	SENT_27	[p1l311t2028r427b2056],
6	;	:	O	;	_	0	SENT_27	[p1l311t2028r427b2056],
7	Cytochrome	NNP	O	Cytochrome	dep	5	SENT_27	[p1l441t2028r602b2058],
8	P450	NN	O	p450	nn	9	SENT_27	[p1l614t2028r681b2052],
9	2D6	NN	O	2d6	dep	7	SENT_27	[p1l693t2028r757b2056],
10	;	:	O	;	_	0	SENT_27	[p1l693t2028r757b2056],
11	Genotyping	VBG	O	genotype	dep	3	SENT_27	[p1l771t2028r933b2058],
12	;	:	O	;	_	0	SENT_27	[p1l771t2028r933b2058],
13	Hydrocodone	NN	O	hydrocodone	dep	3	SENT_27	[p1l946t2028r1132b2058],
14	;	:	O	;	_	0	SENT_27	[p1l946t2028r1132b2058],
15	Oxycodone	NNP	O	Oxycodone	dep	13	SENT_27	[p1l1146t2028r1304b2058],
16	;	:	O	;	_	0	SENT_27	[p1l1146t2028r1304b2058],
17	Pain	NN	O	pain	dep	15	SENT_27	[p1l1317t2028r1375b2051],

1	1	LS	NUMBER	1	_	0	SENT_28	[p1l13t2263r69b2321],
2	.	.	O	.	_	0	SENT_28	[p1l13t2263r69b2321],

1	Introduction	NN	O	introduction	_	0	SENT_29	[p1l102t2263r535b2320],

1	Codeine	NNP	O	Codeine	nsubjpass	3	SENT_30	[p1l107t2456r374b2514],
2	is	VBZ	O	be	auxpass	3	SENT_30	[p1l429t2456r477b2514],
3	metabolized	VBN	O	metabolize	_	0	SENT_30	[p1l531t2456r927b2514],
4	by	IN	O	by	_	0	SENT_30	[p1l977t2456r1058b2530],
5	the	DT	O	the	det	11	SENT_30	[p1l1110t2456r1207b2514],
6	cytochrome	NN	O	cytochrome	nn	11	SENT_30	[p1l1261t2456r1640b2530],
7	P450	NN	O	p450	nn	11	SENT_30	[p1l1693t2458r1857b2514],
8	2D6	NN	O	2d6	nn	11	SENT_30	[p1l1912t2458r2048b2514],
9	(	CD	NUMBER	(	num	11	SENT_30	[p1l11t2552r350b2625],
10	CYPZD6	NN	O	cypzd6	nn	11	SENT_30	[p1l11t2552r350b2625],
11	)	NN	O	)	agent	3	SENT_30	[p1l11t2552r350b2625],
12	to	TO	O	to	_	0	SENT_30	[p1l375t2560r434b2609],
13	morphine	NN	O	morphine	prep_to	11	SENT_30	[p1l459t2552r776b2625],
14	.	.	O	.	_	0	SENT_30	[p1l459t2552r776b2625],

1	Codeine	NNP	O	Codeine	nsubj	6	SENT_31	[p1l807t2552r1068b2610],
2	is	VBZ	O	be	cop	6	SENT_31	[p1l1094t2552r1142b2609],
3	a	DT	O	a	det	6	SENT_31	[p1l1169t2571r1202b2609],
4	much	JJ	O	much	amod	6	SENT_31	[p1l1225t2552r1402b2610],
5	weaker	JJR	O	weaker	dep	4	SENT_31	[p1l1424t2552r1654b2610],
6	agonist	NN	O	agonist	_	0	SENT_31	[p1l1677t2552r1904b2626],
7	at	IN	O	at	_	0	SENT_31	[p1l1928t2560r1983b2609],
8	u	NN	O	u	nn	10	SENT_31	[p1l2008t2572r2048b2624],
9	opioid	NN	O	opioid	nn	10	SENT_31	[p1l10t2649r211b2722],
10	receptors	NNS	O	receptor	prep_at	6	SENT_31	[p1l235t2657r520b2722],
11	than	IN	O	than	_	0	SENT_31	[p1l548t2649r684b2706],
12	morphine	NN	O	morphine	prep_than	10	SENT_31	[p1l709t2649r1026b2722],
13	.	.	O	.	_	0	SENT_31	[p1l709t2649r1026b2722],

1	Therefore	RB	O	therefore	advmod	7	SENT_32	[p1l1059t2649r1382b2718],
2	,	,	O	,	_	0	SENT_32	[p1l1059t2649r1382b2718],
3	codeine	NN	O	codeine	nn	4	SENT_32	[p1l1413t2649r1655b2706],
4	analgesia	NN	O	analgesia	nsubj	7	SENT_32	[p1l1683t2649r1974b2722],
5	is	VBZ	O	be	cop	7	SENT_32	[p1l2001t2649r2049b2706],
6	highly	RB	O	highly	advmod	7	SENT_32	[p1l8t2744r210b2818],
7	dependent	JJ	O	dependent	_	0	SENT_32	[p1l252t2744r576b2818],
8	on	IN	O	on	_	0	SENT_32	[p1l617t2763r695b2802],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_32	[p1l737t2746r1024b2802],
10	activity	NN	O	activity	prep_on	7	SENT_32	[p1l1069t2744r1310b2818],
11	.	.	O	.	_	0	SENT_32	[p1l1069t2744r1310b2818],

1	CYPZD6	NN	O	cypzd6	nn	3	SENT_33	[p1l1357t2746r1645b2802],
2	poor	JJ	O	poor	amod	3	SENT_33	[p1l1687t2763r1835b2818],
3	metabolizers	NNS	O	metabolizer	nsubj	4	SENT_33	[p1l1873t2752r2049b2802, p1l7t2840r254b2898],
4	(	VBP	O	(	_	0	SENT_33	[p1l274t2841r484b2914],
5	PMs	NNS	O	pm	dobj	4	SENT_33	[p1l274t2841r484b2914],
6	)	CD	NUMBER	)	num	5	SENT_33	[p1l274t2841r484b2914],
7	,	,	O	,	_	0	SENT_33	[p1l274t2841r484b2914],
8	who	WP	O	who	nsubj	9	SENT_33	[p1l502t2840r637b2898],
9	lack	VBP	O	lack	rcmod	5	SENT_33	[p1l657t2840r787b2898],
10	CYP2D6	NN	O	cyp2d6	dobj	9	SENT_33	[p1l803t2842r1110b2910],
11	,	,	O	,	_	0	SENT_33	[p1l803t2842r1110b2910],
12	account	NN	O	account	rcmod	5	SENT_33	[p1l1130t2849r1374b2898],
13	for	IN	O	for	_	0	SENT_33	[p1l1391t2840r1481b2898],
14	7	CD	PERCENT	7	num	15	SENT_33	[p1l1497t2842r1599b2899],
15	%	NN	PERCENT	%	prep_for	12	SENT_33	[p1l1497t2842r1599b2899],
16	of	IN	O	of	_	0	SENT_33	[p1l1617t2841r1691b2898],
17	Caucasians	NNPS	MISC	Caucasians	prep_of	15	SENT_33	[p1l1698t2840r2049b2898],
18	and	CC	O	and	_	0	SENT_33	[p1l10t2937r123b2995],
19	l	NN	O	l	rcmod	5	SENT_33	[p1l155t2938r338b2996],
20	—	CD	PERCENT	—	number	21	SENT_33	[p1l155t2938r338b2996],
21	3	CD	PERCENT	3	num	22	SENT_33	[p1l155t2938r338b2996],
22	%	NN	PERCENT	%	dobj	19	SENT_33	[p1l155t2938r338b2996],
23	of	IN	O	of	_	0	SENT_33	[p1l364t2937r438b2995],
24	other	JJ	O	other	amod	25	SENT_33	[p1l453t2937r614b2995],
25	races	NNS	O	race	prep_of	22	SENT_33	[p1l636t2956r811b2995],
26	.	.	O	.	_	0	SENT_33	[p1l636t2956r811b2995],

1	Powerful	JJ	O	powerful	amod	3	SENT_34	[p1l840t2937r1127b2995],
2	CYP2D6	NN	O	cyp2d6	nn	3	SENT_34	[p1l1154t2938r1441b2995],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_34	[p1l1469t2937r1767b2995],
4	(	VBP	O	(	_	0	SENT_34	[p1l1794t2937r1962b3010],
5	such	JJ	O	such	_	0	SENT_34	[p1l1794t2937r1962b3010],
6	as	IN	O	as	_	0	SENT_34	[p1l1988t2956r2049b2995],
7	quinidine	NN	O	quinidine	nn	14	SENT_34	[p1l10t3032r322b3106],
8	,	,	O	,	_	0	SENT_34	[p1l10t3032r322b3106],
9	paroxetine	NN	O	paroxetine	conj_and	7	SENT_34	[p1l348t3032r696b3106],
10	,	,	O	,	_	0	SENT_34	[p1l348t3032r696b3106],
11	ﬂuoxetine	NN	O	ﬂuoxetine	conj_and	7	SENT_34	[p1l725t3032r1040b3089],
12	and	CC	O	and	_	0	SENT_34	[p1l1066t3032r1179b3089],
13	bupropion	NN	O	bupropion	conj_and	7	SENT_34	[p1l1201t3032r1551b3106],
14	)	NN	O	)	prep_such_as	4	SENT_34	[p1l1201t3032r1551b3106],
15	can	MD	O	can	aux	16	SENT_34	[p1l1578t3051r1685b3089],
16	change	VB	O	change	rcmod	14	SENT_34	[p1l1710t3032r1931b3106],
17	the	DT	O	the	det	18	SENT_34	[p1l1955t3032r2049b3089],
18	phenotype	NN	O	phenotype	dobj	16	SENT_34	[p1l7t3128r337b3202],
19	of	IN	O	of	_	0	SENT_34	[p1l380t3128r454b3186],
20	normal	JJ	O	normal	amod	21	SENT_34	[p1l484t3128r707b3186],
21	subjects	NNS	O	subject	prep_of	18	SENT_34	[p1l750t3128r999b3202],
22	(	JJ	O	(	amod	18	SENT_34	[p1l1043t3128r1253b3202],
23	called	VBN	O	call	partmod	18	SENT_34	[p1l1043t3128r1253b3202],
24	extensive	JJ	O	extensive	amod	25	SENT_34	[p1l1295t3128r1589b3186],
25	metabolizers	NNS	O	metabolizer	dep	23	SENT_34	[p1l1631t3128r2047b3198],
26	,	,	O	,	_	0	SENT_34	[p1l1631t3128r2047b3198],
27	EMS	NNP	ORGANIZATION	EMS	appos	25	SENT_34	[p1l9t3225r182b3297],
28	)	CD	NUMBER	)	num	27	SENT_34	[p1l9t3225r182b3297],
29	to	TO	O	to	_	0	SENT_34	[p1l220t3232r280b3282],
30	the	DT	O	the	det	32	SENT_34	[p1l318t3224r413b3282],
31	PM	NN	O	pm	nn	32	SENT_34	[p1l451t3227r566b3281],
32	phenotype	NN	O	phenotype	prep_to	27	SENT_34	[p1l602t3224r931b3298],
33	as	RB	O	as	advmod	34	SENT_34	[p1l972t3243r1034b3282],
34	long	RB	O	long	advmod	23	SENT_34	[p1l1073t3224r1212b3298],
35	as	IN	O	as	mark	38	SENT_34	[p1l1251t3243r1313b3282],
36	they	PRP	O	they	nsubj	38	SENT_34	[p1l1351t3224r1488b3298],
37	are	VBP	O	be	aux	38	SENT_34	[p1l1526t3243r1618b3282],
38	taking	VBG	O	take	ccomp	34	SENT_34	[p1l1656t3224r1852b3298],
39	these	DT	O	these	det	40	SENT_34	[p1l1889t3224r2049b3282],
40	medications	NNS	O	medication	dobj	38	SENT_34	[p1l8t3321r403b3379],
41	.	.	O	.	_	0	SENT_34	[p1l8t3321r403b3379],

1	The	DT	O	the	det	2	SENT_35	[p1l429t3321r549b3378],
2	review	NN	O	review	nsubj	13	SENT_35	[p1l569t3321r783b3379],
3	of	IN	O	of	_	0	SENT_35	[p1l803t3321r877b3378],
4	Lotsch	NNP	O	Lotsch	prep_of	2	SENT_35	[p1l887t3321r1101b3378],
5	et	FW	O	et	nn	7	SENT_35	[p1l1122t3329r1177b3378],
6	al.	FW	O	al.	nn	7	SENT_35	[p1l1196t3321r1264b3378],
7	(	FW	O	(	dep	4	SENT_35	[p1l1291t3321r1498b3394],
8	2004	CD	DATE	2004	num	9	SENT_35	[p1l1291t3321r1498b3394],
9	)	CD	NUMBER	)	dep	7	SENT_35	[p1l1291t3321r1498b3394],
10	found	VBN	O	find	partmod	9	SENT_35	[p1l1520t3321r1704b3379],
11	six	CD	NUMBER	six	num	12	SENT_35	[p1l1725t3321r1813b3378],
12	studies	NNS	O	study	dobj	10	SENT_35	[p1l1836t3321r2049b3379],
13	focused	VBD	O	focus	_	0	SENT_35	[p1l10t3417r254b3474],
14	on	IN	O	on	_	0	SENT_35	[p1l286t3435r364b3474],
15	codeine	NN	O	codeine	nn	17	SENT_35	[p1l396t3417r638b3474],
16	analgesic	JJ	O	analgesic	amod	17	SENT_35	[p1l672t3417r961b3490],
17	response	NN	O	response	prep_on	13	SENT_35	[p1l993t3435r1285b3490],
18	,	,	O	,	_	0	SENT_35	[p1l993t3435r1285b3490],
19	including	VBG	O	include	_	0	SENT_35	[p1l1321t3417r1616b3490],
20	45	CD	NUMBER	45	num	22	SENT_35	[p1l1648t3418r1723b3474],
21	CYP2D6	NN	O	cyp2d6	nn	22	SENT_35	[p1l1760t3418r2048b3474],
22	PMs	NNS	O	pm	prep_including	17	SENT_35	[p1l8t3515r152b3570],
23	identiﬁed	VBN	O	identiﬁed	partmod	22	SENT_35	[p1l186t3512r485b3570],
24	by	IN	O	by	_	0	SENT_35	[p1l514t3512r594b3586],
25	pheno	NN	O	pheno	nn	26	SENT_35	[p1l623t3512r816b3586],
26	or/and	NN	O	or/and	agent	23	SENT_35	[p1l851t3512r1051b3570],
27	genotyping	VBG	O	genotype	partmod	26	SENT_35	[p1l1082t3512r1436b3586],
28	(	CD	NUMBER	(	num	29	SENT_35	[p1l1470t3512r1837b3586],
29	Desmeules	NNP	O	Desmeules	dobj	27	SENT_35	[p1l1470t3512r1837b3586],
30	et	FW	O	et	nn	31	SENT_35	[p1l1871t3520r1926b3570],
31	al.	FW	O	al.	dep	29	SENT_35	[p1l1958t3512r2048b3582],
32	,	,	O	,	_	0	SENT_35	[p1l1958t3512r2048b3582],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_36	[p1l102t3718r480b3764],
2	:	:	O	:	_	0	SENT_36	[p1l102t3718r480b3764],
3	CYP	NN	O	cyp	dep	1	SENT_36	[p1l509t3719r638b3774],
4	,	,	O	,	_	0	SENT_36	[p1l509t3719r638b3774],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_36	[p1l667t3718r966b3778],
6	P450	NN	O	p450	appos	1	SENT_36	[p1l992t3719r1138b3774],
7	;	:	O	;	_	0	SENT_36	[p1l992t3719r1138b3774],
8	CYP2D6	NN	O	cyp2d6	dep	6	SENT_36	[p1l1166t3719r1414b3774],
9	,	,	O	,	_	0	SENT_36	[p1l1166t3719r1414b3774],
10	cytochrome	NN	O	cytochrome	nn	12	SENT_36	[p1l1442t3718r1742b3778],
11	P450	NN	O	p450	nn	12	SENT_36	[p1l1767t3719r1897b3764],
12	2D6	NN	O	2d6	appos	1	SENT_36	[p1l1923t3719r2048b3774],
13	;	:	O	;	_	0	SENT_36	[p1l1923t3719r2048b3774],

1	CYP3A	NN	O	cyp3a	_	0	SENT_37	[p2l10t18r229b74],
2	,	,	O	,	_	0	SENT_37	[p2l10t18r229b74],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_37	[p2l278t17r586b77],
4	P450	NN	O	p450	nn	5	SENT_37	[p2l631t19r764b64],
5	3A	NN	O	3a	appos	1	SENT_37	[p2l812t19r905b74],
6	;	:	O	;	_	0	SENT_37	[p2l812t19r905b74],
7	EM	NNP	O	EM	dep	1	SENT_37	[p2l952t19r1062b74],
8	,	,	O	,	_	0	SENT_37	[p2l952t19r1062b74],
9	extensive	JJ	O	extensive	amod	10	SENT_37	[p2l1111t17r1358b64],
10	metabolizer	NN	O	metabolizer	appos	7	SENT_37	[p2l1403t17r1728b74],
11	;	:	O	;	_	0	SENT_37	[p2l1403t17r1728b74],
12	PM	NNP	O	PM	dep	1	SENT_37	[p2l1776t19r1883b74],
13	,	,	O	,	_	0	SENT_37	[p2l1776t19r1883b74],
14	poor	JJ	O	poor	amod	15	SENT_37	[p2l1929t33r2052b77],
15	metabolizer	NN	O	metabolizer	appos	12	SENT_37	[p2l8t98r323b155],
16	;	:	O	;	_	0	SENT_37	[p2l8t98r323b155],
17	PRN	NNP	ORGANIZATION	PRN	dep	1	SENT_37	[p2l347t100r485b155],
18	,	,	O	,	_	0	SENT_37	[p2l347t100r485b155],
19	as	IN	O	as	mark	20	SENT_37	[p2l509t114r558b145],
20	needed	VBN	O	need	dep	17	SENT_37	[p2l580t98r776b155],
21	;	:	O	;	_	0	SENT_37	[p2l580t98r776b155],
22	UM	NNP	O	UM	dep	17	SENT_37	[p2l798t100r916b155],
23	,	,	O	,	_	0	SENT_37	[p2l798t100r916b155],
24	ultrarapid	JJ	O	ultrarapid	amod	25	SENT_37	[p2l938t98r1186b158],
25	metabolizer	NN	O	metabolizer	appos	22	SENT_37	[p2l1205t98r1515b145],
26	.	.	O	.	_	0	SENT_37	[p2l1205t98r1515b145],

1	*	NN	O	*	_	0	SENT_38	[p2l45t179r69b205],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_38	[p2l104t179r483b239],
3	author	NN	O	author	dobj	2	SENT_38	[p2l520t179r690b226],
4	.	.	O	.	_	0	SENT_38	[p2l520t179r690b226],

1	Mental	NNP	ORGANIZATION	Mental	nn	4	SENT_39	[p2l729t179r909b226],
2	Health	NNP	ORGANIZATION	Health	nn	4	SENT_39	[p2l944t179r1113b226],
3	Research	NNP	ORGANIZATION	Research	nn	4	SENT_39	[p2l1148t179r1381b226],
4	Center	NNP	ORGANIZATION	Center	_	0	SENT_39	[p2l1417t180r1587b226],
5	at	IN	O	at	_	0	SENT_39	[p2l1621t186r1666b225],
6	Eastern	NNP	ORGANIZATION	Eastern	nn	8	SENT_39	[p2l1700t181r1890b226],
7	State	NNP	ORGANIZATION	State	nn	8	SENT_39	[p2l1927t180r2050b226],
8	Hospital	NNP	ORGANIZATION	Hospital	prep_at	4	SENT_39	[p2l8t260r238b320],
9	,	,	O	,	_	0	SENT_39	[p2l8t260r238b320],
10	627	CD	NUMBER	627	appos	4	SENT_39	[p2l264t262r356b307],
11	West	NNP	LOCATION	West	amod	10	SENT_39	[p2l381t262r507b307],
12	Fourth	JJ	LOCATION	fourth	advmod	10	SENT_39	[p2l529t260r700b307],
13	St.	NNP	LOCATION	St.	nn	17	SENT_39	[p2l725t261r803b316],
14	,	,	O	,	_	0	SENT_39	[p2l725t261r803b316],
15	Lexington	NNP	LOCATION	Lexington	appos	17	SENT_39	[p2l829t260r1105b320],
16	,	,	O	,	_	0	SENT_39	[p2l829t260r1105b320],
17	KY	NNP	O	KY	dep	10	SENT_39	[p2l1130t262r1222b306],
18	40508	CD	NUMBER	40508	num	17	SENT_39	[p2l1244t262r1419b316],
19	,	,	O	,	_	0	SENT_39	[p2l1244t262r1419b316],
20	USA	NNP	LOCATION	USA	appos	4	SENT_39	[p2l1443t261r1584b307],
21	.	.	O	.	_	0	SENT_39	[p2l1443t261r1584b307],

1	Tel.	NNP	O	Tel.	_	0	SENT_40	[p2l1612t260r1720b307],
2	:	:	O	:	_	0	SENT_40	[p2l1612t260r1720b307],
3	+1	CD	NUMBER	+1	number	4	SENT_40	[p2l1746t262r1806b306],
4	859 246 7487	CD	NUMBER	859 246 7487	dep	1	SENT_40	[p2l10t343r151b398],[p2l1839t262r1930b307],
5	;	:	O	;	_	0	SENT_40	[p2l10t343r151b398],
6	fax	NN	O	fax	dep	4	SENT_40	[p2l176t341r268b388],
7	:	:	O	:	_	0	SENT_40	[p2l176t341r268b388],
8	+1	CD	NUMBER	+1	number	9	SENT_40	[p2l293t343r353b387],
9	859 246 7019	CD	NUMBER	859 246 7019	dep	6	SENT_40	[p2l616t343r755b388],[p2l384t343r475b388],
10	.	.	O	.	_	0	SENT_40	[p2l616t343r755b388],

1	E-mail	NN	O	e-mail	nn	2	SENT_41	[p2l103t423r281b469],
2	address	NN	O	address	_	0	SENT_41	[p2l300t423r514b469],
3	:	:	O	:	_	0	SENT_41	[p2l300t423r514b469],
4	jdeleon@uky.edu	NN	O	jdeleon@uky.edu	dep	2	SENT_41	[p2l531t423r987b482],
5	(	CD	NUMBER	(	num	4	SENT_41	[p2l1008t423r1064b482],
6	J.	NNP	PERSON	J.	nn	9	SENT_41	[p2l1008t423r1064b482],
7	de	NNP	PERSON	de	nn	9	SENT_41	[p2l1090t423r1147b469],
8	Leon	NNP	PERSON	Leon	nn	9	SENT_41	[p2l1168t423r1333b482],
9	)	NNP	O	)	dep	4	SENT_41	[p2l1168t423r1333b482],
10	.	.	O	.	_	0	SENT_41	[p2l1168t423r1333b482],

1	0278-5846	CD	DURATION	0278-5846	nsubj	5	SENT_42	[p2l10t562r335b614],
2	/	:	O	/	punct	3	SENT_42	[p2l10t562r335b614],
3	$	$	MONEY	$	dep	1	SENT_42	[p2l10t562r335b614],
4	-	:	O	-	_	0	SENT_42	[p2l361t591r378b597],
5	see	VB	O	see	_	0	SENT_42	[p2l404t578r482b610],
6	front	JJ	O	front	amod	7	SENT_42	[p2l506t563r629b610],
7	matter	NN	O	matter	dobj	5	SENT_42	[p2l651t570r814b610],
8	©	CD	NUMBER	©	num	11	SENT_42	[p2l836t564r881b610],
9	2006	CD	DATE	2006	num	11	SENT_42	[p2l905t564r1032b609],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_42	[p2l1056t563r1265b610],
11	Inc.	NNP	ORGANIZATION	Inc.	dep	7	SENT_42	[p2l1287t565r1379b610],
12	.	.	O	.	_	0	SENT_42	[p2l1287t565r1379b610],

1	All	DT	O	all	det	2	SENT_43	[p2l1405t563r1486b609],
2	rights	NNS	O	rights	nsubj	3	SENT_43	[p2l1508t563r1652b623],
3	reserved	VBN	O	reserve	_	0	SENT_43	[p2l1675t563r1903b610],
4	.	.	O	.	_	0	SENT_43	[p2l1675t563r1903b610],

1	doi	FW	O	doi	_	0	SENT_44	[p2l9t644r867b704],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_44	[p2l9t644r867b704],
3	/	:	O	/	punct	5	SENT_44	[p2l9t644r867b704],
4	j.	NN	O	j.	nn	5	SENT_44	[p2l9t644r867b704],
5	pnpbp	NN	O	pnpbp	dep	2	SENT_44	[p2l9t644r867b704],
6	.2006.03.018	CD	NUMBER	.2006.03.018	dep	2	SENT_44	[p2l9t644r867b704],

1	1991	CD	DATE	1991	_	0	SENT_45	[p2l62t996r234b1066],
2	;	:	O	;	_	0	SENT_45	[p2l62t996r234b1066],
3	Eckhardt	NNP	PERSON	Eckhardt	dep	1	SENT_45	[p2l264t995r557b1054],
4	et	FW	O	et	nn	5	SENT_45	[p2l583t1003r640b1054],
5	al.	FW	O	al.	dep	1	SENT_45	[p2l665t995r758b1066],
6	,	,	O	,	_	0	SENT_45	[p2l665t995r758b1066],
7	1998	CD	DATE	1998	appos	1	SENT_45	[p2l795t996r967b1066],
8	;	:	O	;	_	0	SENT_45	[p2l795t996r967b1066],
9	Persson	NNP	PERSON	Persson	dep	7	SENT_45	[p2l997t998r1249b1054],
10	et	FW	O	et	nn	11	SENT_45	[p2l1275t1003r1332b1054],
11	al.	FW	O	al.	dep	1	SENT_45	[p2l1358t995r1450b1066],
12	,	,	O	,	_	0	SENT_45	[p2l1358t995r1450b1066],
13	1995	CD	DATE	1995	appos	11	SENT_45	[p2l1488t996r1660b1066],
14	;	:	O	;	_	0	SENT_45	[p2l1488t996r1660b1066],
15	Poulsen	NNP	PERSON	Poulsen	dep	11	SENT_45	[p2l1689t995r1947b1054],
16	et	FW	O	et	nn	17	SENT_45	[p2l1973t1003r2030b1054],
17	al.	FW	O	al.	dep	15	SENT_45	[p2l2055t995r2148b1066],
18	,	,	O	,	_	0	SENT_45	[p2l2055t995r2148b1066],
19	1996	CD	DATE	1996	num	21	SENT_45	[p2l62t1096r234b1166],
20	;	:	DATE	;	_	0	SENT_45	[p2l62t1096r234b1166],
21	1998	CD	DATE	1998	appos	17	SENT_45	[p2l271t1096r443b1166],
22	;	:	O	;	_	0	SENT_45	[p2l271t1096r443b1166],
23	Sindrup	NNP	O	Sindrup	dep	11	SENT_45	[p2l474t1094r724b1170],
24	et	FW	O	et	nn	25	SENT_45	[p2l752t1103r809b1153],
25	al.	FW	O	al.	dep	23	SENT_45	[p2l833t1094r925b1166],
26	,	,	O	,	_	0	SENT_45	[p2l833t1094r925b1166],
27	1990	CD	DATE	1990	num	28	SENT_45	[p2l960t1095r1156b1170],
28	)	NN	O	)	appos	1	SENT_45	[p2l960t1095r1156b1170],
29	.	.	O	.	_	0	SENT_45	[p2l960t1095r1156b1170],

1	Five	CD	NUMBER	five	nsubj	5	SENT_46	[p2l1185t1094r1328b1153],
2	of	IN	O	of	_	0	SENT_46	[p2l1353t1095r1429b1153],
3	those	DT	O	those	det	4	SENT_46	[p2l1441t1094r1610b1153],
4	studies	NNS	O	study	prep_of	1	SENT_46	[p2l1638t1094r1857b1153],
5	reported	VBD	O	report	dep	16	SENT_46	[p2l1882t1094r2152b1170],
6	lack	NN	O	lack	dobj	5	SENT_46	[p2l55t1193r189b1252],
7	of	IN	O	of	_	0	SENT_46	[p2l213t1193r288b1252],
8	analgesic	JJ	O	analgesic	amod	9	SENT_46	[p2l304t1193r600b1269],
9	effects	NNS	O	effect	prep_of	6	SENT_46	[p2l627t1193r835b1252],
10	for	IN	O	for	_	0	SENT_46	[p2l863t1193r955b1252],
11	codeine	NN	O	codeine	nn	12	SENT_46	[p2l979t1193r1228b1252],
12	treatment	NN	O	treatment	prep_for	6	SENT_46	[p2l1253t1201r1573b1265],
13	,	,	O	,	_	0	SENT_46	[p2l1253t1201r1573b1265],
14	and	CC	O	and	_	0	SENT_46	[p2l1602t1193r1718b1252],
15	one	CD	NUMBER	one	conj_and	6	SENT_46	[p2l1743t1213r1857b1252],
16	reported	VBD	O	report	_	0	SENT_46	[p2l1882t1193r2152b1269],
17	decreased	VBN	O	decrease	amod	18	SENT_46	[p2l55t1292r371b1351],
18	analgesia	NN	O	analgesia	dobj	16	SENT_46	[p2l397t1292r696b1368],
19	in	IN	O	in	_	0	SENT_46	[p2l721t1292r783b1350],
20	postoperative	JJ	O	postoperative	amod	23	SENT_46	[p2l805t1292r1240b1367],
21	pain	NN	O	pain	dep	20	SENT_46	[p2l1265t1292r1406b1367],
22	(	CD	NUMBER	(	num	21	SENT_46	[p2l1432t1292r1713b1367],
23	Poulsen	NNP	PERSON	Poulsen	prep_in	16	SENT_46	[p2l1432t1292r1713b1367],
24	et	FW	O	et	nn	25	SENT_46	[p2l1739t1300r1796b1351],
25	al.	FW	O	al.	nsubj	16	SENT_46	[p2l1821t1292r1913b1363],
26	,	,	O	,	_	0	SENT_46	[p2l1821t1292r1913b1363],
27	1998	CD	DATE	1998	num	28	SENT_46	[p2l1950t1292r2146b1367],
28	)	NN	O	)	appos	25	SENT_46	[p2l1950t1292r2146b1367],
29	.	.	O	.	_	0	SENT_46	[p2l1950t1292r2146b1367],

1	Large	JJ	O	large	amod	3	SENT_47	[p2l54t1393r239b1466],
2	prospective	JJ	O	prospective	amod	3	SENT_47	[p2l256t1391r628b1466],
3	studies	NNS	O	study	nsubj	10	SENT_47	[p2l649t1391r868b1450],
4	in	IN	O	in	_	0	SENT_47	[p2l889t1391r950b1449],
5	the	DT	O	the	det	7	SENT_47	[p2l966t1391r1063b1450],
6	clinical	JJ	O	clinical	amod	7	SENT_47	[p2l1083t1391r1317b1450],
7	environment	NN	O	environment	prep_in	3	SENT_47	[p2l1336t1391r1745b1450],
8	do	VBP	O	do	aux	10	SENT_47	[p2l1762t1391r1840b1450],
9	not	RB	O	not	neg	10	SENT_47	[p2l1859t1399r1964b1450],
10	exist	VB	O	exist	_	0	SENT_47	[p2l1981t1391r2148b1462],
11	,	,	O	,	_	0	SENT_47	[p2l1981t1391r2148b1462],
12	but	CC	O	but	_	0	SENT_47	[p2l52t1490r158b1549],
13	it	PRP	O	it	nsubj	15	SENT_47	[p2l174t1490r218b1549],
14	appears	VBZ	O	appear	cop	15	SENT_47	[p2l234t1510r477b1566],
15	reasonable	JJ	O	reasonable	conj_but	10	SENT_47	[p2l494t1490r839b1549],
16	to	TO	O	to	aux	17	SENT_47	[p2l856t1499r917b1549],
17	avoid	VB	O	avoid	xcomp	15	SENT_47	[p2l937t1490r1116b1549],
18	codeine	NN	O	codeine	nn	19	SENT_47	[p2l1133t1490r1382b1549],
19	use	NN	O	use	dobj	17	SENT_47	[p2l1398t1510r1505b1549],
20	in	IN	O	in	_	0	SENT_47	[p2l1525t1490r1586b1548],
21	CYP2D6	NNP	O	CYP2D6	nn	22	SENT_47	[p2l1604t1492r1900b1549],
22	PMs	NNP	O	PMs	prep_in	17	SENT_47	[p2l1919t1493r2066b1549],
23	or	CC	O	or	_	0	SENT_47	[p2l2086t1510r2153b1549],
24	in	IN	O	in	_	0	SENT_47	[p2l55t1589r117b1647],
25	those	DT	O	those	nsubj	26	SENT_47	[p2l138t1589r307b1648],
26	taking	VBG	O	take	prep_in	17	SENT_47	[p2l332t1589r534b1665],
27	these	DT	O	these	det	30	SENT_47	[p2l556t1589r721b1648],
28	powerful	JJ	O	powerful	amod	30	SENT_47	[p2l743t1589r1037b1665],
29	CYP2D6	NN	O	cyp2d6	nn	30	SENT_47	[p2l1061t1591r1358b1649],
30	inhibitors	NNS	O	inhibitor	dobj	26	SENT_47	[p2l1384t1589r1706b1648],
31	.	.	O	.	_	0	SENT_47	[p2l1384t1589r1706b1648],

1	CYP2D6	NN	O	cyp2d6	nsubj	2	SENT_48	[p2l154t1689r451b1747],
2	metabolizes	VBZ	O	metabolize	_	0	SENT_48	[p2l482t1688r865b1747],
3	other	JJ	O	other	amod	5	SENT_48	[p2l898t1688r1063b1747],
4	opioid	JJ	O	opioid	amod	5	SENT_48	[p2l1092t1688r1299b1764],
5	analgesics	NNS	O	analgesic	dobj	2	SENT_48	[p2l1328t1688r1674b1764],
6	,	,	O	,	_	0	SENT_48	[p2l1328t1688r1674b1764],
7	including	VBG	O	include	_	0	SENT_48	[p2l1708t1688r2011b1764],
8	tramadol	NN	O	tramadol	prep_including	5	SENT_48	[p2l2041t1696r2149b1747, p2l53t1787r273b1858],
9	,	,	O	,	_	0	SENT_48	[p2l2041t1696r2149b1747, p2l53t1787r273b1858],
10	dihydrocodeine	NN	O	dihydrocodeine	prep_including	5	SENT_48	[p2l307t1787r826b1863],
11	,	,	O	,	_	0	SENT_48	[p2l307t1787r826b1863],
12	oxycodone	NN	O	oxycodone	prep_including	5	SENT_48	[p2l861t1787r1215b1863],
13	and	CC	O	and	_	0	SENT_48	[p2l1248t1787r1364b1846],
14	hydrocodone	NN	O	hydrocodone	prep_including	5	SENT_48	[p2l1392t1787r1835b1863],
15	,	,	O	,	_	0	SENT_48	[p2l1392t1787r1835b1863],
16	although	IN	O	although	mark	22	SENT_48	[p2l1869t1787r2151b1863],
17	they	PRP	O	they	nsubjpass	22	SENT_48	[p2l53t1886r193b1962],
18	have	VBP	O	have	aux	22	SENT_48	[p2l209t1886r362b1945],
19	been	VBN	O	be	auxpass	22	SENT_48	[p2l380t1886r535b1945],
20	less	JJR	O	less	advmod	22	SENT_48	[p2l554t1886r671b1945],
21	systematically	RB	O	systematically	advmod	22	SENT_48	[p2l693t1886r1152b1962],
22	studied	VBN	O	study	advcl	2	SENT_48	[p2l1172t1886r1403b1945],
23	(	CD	NUMBER	(	xcomp	22	SENT_48	[p2l1423t1886r1667b1962],
24	Lotsch	NNP	O	Lotsch	dep	23	SENT_48	[p2l1423t1886r1667b1962],
25	et	FW	O	et	nn	26	SENT_48	[p2l1687t1895r1744b1945],
26	al.	FW	O	al.	dep	23	SENT_48	[p2l1762t1886r1854b1958],
27	,	,	O	,	_	0	SENT_48	[p2l1762t1886r1854b1958],
28	2004	CD	DATE	2004	num	29	SENT_48	[p2l1876t1887r2080b1962],
29	)	NN	O	)	appos	26	SENT_48	[p2l1876t1887r2080b1962],
30	.	.	O	.	_	0	SENT_48	[p2l1876t1887r2080b1962],

1	It	PRP	O	it	nsubj	3	SENT_49	[p2l2104t1889r2152b1945],
2	is	VBZ	O	be	cop	3	SENT_49	[p2l55t1985r104b2044],
3	unclear	JJ	O	unclear	_	0	SENT_49	[p2l133t1985r374b2044],
4	Whether	IN	O	whether	complm	12	SENT_49	[p2l400t1985r663b2044],
5	these	DT	O	these	det	7	SENT_49	[p2l689t1985r854b2044],
6	other	JJ	O	other	amod	7	SENT_49	[p2l886t1985r1052b2044],
7	pro-drugs	NNS	O	pro-drug	nsubj	12	SENT_49	[p2l1077t1985r1391b2061],
8	may	MD	O	may	aux	12	SENT_49	[p2l1422t2005r1562b2061],
9	be	VB	O	be	cop	12	SENT_49	[p2l1590t1985r1667b2044],
10	as	IN	O	as	dep	12	SENT_49	[p2l1698t2005r1761b2044],
11	completely	RB	O	completely	advmod	12	SENT_49	[p2l1794t1985r2151b2061],
12	dependent	JJ	O	dependent	ccomp	3	SENT_49	[p2l55t2084r387b2159],
13	as	IN	O	as	_	0	SENT_49	[p2l412t2103r475b2143],
14	codeine	NN	O	codeine	prep_as	12	SENT_49	[p2l501t2084r749b2143],
15	on	IN	O	on	_	0	SENT_49	[p2l775t2103r856b2143],
16	CYP2D6	NN	O	cyp2d6	prep_on	12	SENT_49	[p2l881t2085r1176b2143],
17	for	IN	O	for	_	0	SENT_49	[p2l1203t2084r1296b2143],
18	their	PRP$	O	they	poss	19	SENT_49	[p2l1317t2084r1465b2143],
19	analgesia	NN	O	analgesia	prep_for	16	SENT_49	[p2l1488t2084r1801b2160],
20	.	.	O	.	_	0	SENT_49	[p2l1488t2084r1801b2160],

1	We	PRP	O	we	nsubj	2	SENT_50	[p2l152t2185r259b2242],
2	describe	VBP	O	describe	_	0	SENT_50	[p2l296t2183r566b2242],
3	a	DT	O	a	det	4	SENT_50	[p2l604t2202r638b2241],
4	patient	NN	O	patient	nsubj	5	SENT_50	[p2l669t2183r895b2258],
5	identiﬁed	VBD	O	identiﬁed	ccomp	2	SENT_50	[p2l929t2183r1242b2242],
6	as	IN	O	as	_	0	SENT_50	[p2l1277t2202r1341b2242],
7	a	DT	O	a	det	9	SENT_50	[p2l1378t2202r1413b2241],
8	CYP2D6	NN	O	cyp2d6	nn	9	SENT_50	[p2l1448t2184r1747b2242],
9	PM	NN	O	pm	prep_as	5	SENT_50	[p2l1784t2185r1901b2241],
10	with	IN	O	with	_	0	SENT_50	[p2l1935t2183r2082b2242],
11	a	DT	O	a	det	12	SENT_50	[p2l2117t2202r2152b2241],
12	history	NN	O	history	prep_with	5	SENT_50	[p2l53t2282r281b2358],
13	of	IN	O	of	_	0	SENT_50	[p2l310t2282r385b2341],
14	problems	NNS	O	problem	prep_of	12	SENT_50	[p2l400t2282r705b2358],
15	with	IN	O	with	_	0	SENT_50	[p2l733t2282r879b2341],
16	opioid	JJ	O	opioid	amod	17	SENT_50	[p2l908t2282r1117b2358],
17	analgesics	NNS	O	analgesic	prep_with	14	SENT_50	[p2l1145t2282r1496b2358],
18	.	.	O	.	_	0	SENT_50	[p2l1145t2282r1496b2358],

1	2	LS	NUMBER	2	_	0	SENT_51	[p2l54t2483r115b2541],
2	.	.	O	.	_	0	SENT_51	[p2l54t2483r115b2541],

1	Methods	NNS	O	method	_	0	SENT_52	[p2l149t2484r453b2540],

1	The	DT	O	the	det	2	SENT_53	[p2l154t2680r279b2739],
2	patient	NN	O	patient	nsubj	6	SENT_53	[p2l309t2680r534b2756],
3	was	VBD	O	be	cop	6	SENT_53	[p2l562t2700r688b2739],
4	an	DT	O	a	det	6	SENT_53	[p2l722t2700r797b2739],
5	85-year-old	JJ	DURATION	85-year-old	amod	6	SENT_53	[p2l831t2680r1210b2756],
6	female	JJ	O	female	_	0	SENT_53	[p2l1242t2680r1461b2739],
7	Caucasian	JJ	MISC	caucasian	amod	6	SENT_53	[p2l1494t2680r1831b2740],
8	who	WP	O	who	nsubj	9	SENT_53	[p2l1859t2680r2000b2739],
9	had	VBD	O	have	rcmod	6	SENT_53	[p2l2031t2680r2151b2739],
10	hip	NN	O	hip	nn	11	SENT_53	[p2l53t2779r156b2855],
11	surgery	NN	O	surgery	dobj	9	SENT_53	[p2l204t2799r457b2855],
12	.	.	O	.	_	0	SENT_53	[p2l204t2799r457b2855],

1	She	PRP	O	she	nsubj	2	SENT_54	[p2l510t2779r628b2838],
2	had	VBD	O	have	_	0	SENT_54	[p2l672t2779r792b2838],
3	a	DT	O	a	det	5	SENT_54	[p2l837t2799r871b2838],
4	long	JJ	O	long	amod	5	SENT_54	[p2l915t2779r1059b2855],
5	history	NN	O	history	dobj	2	SENT_54	[p2l1103t2779r1332b2855],
6	of	IN	O	of	_	0	SENT_54	[p2l1377t2779r1453b2838],
7	codeine	NN	O	codeine	nn	8	SENT_54	[p2l1488t2779r1741b2838],
8	intolerance	NN	O	intolerance	prep_of	5	SENT_54	[p2l1788t2779r2149b2838],
9	resulting	VBG	O	result	partmod	8	SENT_54	[p2l53t2878r339b2954],
10	in	IN	O	in	_	0	SENT_54	[p2l362t2878r424b2936],
11	nausea	NN	O	nausea	prep_in	9	SENT_54	[p2l443t2897r668b2937],
12	and	CC	O	and	_	0	SENT_54	[p2l689t2878r807b2937],
13	vomiting	NN	O	vomiting	conj_and	11	SENT_54	[p2l826t2878r1139b2954],
14	.	.	O	.	_	0	SENT_54	[p2l826t2878r1139b2954],

1	Codeine	NNP	O	Codeine	nsubjpass	4	SENT_55	[p2l1167t2878r1438b2937],
2	was	VBD	O	be	auxpass	4	SENT_55	[p2l1460t2897r1585b2937],
3	even	RB	O	even	advmod	4	SENT_55	[p2l1610t2897r1763b2937],
4	noted	VBN	O	note	_	0	SENT_55	[p2l1783t2878r1967b2937],
5	as	IN	O	as	_	0	SENT_55	[p2l1988t2897r2051b2937],
6	an	DT	O	a	det	7	SENT_55	[p2l2076t2897r2151b2936],
7	allergy	NN	O	allergy	prep_as	4	SENT_55	[p2l55t2977r280b3052],
8	on	IN	O	on	_	0	SENT_55	[p2l304t2996r384b3036],
9	her	PRP$	O	she	poss	10	SENT_55	[p2l406t2977r512b3036],
10	chart	NN	O	chart	prep_on	7	SENT_55	[p2l535t2977r711b3036],
11	.	.	O	.	_	0	SENT_55	[p2l535t2977r711b3036],

1	After	IN	O	after	_	0	SENT_56	[p2l738t2977r912b3036],
2	the	DT	O	the	det	3	SENT_56	[p2l933t2977r1031b3036],
3	problems	NNS	O	problem	prep_after	5	SENT_56	[p2l1054t2977r1360b3052],
4	she	PRP	O	she	nsubj	5	SENT_56	[p2l1387t2977r1492b3036],
5	had	VBD	O	have	_	0	SENT_56	[p2l1516t2977r1635b3036],
6	during	IN	O	during	_	0	SENT_56	[p2l1658t2977r1871b3052],
7	her	PRP$	O	she	poss	8	SENT_56	[p2l1894t2977r2000b3036],
8	first	JJ	ORDINAL	first	prep_during	5	SENT_56	[p2l2023t2977r2151b3036],

1	MT	NNP	O	MT	nn	2	SENT_57	[p2l179t3128r237b3151],
2	Susce	NNP	O	Susce	_	0	SENT_57	[p2l251t3128r326b3151],
3	et	FW	O	et	nn	4	SENT_57	[p2l338t3131r361b3151],
4	al.	FW	O	al.	dep	2	SENT_57	[p2l372t3127r401b3151],
5	/	:	O	/	punct	2	SENT_57	[p2l415t3127r429b3151],
6	Progress	NNP	O	Progress	dep	2	SENT_57	[p2l435t3128r552b3158],
7	in	IN	O	in	_	0	SENT_57	[p2l565t3129r588b3151],
8	Neuro-Psychopharmacology	NNP	ORGANIZATION	Neuro-Psychopharmacology	nn	11	SENT_57	[p2l600t3127r978b3158],
9	&	CC	ORGANIZATION	&	_	0	SENT_57	[p2l990t3128r1013b3151],
10	Biological	NNP	ORGANIZATION	Biological	nn	11	SENT_57	[p2l1025t3127r1163b3158],
11	Psychiatry	NNP	ORGANIZATION	Psychiatry	prep_in	6	SENT_57	[p2l1173t3127r1313b3158],
12	30	CD	NUMBER	30	number	13	SENT_57	[p2l1326t3128r1358b3151],
13	(	CD	NUMBER	(	dep	11	SENT_57	[p2l1371t3127r1455b3158],
14	2006	CD	DATE	2006	num	15	SENT_57	[p2l1371t3127r1455b3158],
15	)	CD	NUMBER	)	dep	11	SENT_57	[p2l1371t3127r1455b3158],
16	13564358	CD	NUMBER	13564358	number	17	SENT_57	[p2l1469t3128r1616b3151],
17	1357	CD	DATE	1357	dep	15	SENT_57	[p2l1920t3128r1981b3151],

1	admission	NN	O	admission	nsubj	4	SENT_58	[p2l9t3311r365b3384],
2	,	,	O	,	_	0	SENT_58	[p2l9t3311r365b3384],
3	she	PRP	O	she	nsubj	4	SENT_58	[p2l407t3311r514b3372],
4	agreed	VBD	O	agree	_	0	SENT_58	[p2l552t3311r773b3389],
5	to	TO	O	to	aux	6	SENT_58	[p2l808t3319r870b3372],
6	sign	VB	O	sign	xcomp	4	SENT_58	[p2l910t3311r1047b3389],
7	a	DT	O	a	det	9	SENT_58	[p2l1084t3331r1119b3371],
8	consent	NN	O	consent	nn	9	SENT_58	[p2l1155t3319r1410b3372],
9	form	NN	O	form	dobj	6	SENT_58	[p2l1447t3311r1607b3372],
10	for	IN	O	for	_	0	SENT_58	[p2l1643t3311r1739b3372],
11	one	CD	NUMBER	one	prep_for	6	SENT_58	[p2l1774t3331r1892b3372],
12	of	IN	O	of	_	0	SENT_58	[p2l1930t3311r2007b3372],
13	our	PRP$	O	we	poss	14	SENT_58	[p2l2034t3330r2146b3372],
14	studies	NNS	O	study	prep_of	11	SENT_58	[p2l10t3412r237b3473],
15	and	CC	O	and	_	0	SENT_58	[p2l277t3412r396b3473],
16	be	VB	O	be	auxpass	17	SENT_58	[p2l430t3412r509b3473],
17	genotyped	VBN	O	genotype	xcomp	4	SENT_58	[p2l547t3412r897b3490],
18	for	IN	O	for	_	0	SENT_58	[p2l934t3413r1030b3473],
19	CYP2D6	NN	O	cyp2d6	prep_for	17	SENT_58	[p2l1066t3414r1389b3473],
20	.	.	O	.	_	0	SENT_58	[p2l1066t3414r1389b3473],

1	Her	PRP$	O	she	poss	2	SENT_59	[p2l1430t3415r1556b3473],
2	genotype	NN	O	genotype	nsubj	16	SENT_59	[p2l1590t3421r1896b3490],
3	in	IN	O	in	_	0	SENT_59	[p2l1934t3413r1997b3472],
4	our	PRP$	O	we	poss	8	SENT_59	[p2l2034t3432r2146b3473],
5	laboratory	NN	O	laboratory	nn	8	SENT_59	[p2l9t3513r351b3591],
6	(	FW	O	(	nn	8	SENT_59	[p2l380t3513r482b3590],
7	de	FW	O	de	nn	8	SENT_59	[p2l380t3513r482b3590],
8	Leon	NNP	O	Leon	prep_in	2	SENT_59	[p2l511t3516r683b3574],
9	et	FW	O	et	nn	10	SENT_59	[p2l712t3521r769b3574],
10	al.	FW	O	al.	dep	2	SENT_59	[p2l797t3513r892b3586],
11	,	,	O	,	_	0	SENT_59	[p2l797t3513r892b3586],
12	2005	CD	DATE	2005	num	13	SENT_59	[p2l924t3513r1117b3590],
13	)	NN	O	)	appos	2	SENT_59	[p2l924t3513r1117b3590],
14	was	VBD	O	be	cop	16	SENT_59	[p2l1145t3533r1273b3574],
15	CYP2D6	NNP	O	CYP2D6	nn	16	SENT_59	[p2l1305t3514r1609b3574],
16	PM	NNP	O	PM	_	0	SENT_59	[p2l1639t3516r1759b3573],
17	(	CD	NUMBER	(	num	16	SENT_59	[p2l1789t3513r1922b3590],
18	*	CD	NUMBER	*	number	19	SENT_59	[p2l1789t3513r1922b3590],
19	4	CD	NUMBER	4	amod	16	SENT_59	[p2l1789t3513r1922b3590],
20	/	:	O	/	punct	21	SENT_59	[p2l1789t3513r1922b3590],
21	*	CD	NUMBER	*	dep	19	SENT_59	[p2l1927t3513r2049b3590],
22	6	CD	NUMBER	6	num	23	SENT_59	[p2l1927t3513r2049b3590],
23	)	NN	O	)	dep	21	SENT_59	[p2l1927t3513r2049b3590],
24	.	.	O	.	_	0	SENT_59	[p2l1927t3513r2049b3590],

1	3	LS	NUMBER	3	_	0	SENT_60	[p2l7t3718r70b3777],
2	.	.	O	.	_	0	SENT_60	[p2l7t3718r70b3777],

1	Results	NNS	O	result	_	0	SENT_61	[p2l105t3719r362b3776],

1	3.1	CD	NUMBER	3.1	_	0	SENT_62	[p3l9t122r124b181],
2	.	.	O	.	_	0	SENT_62	[p3l9t122r124b181],

1	First	JJ	ORDINAL	first	amod	2	SENT_63	[p3l160t123r327b181],
2	admission	NN	O	admission	_	0	SENT_63	[p3l355t121r692b181],

1	The	DT	O	the	det	2	SENT_64	[p3l110t324r237b385],
2	patient	NN	O	patient	nsubjpass	10	SENT_64	[p3l265t324r494b402],
3	fractured	VBD	O	fracture	_	0	SENT_64	[p3l523t324r821b385],
4	her	PRP$	O	she	poss	6	SENT_64	[p3l849t324r957b385],
5	right	JJ	O	right	amod	6	SENT_64	[p3l982t324r1140b402],
6	hip	NN	O	hip	dobj	3	SENT_64	[p3l1166t324r1291b401],
7	,	,	O	,	_	0	SENT_64	[p3l1166t324r1291b401],
8	and	CC	O	and	_	0	SENT_64	[p3l1324t324r1444b385],
9	was	VBD	O	be	auxpass	10	SENT_64	[p3l1470t343r1598b385],
10	transferred	VBN	O	transfer	conj_and	3	SENT_64	[p3l1628t324r1989b385],
11	to	TO	O	to	_	0	SENT_64	[p3l2016t332r2078b385],
12	a	DT	O	a	det	14	SENT_64	[p3l2110t344r2145b384],
13	rehabilitation	NN	O	rehabilitation	nn	14	SENT_64	[p3l7t426r452b487],
14	hospital	NN	O	hospital	prep_to	10	SENT_64	[p3l480t426r745b504],
15	after	IN	O	after	mark	19	SENT_64	[p3l776t427r927b487],
16	stabilization	NN	O	stabilization	nn	17	SENT_64	[p3l956t426r1361b487],
17	pins	NNS	O	pin	nsubjpass	19	SENT_64	[p3l1388t426r1527b504],
18	were	VBD	O	be	auxpass	19	SENT_64	[p3l1556t446r1717b487],
19	placed	VBN	O	place	advcl	10	SENT_64	[p3l1745t426r1981b504],
20	.	.	O	.	_	0	SENT_64	[p3l1745t426r1981b504],

1	The	DT	O	the	det	3	SENT_65	[p3l2016t426r2142b487],
2	rehabilitation	NN	O	rehabilitation	nn	3	SENT_65	[p3l7t528r453b589],
3	process	NN	O	process	nsubjpass	5	SENT_65	[p3l477t548r728b606],
4	was	VBD	O	be	auxpass	5	SENT_65	[p3l755t548r883b589],
5	complicated	VBN	O	complicate	_	0	SENT_65	[p3l912t528r1320b606],
6	by	IN	O	by	_	0	SENT_65	[p3l1345t528r1430b606],
7	multiple	JJ	O	multiple	amod	8	SENT_65	[p3l1456t528r1733b606],
8	episodes	NNS	O	episode	agent	5	SENT_65	[p3l1762t528r2047b606],
9	of	IN	O	of	_	0	SENT_65	[p3l2077t528r2154b589],
10	nausea	NN	O	nausea	prep_of	8	SENT_65	[p3l7t649r236b691],
11	and	CC	O	and	_	0	SENT_65	[p3l281t630r400b691],
12	vomiting	VBG	O	vomit	prep_of	8	SENT_65	[p3l442t630r745b708],
13	during	IN	O	during	_	0	SENT_65	[p3l791t630r1008b708],
14	oxycodone	NN	O	oxycodone	nn	15	SENT_65	[p3l1053t630r1421b708],
15	treatment	NN	O	treatment	prep_during	10	SENT_65	[p3l1466t638r1797b691],
16	.	.	O	.	_	0	SENT_65	[p3l1466t638r1797b691],

1	She	PRP	O	she	nsubjpass	3	SENT_66	[p3l1849t630r1969b691],
2	was	VBD	O	be	auxpass	3	SENT_66	[p3l2014t650r2141b691],
3	threatened	VBN	O	threaten	_	0	SENT_66	[p3l7t732r356b793],
4	with	IN	O	with	_	0	SENT_66	[p3l385t732r534b793],
5	discharge	NN	O	discharge	prep_with	3	SENT_66	[p3l567t732r885b810],
6	due	JJ	O	due	_	0	SENT_66	[p3l918t732r1035b793],
7	to	TO	O	to	_	0	SENT_66	[p3l1068t741r1129b793],
8	noncompliance	NN	O	noncompliance	prep_due_to	3	SENT_66	[p3l1162t732r1675b810],
9	at	IN	O	at	_	0	SENT_66	[p3l1709t741r1767b793],
10	one	CD	NUMBER	one	num	11	SENT_66	[p3l1798t752r1916b793],
11	point	NN	O	point	prep_at	8	SENT_66	[p3l1947t732r2140b810],
12	;	:	O	;	_	0	SENT_66	[p3l1947t732r2140b810],
13	the	DT	O	the	det	14	SENT_66	[p3l7t834r107b895],
14	family	NN	O	family	nsubj	15	SENT_66	[p3l138t834r353b912],
15	had	VBD	O	have	parataxis	3	SENT_66	[p3l380t834r502b895],
16	to	TO	O	to	aux	17	SENT_66	[p3l529t843r591b895],
17	intervene	VB	O	intervene	xcomp	15	SENT_66	[p3l622t834r947b895],
18	.	.	O	.	_	0	SENT_66	[p3l622t834r947b895],

1	The	DT	O	the	det	2	SENT_67	[p3l982t834r1109b895],
2	experience	NN	O	experience	nsubj	5	SENT_67	[p3l1139t834r1498b912],
3	was	VBD	O	be	cop	5	SENT_67	[p3l1527t854r1655b895],
4	very	RB	O	very	advmod	5	SENT_67	[p3l1684t854r1832b912],
5	negative	JJ	O	negative	_	0	SENT_67	[p3l1860t834r2142b912],
6	to	TO	O	to	_	0	SENT_67	[p3l7t944r69b997],
7	the	DT	O	the	det	8	SENT_67	[p3l92t936r191b997],
8	patient	NN	O	patient	prep_to	5	SENT_67	[p3l212t936r458b1013],
9	,	,	O	,	_	0	SENT_67	[p3l212t936r458b1013],
10	who	WP	O	who	nsubj	11	SENT_67	[p3l482t936r625b997],
11	lost	VBD	O	lose	rcmod	8	SENT_67	[p3l649t936r768b997],
12	20	CD	NUMBER	20	num	13	SENT_67	[p3l789t937r870b996],
13	lb	NN	O	lb	dobj	11	SENT_67	[p3l894t936r954b997],
14	during	IN	O	during	_	0	SENT_67	[p3l979t936r1195b1014],
15	her	PRP$	O	she	poss	17	SENT_67	[p3l1216t936r1324b997],
16	17-day	JJ	DURATION	17-day	amod	17	SENT_67	[p3l1352t936r1576b1014],
17	admission	NN	O	admission	prep_during	11	SENT_67	[p3l1599t936r1937b997],
18	to	TO	O	to	_	0	SENT_67	[p3l1957t944r2019b997],
19	the	DT	O	the	det	21	SENT_67	[p3l2042t936r2142b997],
20	rehabilitation	NN	O	rehabilitation	nn	21	SENT_67	[p3l7t1038r453b1098],
21	hospital	NN	O	hospital	prep_to	11	SENT_67	[p3l501t1038r783b1115],
22	.	.	O	.	_	0	SENT_67	[p3l501t1038r783b1115],

1	Her	PRP$	O	she	poss	2	SENT_68	[p3l838t1040r964b1098],
2	medications	NNS	O	medication	nsubj	3	SENT_68	[p3l1011t1038r1414b1098],
3	included	VBD	O	include	_	0	SENT_68	[p3l1467t1038r1755b1098],
4	nifedipine	NN	O	nifedipine	dobj	3	SENT_68	[p3l1804t1038r2142b1115],
5	sustained	JJ	O	sustained	amod	10	SENT_68	[p3l10t1140r319b1201],
6	release	NN	O	release	nn	10	SENT_68	[p3l344t1140r573b1201],
7	(	NN	O	(	nn	10	SENT_68	[p3l602t1140r751b1217],
8	240	CD	NUMBER	240	num	10	SENT_68	[p3l602t1140r751b1217],
9	mg/day	JJ	O	mg/day	amod	10	SENT_68	[p3l778t1140r1075b1218],
10	)	NN	O	)	dep	4	SENT_68	[p3l778t1140r1075b1218],
11	,	,	O	,	_	0	SENT_68	[p3l778t1140r1075b1218],
12	doxazosin	NN	O	doxazosin	nn	13	SENT_68	[p3l1106t1140r1446b1201],
13	(	NN	O	(	dobj	3	SENT_68	[p3l1473t1140r1537b1217],
14	4	CD	NUMBER	4	num	16	SENT_68	[p3l1473t1140r1537b1217],
15	mg/day	NN	O	mg/day	nn	16	SENT_68	[p3l1564t1140r1861b1218],
16	)	NN	O	)	dep	13	SENT_68	[p3l1564t1140r1861b1218],
17	,	,	O	,	_	0	SENT_68	[p3l1564t1140r1861b1218],
18	entericcoated	JJ	O	entericcoated	amod	20	SENT_68	[p3l1892t1140r2142b1201, p3l9t1242r226b1303],
19	aspirin	NN	O	aspirin	nn	20	SENT_68	[p3l262t1242r488b1320],
20	(	NN	O	(	conj_and	4	SENT_68	[p3l525t1243r624b1320],
21	81	CD	NUMBER	81	num	23	SENT_68	[p3l525t1243r624b1320],
22	mg/day	NN	O	mg/day	nn	23	SENT_68	[p3l669t1242r966b1320],
23	)	NN	O	)	dep	20	SENT_68	[p3l669t1242r966b1320],
24	,	,	O	,	_	0	SENT_68	[p3l669t1242r966b1320],
25	hydrochlorothiazide	NN	O	hydrochlorothiazide	dobj	3	SENT_68	[p3l1005t1242r1681b1320],
26	(	CD	NUMBER	(	number	27	SENT_68	[p3l1721t1243r1824b1320],
27	25	CD	NUMBER	25	num	29	SENT_68	[p3l1721t1243r1824b1320],
28	mg/day	NN	O	mg/day	nn	29	SENT_68	[p3l1864t1242r2142b1320],
29	)	NN	O	)	dep	25	SENT_68	[p3l1864t1242r2142b1320],
30	and	CC	O	and	_	0	SENT_68	[p3l9t1344r128b1405],
31	loratadine	NN	O	loratadine	conj_and	4	SENT_68	[p3l162t1344r493b1405],
32	(	CD	NUMBER	(	number	33	SENT_68	[p3l529t1344r635b1421],
33	10	CD	NUMBER	10	num	35	SENT_68	[p3l529t1344r635b1421],
34	mg/day	NN	O	mg/day	nn	35	SENT_68	[p3l670t1344r965b1422],
35	)	NN	O	)	dep	31	SENT_68	[p3l670t1344r965b1422],
36	.	.	O	.	_	0	SENT_68	[p3l670t1344r965b1422],

1	Loratadine	NN	O	loratadine	nsubjpass	3	SENT_69	[p3l1003t1344r1364b1405],
2	is	VBZ	O	be	auxpass	3	SENT_69	[p3l1400t1344r1450b1405],
3	metabolized	VBN	O	metabolize	_	0	SENT_69	[p3l1484t1344r1894b1405],
4	by	IN	O	by	_	0	SENT_69	[p3l1925t1344r2010b1422],
5	the	DT	O	the	det	7	SENT_69	[p3l2042t1344r2142b1405],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_69	[p3l9t1446r402b1524],
7	P450	NN	O	p450	agent	3	SENT_69	[p3l449t1447r620b1506],
8	3A	NN	O	3a	nn	11	SENT_69	[p3l670t1447r770b1506],
9	(	CD	NUMBER	(	num	11	SENT_69	[p3l818t1446r1135b1523],
10	CYP3A	NN	O	cyp3a	nn	11	SENT_69	[p3l818t1446r1135b1523],
11	)	NN	O	)	dep	7	SENT_69	[p3l818t1446r1135b1523],
12	and	CC	O	and	_	0	SENT_69	[p3l1185t1446r1305b1507],
13	has	VBZ	O	have	conj_and	3	SENT_69	[p3l1350t1446r1459b1507],
14	a	DT	O	a	det	17	SENT_69	[p3l1509t1466r1544b1506],
15	minor	JJ	O	minor	amod	17	SENT_69	[p3l1589t1446r1790b1507],
16	CYP2D6	NN	O	cyp2d6	nn	17	SENT_69	[p3l1836t1447r2140b1507],
17	component	NN	O	component	dobj	13	SENT_69	[p3l9t1557r397b1626],
18	.	.	O	.	_	0	SENT_69	[p3l9t1557r397b1626],

1	None	NN	O	none	nsubj	6	SENT_70	[p3l440t1551r623b1609],
2	of	IN	O	of	_	0	SENT_70	[p3l667t1549r744b1609],
3	the	DT	O	the	det	5	SENT_70	[p3l774t1548r874b1609],
4	other	JJ	O	other	amod	5	SENT_70	[p3l917t1548r1088b1609],
5	drugs	NNS	O	drug	prep_of	1	SENT_70	[p3l1129t1548r1312b1626],
6	appeared	VBD	O	appear	_	0	SENT_70	[p3l1356t1548r1656b1626],
7	to	TO	O	to	aux	8	SENT_70	[p3l1697t1557r1759b1609],
8	have	VB	O	have	xcomp	6	SENT_70	[p3l1801t1548r1958b1609],
9	substantial	JJ	O	substantial	amod	11	SENT_70	[p3l2003t1548r2142b1609, p3l10t1650r246b1710],
10	CYP2D6	NN	O	cyp2d6	nn	11	SENT_70	[p3l281t1652r585b1710],
11	involvement	NN	O	involvement	dobj	8	SENT_70	[p3l621t1650r1041b1710],
12	in	IN	O	in	_	0	SENT_70	[p3l1072t1650r1135b1709],
13	their	PRP$	O	they	poss	14	SENT_70	[p3l1166t1650r1319b1710],
14	metabolism	NN	O	metabolism	prep_in	11	SENT_70	[p3l1349t1650r1756b1710],
15	.	.	O	.	_	0	SENT_70	[p3l1349t1650r1756b1710],

1	Combined	VBN	O	combine	amod	2	SENT_71	[p3l1794t1650r2144b1710],
2	oxycodone	NN	O	oxycodone	nsubjpass	6	SENT_71	[p3l9t1751r371b1829],
3	and	CC	O	and	_	0	SENT_71	[p3l392t1751r509b1812],
4	acetaminophen	NN	O	acetaminophen	nsubjpass	6	SENT_71	[p3l529t1751r1027b1828],
5	was	VBD	O	be	auxpass	6	SENT_71	[p3l1044t1770r1171b1812],
6	used	VBN	O	use	_	0	SENT_71	[p3l1190t1751r1344b1812],
7	as	IN	O	as	_	0	SENT_71	[p3l1363t1771r1427b1812],
8	an	DT	O	a	det	9	SENT_71	[p3l1449t1770r1525b1811],
9	analgesic	JJ	O	analgesic	prep_as	6	SENT_71	[p3l1545t1751r1863b1829],
10	.	.	O	.	_	0	SENT_71	[p3l1545t1751r1863b1829],

1	Initially	RB	O	initially	advmod	2	SENT_72	[p3l1887t1751r2144b1829],
2	prescribed	VBN	O	prescribe	dep	22	SENT_72	[p3l6t1853r350b1930],
3	at	IN	O	at	_	0	SENT_72	[p3l375t1861r432b1913],
4	5	CD	NUMBER	5	num	5	SENT_72	[p3l458t1855r490b1913],
5	mg	NN	O	mg	prep_at	2	SENT_72	[p3l520t1872r625b1930],
6	of	IN	O	of	_	0	SENT_72	[p3l652t1853r729b1913],
7	oxycodone	NN	O	oxycodone	prep_of	5	SENT_72	[p3l744t1853r1105b1930],
8	and	CC	O	and	_	0	SENT_72	[p3l1132t1853r1250b1913],
9	500	CD	NUMBER	500	num	10	SENT_72	[p3l1277t1854r1396b1913],
10	mg	NN	O	mg	conj_and	5	SENT_72	[p3l1422t1872r1528b1930],
11	of	IN	O	of	_	0	SENT_72	[p3l1554t1853r1631b1913],
12	acetaminophen	NN	O	acetaminophen	prep_of	10	SENT_72	[p3l1646t1853r2144b1930],
13	(	CD	NUMBER	(	number	14	SENT_72	[p3l9t1955r247b2032],
14	5/500	CD	NUMBER	5/500	num	15	SENT_72	[p3l9t1955r247b2032],
15	)	NN	O	)	dobj	2	SENT_72	[p3l9t1955r247b2032],
16	every	DT	O	every	det	18	SENT_72	[p3l278t1975r459b2033],
17	12	CD	NUMBER	12	num	18	SENT_72	[p3l494t1956r566b2015],
18	h	NN	O	h	dep	15	SENT_72	[p3l595t1955r654b2028],
19	,	,	O	,	_	0	SENT_72	[p3l595t1955r654b2028],
20	it	PRP	O	it	nsubjpass	22	SENT_72	[p3l686t1955r730b2015],
21	was	VBD	O	be	auxpass	22	SENT_72	[p3l755t1975r881b2016],
22	increased	VBN	O	increase	_	0	SENT_72	[p3l912t1955r1220b2016],
23	to	TO	O	to	_	0	SENT_72	[p3l1247t1963r1309b2016],
24	10/1000	CD	NUMBER	10/1000	num	27	SENT_72	[p3l1347t1955r1607b2016],
25	every	DT	O	every	det	27	SENT_72	[p3l1639t1974r1819b2033],
26	12	CD	NUMBER	12	num	27	SENT_72	[p3l1855t1956r1926b2015],
27	h	NN	O	h	prep_to	22	SENT_72	[p3l1956t1955r1997b2015],
28	and	CC	O	and	_	0	SENT_72	[p3l2026t1955r2144b2016],
29	then	RB	O	then	advmod	30	SENT_72	[p3l7t2057r150b2118],
30	7.5	CD	NUMBER	7.5	conj_and	27	SENT_72	[p3l171t2057r417b2118],
31	/	:	O	/	punct	32	SENT_72	[p3l171t2057r417b2118],
32	750	CD	NUMBER	750	dep	22	SENT_72	[p3l171t2057r417b2118],
33	every	DT	O	every	det	35	SENT_72	[p3l441t2077r621b2135],
34	6	CD	NUMBER	6	num	35	SENT_72	[p3l644t2059r680b2118],
35	h.	NN	O	h.	nsubjpass	41	SENT_72	[p3l702t2057r759b2118],
36	Finally	RB	O	finally	advmod	41	SENT_72	[p3l784t2057r1016b2135],
37	the	DT	O	the	det	38	SENT_72	[p3l1035t2057r1134b2118],
38	dose	NN	O	dose	nsubjpass	41	SENT_72	[p3l1157t2057r1306b2118],
39	was	VBD	O	be	auxpass	41	SENT_72	[p3l1325t2077r1452b2118],
40	slowly	RB	O	slowly	advmod	41	SENT_72	[p3l1477t2057r1695b2135],
41	reduced	VBN	O	reduce	rcmod	32	SENT_72	[p3l1713t2057r1975b2118],
42	until	IN	O	until	mark	45	SENT_72	[p3l1993t2057r2143b2118],
43	she	PRP	O	she	nsubjpass	45	SENT_72	[p3l10t2159r116b2220],
44	was	VBD	O	be	auxpass	45	SENT_72	[p3l154t2179r281b2220],
45	discharged	VBN	O	discharge	advcl	22	SENT_72	[p3l323t2159r677b2237],
46	on	IN	O	on	_	0	SENT_72	[p3l717t2179r799b2220],
47	5/500	CD	NUMBER	5/500	prep_on	45	SENT_72	[p3l840t2159r1023b2220],
48	every	DT	O	every	det	51	SENT_72	[p3l1066t2179r1246b2237],
49	12	CD	NUMBER	12	num	51	SENT_72	[p3l1293t2161r1364b2219],
50	h.	NN	O	h.	nn	51	SENT_72	[p3l1405t2159r1462b2220],
51	Analgesia	NN	O	analgesia	nsubjpass	54	SENT_72	[p3l1504t2159r1835b2237],
52	was	VBD	O	be	auxpass	54	SENT_72	[p3l1872t2179r1999b2220],
53	not	RB	O	not	neg	54	SENT_72	[p3l2038t2167r2145b2220],
54	achieved	VBN	O	achieve	rcmod	47	SENT_72	[p3l9t2261r318b2334],
55	;	:	O	;	_	0	SENT_72	[p3l9t2261r318b2334],
56	she	PRP	O	she	nsubj	57	SENT_72	[p3l360t2261r466b2322],
57	received	VBD	O	receive	parataxis	22	SENT_72	[p3l503t2261r782b2322],
58	several	JJ	O	several	amod	59	SENT_72	[p3l819t2261r1046b2322],
59	doses	NNS	O	dose	dobj	57	SENT_72	[p3l1084t2261r1264b2322],
60	of	IN	O	of	_	0	SENT_72	[p3l1304t2261r1381b2322],
61	tramadol	NN	O	tramadol	nn	64	SENT_72	[p3l1405t2261r1697b2322],
62	100	CD	NUMBER	100	num	64	SENT_72	[p3l1742t2262r1855b2321],
63	mg	NN	O	mg	nn	64	SENT_72	[p3l1893t2281r1999b2339],
64	pm	NN	O	pm	prep_of	59	SENT_72	[p3l2033t2280r2144b2338],
65	every	DT	O	every	det	67	SENT_72	[p3l9t2383r190b2441],
66	6	CD	NUMBER	6	num	67	SENT_72	[p3l219t2365r255b2424],
67	h	NN	O	h	npadvmod	57	SENT_72	[p3l284t2363r325b2423],
68	during	IN	O	during	_	0	SENT_72	[p3l353t2363r567b2441],
69	the	DT	O	the	det	70	SENT_72	[p3l594t2363r692b2424],
70	admission	NN	O	admission	prep_during	57	SENT_72	[p3l723t2363r1071b2424],
71	.	.	O	.	_	0	SENT_72	[p3l723t2363r1071b2424],

1	She	PRP	O	she	nsubj	3	SENT_73	[p3l1106t2363r1224b2424],
2	also	RB	O	also	advmod	3	SENT_73	[p3l1255t2363r1383b2424],
3	received	VBD	O	receive	_	0	SENT_73	[p3l1411t2363r1690b2424],
4	several	JJ	O	several	amod	5	SENT_73	[p3l1719t2363r1946b2424],
5	treatments	NNS	O	treatment	dobj	3	SENT_73	[p3l1973t2372r2142b2424, p3l7t2474r201b2526],
6	for	IN	O	for	_	0	SENT_73	[p3l232t2465r326b2526],
7	nausea/vomiting	VBG	O	nausea/vomiting	prepc_for	3	SENT_73	[p3l350t2465r894b2543],
8	including	VBG	O	include	_	0	SENT_73	[p3l923t2465r1232b2543],
9	pms	NNS	O	pm	prep_including	7	SENT_73	[p3l1258t2485r1399b2543],
10	of	IN	O	of	_	0	SENT_73	[p3l1428t2465r1505b2526],
11	aluminum	NN	O	aluminum	nn	12	SENT_73	[p3l1523t2465r1857b2526],
12	hydroxide	NN	O	hydroxide	prep_of	9	SENT_73	[p3l1882t2465r2142b2543, p3l9t2567r106b2628],
13	and	CC	O	and	_	0	SENT_73	[p3l135t2567r253b2628],
14	magnesium	NN	O	magnesium	nn	15	SENT_73	[p3l279t2567r661b2645],
15	hydroxide	NN	O	hydroxide	conj_and	12	SENT_73	[p3l686t2567r1039b2645],
16	,	,	O	,	_	0	SENT_73	[p3l686t2567r1039b2645],
17	promethazine	NN	O	promethazine	conj_and	12	SENT_73	[p3l1067t2567r1534b2644],
18	,	,	O	,	_	0	SENT_73	[p3l1067t2567r1534b2644],
19	and	CC	O	and	_	0	SENT_73	[p3l1565t2567r1683b2628],
20	three	CD	DURATION	three	num	21	SENT_73	[p3l1709t2567r1870b2628],
21	days	NNS	NUMBER	day	conj_and	12	SENT_73	[p3l1900t2567r2048b2645],
22	of	IN	O	of	_	0	SENT_73	[p3l2077t2567r2154b2628],
23	unsuccessful	JJ	O	unsuccessful	amod	24	SENT_73	[p3l6t2669r428b2729],
24	treatment	NN	O	treatment	prep_of	21	SENT_73	[p3l473t2677r783b2729],
25	with	IN	O	with	_	0	SENT_73	[p3l827t2669r975b2730],
26	ranitidine	NN	O	ranitidine	prep_with	24	SENT_73	[p3l1019t2669r1348b2730],
27	.	.	O	.	_	0	SENT_73	[p3l1019t2669r1348b2730],

1	Finally	RB	O	finally	advmod	5	SENT_74	[p3l1399t2669r1643b2746],
2	,	,	O	,	_	0	SENT_74	[p3l1399t2669r1643b2746],
3	she	PRP	O	she	nsubjpass	5	SENT_74	[p3l1696t2669r1801b2729],
4	was	VBD	O	be	auxpass	5	SENT_74	[p3l1847t2688r1974b2729],
5	discharged	VBN	O	discharge	_	0	SENT_74	[p3l2023t2669r2142b2729, p3l9t2771r268b2849],
6	on	IN	O	on	_	0	SENT_74	[p3l301t2790r383b2832],
7	famotidine	NN	O	famotidine	nn	9	SENT_74	[p3l418t2771r771b2832],
8	80	CD	NUMBER	80	num	9	SENT_74	[p3l808t2772r885b2831],
9	mg/day	NN	O	mg/day	prep_on	5	SENT_74	[p3l920t2771r1169b2849],
10	to	TO	O	to	aux	11	SENT_74	[p3l1201t2779r1263b2832],
11	try	VB	O	try	xcomp	5	SENT_74	[p3l1297t2779r1388b2849],
12	to	TO	O	to	aux	13	SENT_74	[p3l1420t2779r1483b2832],
13	control	VB	O	control	xcomp	11	SENT_74	[p3l1519t2771r1749b2832],
14	her	PRP$	O	she	poss	15	SENT_74	[p3l1782t2771r1889b2832],
15	nausea	NN	O	nausea	dobj	13	SENT_74	[p3l1919t2790r2145b2832],
16	associated	VBN	O	associate	partmod	15	SENT_74	[p3l9t2873r346b2934],
17	with	IN	O	with	_	0	SENT_74	[p3l370t2873r517b2934],
18	oxycodone	NN	O	oxycodone	nn	19	SENT_74	[p3l544t2873r905b2951],
19	treatment	NN	O	treatment	prep_with	16	SENT_74	[p3l933t2882r1257b2934],
20	.	.	O	.	_	0	SENT_74	[p3l933t2882r1257b2934],

1	3.2	CD	NUMBER	3.2	_	0	SENT_75	[p3l9t3078r124b3137],
2	.	.	O	.	_	0	SENT_75	[p3l9t3078r124b3137],

1	Second	JJ	ORDINAL	second	amod	4	SENT_76	[p3l162t3077r410b3138],
2	admission	NN	O	admission	nn	4	SENT_76	[p3l436t3077r773b3137],
3	(	NN	O	(	nn	4	SENT_76	[p3l811t3077r1137b3155],
4	genotype	NN	O	genotype	nsubjpass	6	SENT_76	[p3l811t3077r1137b3155],
5	was	VBD	O	be	auxpass	6	SENT_76	[p3l1167t3098r1296b3138],
6	known	VBN	O	know	_	0	SENT_76	[p3l1327t3077r1571b3154],
7	)	IN	O	)	prep	6	SENT_76	[p3l1327t3077r1571b3154],

1	A	DT	DATE	a	det	2	SENT_77	[p3l109t3282r169b3340],
2	year	NN	DATE	year	tmod	7	SENT_77	[p3l190t3300r334b3358],
3	later	RB	DATE	later	advmod	2	SENT_77	[p3l363t3280r519b3354],
4	,	,	O	,	_	0	SENT_77	[p3l363t3280r519b3354],
5	the	DT	O	the	det	6	SENT_77	[p3l552t3280r651b3341],
6	patient	NN	O	patient	nsubj	7	SENT_77	[p3l680t3280r904b3358],
7	had	VBD	O	have	_	0	SENT_77	[p3l933t3280r1053b3341],
8	a	DT	DURATION	a	det	10	SENT_77	[p3l1084t3300r1119b3341],
9	second	JJ	DURATION	second	amod	10	SENT_77	[p3l1150t3280r1378b3341],
10	surgery	NN	O	surgery	dobj	7	SENT_77	[p3l1409t3300r1652b3358],
11	to	TO	O	to	aux	12	SENT_77	[p3l1681t3289r1743b3341],
12	replace	VB	O	replace	infmod	10	SENT_77	[p3l1774t3280r2009b3358],
13	her	PRP$	O	she	poss	15	SENT_77	[p3l2039t3280r2145b3341],
14	right	JJ	O	right	amod	15	SENT_77	[p3l7t3382r162b3460],
15	hip	NN	O	hip	nsubj	16	SENT_77	[p3l189t3382r292b3459],
16	secondary	JJ	O	secondary	xcomp	12	SENT_77	[p3l326t3382r657b3460],
17	to	TO	O	to	_	0	SENT_77	[p3l685t3390r747b3443],
18	avascular	JJ	O	avascular	amod	19	SENT_77	[p3l778t3382r1088b3443],
19	necrosis	NN	O	necrosis	prep_to	16	SENT_77	[p3l1114t3382r1382b3443],
20	from	IN	O	from	_	0	SENT_77	[p3l1413t3382r1572b3443],
21	the	DT	O	the	det	24	SENT_77	[p3l1598t3382r1697b3443],
22	previous	JJ	O	previous	amod	24	SENT_77	[p3l1725t3382r2009b3459],
23	hip	NN	O	hip	nn	24	SENT_77	[p3l2038t3382r2141b3459],
24	pinning	NN	O	pinning	prep_from	19	SENT_77	[p3l6t3484r275b3561],
25	.	.	O	.	_	0	SENT_77	[p3l6t3484r275b3561],

1	After	IN	O	after	_	0	SENT_78	[p3l304t3484r478b3544],
2	four	CD	DURATION	four	num	3	SENT_78	[p3l503t3484r640b3544],
3	days	NNS	NUMBER	day	prep_after	7	SENT_78	[p3l664t3484r830b3561],
4	,	,	O	,	_	0	SENT_78	[p3l664t3484r830b3561],
5	she	PRP	O	she	nsubjpass	7	SENT_78	[p3l861t3484r967b3544],
6	was	VBD	O	be	auxpass	7	SENT_78	[p3l992t3503r1119b3545],
7	sent	VBN	O	send	_	0	SENT_78	[p3l1148t3492r1279b3544],
8	to	TO	O	to	_	0	SENT_78	[p3l1302t3492r1364b3544],
9	the	DT	O	the	det	12	SENT_78	[p3l1389t3484r1489b3544],
10	same	JJ	O	same	amod	12	SENT_78	[p3l1517t3503r1682b3544],
11	rehabilitation	NN	O	rehabilitation	nn	12	SENT_78	[p3l1707t3484r2145b3544],
12	hospital	NN	O	hospital	prep_to	7	SENT_78	[p3l7t3586r267b3663],
13	for	IN	O	for	_	0	SENT_78	[p3l292t3586r386b3647],
14	16	CD	DURATION	16	num	15	SENT_78	[p3l417t3587r489b3646],
15	days	NNS	NUMBER	day	prep_for	12	SENT_78	[p3l516t3586r681b3664],
16	.	.	O	.	_	0	SENT_78	[p3l516t3586r681b3664],

1	This	DT	O	this	det	2	SENT_79	[p3l711t3586r853b3647],
2	time	NN	O	time	tmod	10	SENT_79	[p3l878t3586r1023b3647],
3	a	DT	O	a	det	5	SENT_79	[p3l1048t3606r1083b3646],
4	family	NN	O	family	nn	5	SENT_79	[p3l1107t3586r1320b3664],
5	member	NN	O	member	nsubj	10	SENT_79	[p3l1342t3586r1615b3647],
6	informed	VBN	O	inform	partmod	5	SENT_79	[p3l1637t3586r1938b3647],
7	about	IN	O	about	_	0	SENT_79	[p3l1963t3586r2145b3647],
8	CYP2D6	NN	O	cyp2d6	nn	9	SENT_79	[p3l9t3690r310b3749],
9	genotyping	NN	O	genotyping	prep_about	6	SENT_79	[p3l358t3689r729b3766],
10	explained	VBD	O	explain	_	0	SENT_79	[p3l775t3688r1094b3766],
11	the	DT	O	the	det	14	SENT_79	[p3l1137t3688r1236b3749],
12	possible	JJ	O	possible	amod	14	SENT_79	[p3l1280t3688r1550b3766],
13	pharmacological	JJ	O	pharmacological	amod	14	SENT_79	[p3l1594t3688r2143b3766],
14	reason	NN	O	reason	dobj	10	SENT_79	[p4l7t39r222b80],
15	for	IN	O	for	_	0	SENT_79	[p4l257t19r351b80],
16	her	PRP$	O	she	poss	18	SENT_79	[p4l382t19r489b80],
17	previous	JJ	O	previous	amod	18	SENT_79	[p4l519t19r803b97],
18	lack	NN	O	lack	prep_for	10	SENT_79	[p4l839t19r975b80],
19	of	IN	O	of	_	0	SENT_79	[p4l1008t19r1085b80],
20	appropriate	JJ	O	appropriate	amod	21	SENT_79	[p4l1110t19r1480b97],
21	response	NN	O	response	prep_of	18	SENT_79	[p4l1514t39r1802b97],
22	to	TO	O	to	_	0	SENT_79	[p4l1835t27r1898b80],
23	opioid	JJ	O	opioid	amod	24	SENT_79	[p4l1934t19r2145b97],
24	analgesics	NNS	O	analgesic	prep_to	10	SENT_79	[p4l9t121r343b199],
25	to	TO	O	to	_	0	SENT_79	[p4l384t129r447b182],
26	the	DT	O	the	det	27	SENT_79	[p4l488t121r587b182],
27	anesthesiologist	NN	O	anesthesiologist	prep_to	10	SENT_79	[p4l630t121r1168b199],
28	.	.	O	.	_	0	SENT_79	[p4l630t121r1168b199],

1	He	PRP	O	he	nsubj	2	SENT_80	[p4l1214t123r1310b182],
2	prescribed	VBD	O	prescribe	_	0	SENT_80	[p4l1349t121r1693b198],
3	tegaserod	NN	O	tegaserod	nsubjpass	18	SENT_80	[p4l1732t121r2064b199],
4	,	,	O	,	_	0	SENT_80	[p4l1732t121r2064b199],
5	a	DT	O	a	det	9	SENT_80	[p4l2110t141r2145b181],
6	serotonin	NN	O	serotonin	nn	9	SENT_80	[p4l10t222r314b283],
7	5-HT4	NN	O	5-ht4	nn	9	SENT_80	[p4l360t225r565b296],
8	receptor	NN	O	receptor	nn	9	SENT_80	[p4l610t231r881b300],
9	agonist	NN	O	agonist	appos	3	SENT_80	[p4l924t223r1177b300],
10	,	,	O	,	_	0	SENT_80	[p4l924t223r1177b300],
11	ahead	RB	O	ahead	_	0	SENT_80	[p4l1226t223r1417b284],
12	of	IN	O	of	_	0	SENT_80	[p4l1462t223r1539b283],
13	time	NN	O	time	prep_ahead_of	3	SENT_80	[p4l1571t223r1716b283],
14	and	CC	O	and	_	0	SENT_80	[p4l1762t223r1880b283],
15	hydrocodone/acetaminophen	NN	O	hydrocodone/acetaminophen	prep_ahead_of	3	SENT_80	[p4l1923t223r2143b300, p4l9t325r770b403],
16	5/500	CD	NUMBER	5/500	num	15	SENT_80	[p4l792t325r975b386],
17	was	VBD	O	be	auxpass	18	SENT_80	[p4l997t345r1124b386],
18	used	VBN	O	use	ccomp	2	SENT_80	[p4l1145t325r1299b386],
19	for	IN	O	for	_	0	SENT_80	[p4l1320t325r1414b386],
20	analgesia	NN	O	analgesia	prep_for	18	SENT_80	[p4l1434t325r1738b403],
21	4-5	CD	NUMBER	4-5	num	22	SENT_80	[p4l1758t327r1885b386],
22	times	NNS	O	time	tmod	20	SENT_80	[p4l1910t325r2085b386],
23	a	DT	DURATION	a	det	24	SENT_80	[p4l2110t345r2145b386],
24	day	NN	DURATION	day	tmod	18	SENT_80	[p4l9t427r136b505],
25	.	.	O	.	_	0	SENT_80	[p4l9t427r136b505],

1	She	PRP	O	she	nsubj	2	SENT_81	[p4l168t427r286b488],
2	tolerated	VBD	O	tolerate	_	0	SENT_81	[p4l309t427r595b488],
3	this	DT	O	this	det	4	SENT_81	[p4l617t427r733b488],
4	regimen	NN	O	regimen	nsubj	5	SENT_81	[p4l756t427r1026b505],
5	better	JJR	O	better	xcomp	2	SENT_81	[p4l1047t427r1236b488],
6	and	CC	O	and	_	0	SENT_81	[p4l1257t427r1375b488],
7	received	VBD	O	receive	conj_and	2	SENT_81	[p4l1396t427r1675b488],
8	promethazine	NN	O	promethazine	dobj	7	SENT_81	[p4l1694t427r2143b504],
9	only	RB	O	only	advmod	10	SENT_81	[p4l9t529r155b606],
10	once	RB	DATE	once	advmod	7	SENT_81	[p4l174t548r327b589],
11	during	IN	O	during	_	0	SENT_81	[p4l348t529r561b606],
12	the	DT	O	the	det	14	SENT_81	[p4l580t529r679b589],
13	second	JJ	ORDINAL	second	amod	14	SENT_81	[p4l701t529r929b589],
14	stay	NN	O	stay	prep_during	10	SENT_81	[p4l949t537r1087b606],
15	.	.	O	.	_	0	SENT_81	[p4l949t537r1087b606],

1	The	DT	O	the	det	2	SENT_82	[p4l1113t529r1238b589],
2	difference	NN	O	difference	nsubj	4	SENT_82	[p4l1259t529r1587b589],
3	was	VBD	O	be	cop	4	SENT_82	[p4l1605t548r1732b589],
4	remarkable	JJ	O	remarkable	_	0	SENT_82	[p4l1752t529r2140b602],
5	;	:	O	;	_	0	SENT_82	[p4l1752t529r2140b602],
6	she	PRP	O	she	nsubj	8	SENT_82	[p4l10t631r116b692],
7	was	VBD	O	be	cop	8	SENT_82	[p4l159t650r286b692],
8	able	JJ	O	able	parataxis	4	SENT_82	[p4l334t631r467b692],
9	to	TO	O	to	aux	11	SENT_82	[p4l511t639r573b692],
10	fully	RB	O	fully	advmod	11	SENT_82	[p4l620t631r772b709],
11	participate	VB	O	participate	xcomp	8	SENT_82	[p4l814t631r1158b708],
12	in	IN	O	in	_	0	SENT_82	[p4l1205t631r1267b691],
13	her	PRP$	O	she	poss	14	SENT_82	[p4l1309t631r1416b692],
14	rehabilitation	NN	O	rehabilitation	prep_in	11	SENT_82	[p4l1457t631r1908b692],
15	.	.	O	.	_	0	SENT_82	[p4l1457t631r1908b692],

1	Other	JJ	O	other	amod	2	SENT_83	[p4l1959t631r2146b692],
2	medications	NNS	O	medication	nsubj	4	SENT_83	[p4l7t733r403b794],
3	were	VBD	O	be	cop	4	SENT_83	[p4l423t753r582b794],
4	aspirin	NN	O	aspirin	_	0	SENT_83	[p4l603t733r824b811],
5	(	CD	NUMBER	(	number	6	SENT_83	[p4l844t734r942b811],
6	81	CD	NUMBER	81	num	8	SENT_83	[p4l844t734r942b811],
7	mg/d	NN	O	mg/d	nn	8	SENT_83	[p4l970t733r1184b811],
8	)	NN	O	)	dep	4	SENT_83	[p4l970t733r1184b811],
9	,	,	O	,	_	0	SENT_83	[p4l970t733r1184b811],
10	hydrochlorothiazide	NN	O	hydrochlorothiazide	conj_and	4	SENT_83	[p4l1205t733r1868b811],
11	(	CD	NUMBER	(	number	12	SENT_83	[p4l1890t734r1992b811],
12	25	CD	NUMBER	25	num	13	SENT_83	[p4l1890t734r1992b811],
13	mg	NN	O	mg	dep	10	SENT_83	[p4l2015t733r2145b811],
14	/	:	O	/	punct	16	SENT_83	[p4l2015t733r2145b811],
15	d	NN	O	d	nn	16	SENT_83	[p4l9t835r92b912],
16	)	NN	O	)	dep	13	SENT_83	[p4l9t835r92b912],
17	,	,	O	,	_	0	SENT_83	[p4l9t835r92b912],
18	olmesartan	NN	O	olmesartan	conj_and	4	SENT_83	[p4l130t835r490b896],
19	(	CD	NUMBER	(	number	20	SENT_83	[p4l525t836r629b912],
20	40	CD	NUMBER	40	num	22	SENT_83	[p4l525t836r629b912],
21	mg/d	NN	O	mg/d	nn	22	SENT_83	[p4l665t835r879b913],
22	)	NN	O	)	dep	18	SENT_83	[p4l665t835r879b913],
23	,	,	O	,	_	0	SENT_83	[p4l665t835r879b913],
24	cetirizine	NN	O	cetirizine	conj_and	4	SENT_83	[p4l917t835r1218b896],
25	(	CD	NUMBER	(	number	26	SENT_83	[p4l1254t835r1359b913],
26	10	CD	NUMBER	10	num	28	SENT_83	[p4l1254t835r1359b913],
27	mg/day	NN	O	mg/day	nn	28	SENT_83	[p4l1394t835r1667b913],
28	)	NN	O	)	dep	24	SENT_83	[p4l1394t835r1667b913],
29	and	CC	O	and	_	0	SENT_83	[p4l1704t835r1823b896],
30	docusate	NN	O	docusate	nn	31	SENT_83	[p4l1857t835r2143b896],
31	(	NN	O	(	conj_and	4	SENT_83	[p4l9t937r157b1014],
32	200	CD	NUMBER	200	num	34	SENT_83	[p4l9t937r157b1014],
33	mg/day	JJ	O	mg/day	amod	34	SENT_83	[p4l202t937r493b1015],
34	)	NN	O	)	dep	31	SENT_83	[p4l202t937r493b1015],
35	.	.	O	.	_	0	SENT_83	[p4l202t937r493b1015],

1	Cefuroxime	NNP	MISC	Cefuroxime	nsubjpass	7	SENT_84	[p4l542t937r951b1010],
2	,	,	O	,	_	0	SENT_84	[p4l542t937r951b1010],
3	an	DT	O	a	det	4	SENT_84	[p4l1000t956r1077b997],
4	antibiotic	JJ	O	antibiotic	appos	1	SENT_84	[p4l1122t937r1445b1010],
5	,	,	O	,	_	0	SENT_84	[p4l1122t937r1445b1010],
6	was	VBD	O	be	auxpass	7	SENT_84	[p4l1492t957r1619b998],
7	prescribed	VBN	O	prescribe	_	0	SENT_84	[p4l1662t937r2007b1014],
8	for	IN	O	for	_	0	SENT_84	[p4l2051t937r2146b998],
9	10	CD	DURATION	10	num	10	SENT_84	[p4l16t1040r88b1099],
10	days	NNS	NUMBER	day	prep_for	7	SENT_84	[p4l128t1039r276b1116],
11	of	IN	O	of	_	0	SENT_84	[p4l315t1039r392b1099],
12	the	DT	O	the	det	14	SENT_84	[p4l418t1039r516b1099],
13	16-day	JJ	DURATION	16-day	amod	14	SENT_84	[p4l563t1039r784b1116],
14	admission	NN	O	admission	prep_of	10	SENT_84	[p4l821t1039r1170b1099],
15	.	.	O	.	_	0	SENT_84	[p4l821t1039r1170b1099],

1	This	DT	O	this	det	2	SENT_85	[p4l1212t1039r1355b1099],
2	case	NN	O	case	nsubj	3	SENT_85	[p4l1395t1058r1533b1099],
3	suggests	VBZ	O	suggest	_	0	SENT_85	[p4l1573t1047r1848b1116],
4	that	IN	O	that	complm	8	SENT_85	[p4l1885t1039r2009b1099],
5	the	DT	O	the	det	6	SENT_85	[p4l2044t1039r2142b1099],
6	patient	NN	O	patient	nsubjpass	8	SENT_85	[p4l6t1141r231b1219],
7	was	VBD	O	be	auxpass	8	SENT_85	[p4l252t1161r378b1202],
8	considered	VBN	O	consider	ccomp	3	SENT_85	[p4l405t1141r761b1202],
9	uncooperative	JJ	O	uncooperative	acomp	8	SENT_85	[p4l781t1141r1248b1219],
10	because	IN	O	because	mark	13	SENT_85	[p4l1270t1141r1531b1202],
11	she	PRP	O	she	nsubj	27	SENT_85	[p4l1558t1141r1664b1202],
12	was	VBD	O	be	cop	13	SENT_85	[p4l1687t1161r1813b1202],
13	unable	JJ	O	unable	advcl	8	SENT_85	[p4l1837t1141r2057b1202],
14	to	TO	O	to	aux	15	SENT_85	[p4l2080t1150r2142b1202],
15	tolerate	VB	O	tolerate	xcomp	13	SENT_85	[p4l7t1243r250b1304],
16	rehabilitation	NN	O	rehabilitation	dobj	15	SENT_85	[p4l292t1243r730b1304],
17	due	JJ	O	due	_	0	SENT_85	[p4l772t1243r888b1304],
18	to	TO	O	to	_	0	SENT_85	[p4l931t1251r993b1304],
19	pain	NN	O	pain	prep_due_to	15	SENT_85	[p4l1035t1243r1179b1320],
20	and	CC	O	and	_	0	SENT_85	[p4l1221t1243r1339b1304],
21	opioid	JJ	O	opioid	amod	22	SENT_85	[p4l1382t1243r1592b1320],
22	analgesics	NNS	O	analgesic	prep_due_to	15	SENT_85	[p4l1635t1243r1969b1321],
23	side	JJ	O	side	amod	24	SENT_85	[p4l2015t1243r2143b1304],
24	effects	NNS	O	effect	dep	22	SENT_85	[p4l9t1345r240b1418],
25	,	,	O	,	_	0	SENT_85	[p4l9t1345r240b1418],
26	but	CC	O	but	_	0	SENT_85	[p4l268t1345r376b1405],
27	received	VBD	O	receive	advcl	8	SENT_85	[p4l401t1345r680b1405],
28	better	JJR	O	better	amod	29	SENT_85	[p4l704t1345r892b1405],
29	care	NN	O	care	dobj	27	SENT_85	[p4l918t1364r1051b1405],
30	after	IN	O	after	mark	33	SENT_85	[p4l1080t1345r1228b1405],
31	her	PRP$	O	she	poss	32	SENT_85	[p4l1252t1345r1358b1405],
32	physician	NN	O	physician	nsubj	33	SENT_85	[p4l1381t1345r1698b1422],
33	considered	VBD	O	consider	advcl	27	SENT_85	[p4l1727t1345r2083b1405],
34	a	DT	O	a	det	37	SENT_85	[p4l2110t1364r2145b1405],
35	possible	JJ	O	possible	amod	37	SENT_85	[p4l6t1447r276b1525],
36	genetic	JJ	O	genetic	amod	37	SENT_85	[p4l301t1447r535b1525],
37	reason	NN	O	reason	dobj	33	SENT_85	[p4l560t1466r775b1508],
38	for	IN	O	for	_	0	SENT_85	[p4l801t1447r894b1508],
39	unusual	JJ	O	unusual	amod	41	SENT_85	[p4l915t1447r1173b1508],
40	drug	NN	O	drug	nn	41	SENT_85	[p4l1198t1447r1348b1525],
41	response	NN	O	response	prep_for	33	SENT_85	[p4l1371t1467r1675b1524],
42	.	.	O	.	_	0	SENT_85	[p4l1371t1467r1675b1524],

1	4	LS	NUMBER	4	_	0	SENT_86	[p4l8t1554r70b1614],
2	.	.	O	.	_	0	SENT_86	[p4l8t1554r70b1614],

1	Discussion	NN	O	discussion	_	0	SENT_87	[p4l104t1554r480b1613],

1	The	DT	O	the	det	2	SENT_88	[p4l110t1756r237b1817],
2	patient	NN	O	patient	nsubj	3	SENT_88	[p4l253t1756r483b1834],
3	had	VBD	O	have	_	0	SENT_88	[p4l499t1756r620b1817],
4	a	DT	O	a	det	8	SENT_88	[p4l639t1776r674b1817],
5	long	JJ	O	long	amod	8	SENT_88	[p4l691t1756r1151b1834],
6	—	NN	O	—	nn	8	SENT_88	[p4l691t1756r1151b1834],
7	standing	NN	O	standing	nn	8	SENT_88	[p4l691t1756r1151b1834],
8	intolerance	NN	O	intolerance	dobj	3	SENT_88	[p4l1171t1756r1540b1817],
9	to	TO	O	to	_	0	SENT_88	[p4l1558t1765r1620b1817],
10	codeine	NN	O	codeine	prep_to	8	SENT_88	[p4l1641t1756r1917b1830],
11	,	,	O	,	_	0	SENT_88	[p4l1641t1756r1917b1830],
12	which	WDT	O	which	nsubjpass	14	SENT_88	[p4l1938t1756r2143b1817],
13	was	VBD	O	be	auxpass	14	SENT_88	[p4l6t1878r134b1919],
14	noted	VBN	O	note	rcmod	10	SENT_88	[p4l166t1858r353b1919],
15	as	IN	O	as	_	0	SENT_88	[p4l385t1878r451b1919],
16	an	DT	O	a	det	17	SENT_88	[p4l485t1877r561b1918],
17	allergy	NN	O	allergy	prep_as	14	SENT_88	[p4l593t1858r823b1936],
18	on	IN	O	on	_	0	SENT_88	[p4l854t1878r936b1919],
19	her	PRP$	O	she	poss	20	SENT_88	[p4l966t1858r1074b1919],
20	chart	NN	O	chart	prep_on	17	SENT_88	[p4l1104t1858r1285b1919],
21	.	.	O	.	_	0	SENT_88	[p4l1104t1858r1285b1919],

1	Codeine	NN	O	codeine	nsubj	4	SENT_89	[p4l1322t1858r1599b1919],
2	appears	VBZ	O	appear	cop	4	SENT_89	[p4l1633t1877r1884b1936],
3	clearly	RB	O	clearly	advmod	4	SENT_89	[p4l1919t1858r2143b1936],
4	dependent	JJ	O	dependent	_	0	SENT_89	[p4l9t1960r354b2038],
5	on	IN	O	on	_	0	SENT_89	[p4l384t1980r466b2021],
6	CYPZD6	NN	O	cypzd6	prep_on	4	SENT_89	[p4l498t1962r803b2021],
7	for	IN	O	for	_	0	SENT_89	[p4l837t1961r933b2021],
8	its	PRP$	O	its	poss	10	SENT_89	[p4l963t1961r1036b2021],
9	analgesic	JJ	O	analgesic	amod	10	SENT_89	[p4l1071t1960r1378b2038],
10	effects	NNS	O	effect	prep_for	6	SENT_89	[p4l1412t1961r1645b2021],
11	.	.	O	.	_	0	SENT_89	[p4l1412t1961r1645b2021],

1	However	RB	O	however	advmod	4	SENT_90	[p4l1682t1963r2004b2034],
2	,	,	O	,	_	0	SENT_90	[p4l1682t1963r2004b2034],
3	codeine	NN	O	codeine	nsubj	4	SENT_90	[p4l2039t1980r2141b2021, p4l9t2062r186b2123],
4	appears	VBZ	O	appear	_	0	SENT_90	[p4l207t2082r459b2140],
5	to	TO	O	to	aux	7	SENT_90	[p4l479t2071r541b2123],
6	be	VB	O	be	cop	7	SENT_90	[p4l561t2062r639b2123],
7	able	JJ	O	able	xcomp	4	SENT_90	[p4l660t2062r795b2123],
8	to	TO	O	to	aux	10	SENT_90	[p4l814t2071r876b2123],
9	directly	RB	O	directly	advmod	10	SENT_90	[p4l898t2062r1151b2140],
10	cause	VB	O	cause	xcomp	7	SENT_90	[p4l1171t2082r1353b2123],
11	some	DT	O	some	dobj	10	SENT_90	[p4l1376t2082r1548b2123],
12	of	IN	O	of	_	0	SENT_90	[p4l1569t2062r1646b2123],
13	its	PRP$	O	its	poss	15	SENT_90	[p4l1656t2062r1729b2123],
14	side	JJ	O	side	amod	15	SENT_90	[p4l1752t2062r1882b2123],
15	effects	NNS	O	effect	prep_of	11	SENT_90	[p4l1904t2062r2138b2123],
16	.	.	O	.	_	0	SENT_90	[p4l1904t2062r2138b2123],

1	In	IN	O	in	_	0	SENT_91	[p4l8t2166r75b2224],
2	a	DT	O	a	nsubj	9	SENT_91	[p4l113t2184r147b2224],
3	randomized	VBN	O	randomize	partmod	2	SENT_91	[p4l182t2164r579b2225],
4	double	JJ	O	double	advmod	3	SENT_91	[p4l615t2164r1044b2225],
5	—	RB	O	—	advmod	6	SENT_91	[p4l615t2164r1044b2225],
6	blind	JJ	O	blind	amod	8	SENT_91	[p4l615t2164r1044b2225],
7	placebo-controlled	JJ	O	placebo-controlled	amod	8	SENT_91	[p4l1078t2164r1708b2242],
8	study	NN	O	study	dobj	3	SENT_91	[p4l1747t2164r1925b2242],
9	using	VBG	O	use	prepc_in	28	SENT_91	[p4l1960t2164r2142b2242],
10	morphine	NN	O	morphine	iobj	9	SENT_91	[p4l7t2266r327b2343],
11	and	CC	O	and	_	0	SENT_91	[p4l352t2266r471b2326],
12	codeine	NN	O	codeine	conj_and	10	SENT_91	[p4l494t2266r752b2326],
13	in	IN	O	in	_	0	SENT_91	[p4l776t2266r839b2325],
14	9	CD	NUMBER	9	num	16	SENT_91	[p4l862t2267r898b2326],
15	CYPZD6	NN	O	cypzd6	nn	16	SENT_91	[p4l925t2267r1229b2327],
16	PMs	NNS	O	pm	prep_in	10	SENT_91	[p4l1254t2268r1405b2326],
17	and	CC	O	and	_	0	SENT_91	[p4l1430t2266r1550b2327],
18	9	CD	NUMBER	9	num	20	SENT_91	[p4l1573t2267r1609b2326],
19	CYP2D6	NN	O	cyp2d6	nn	20	SENT_91	[p4l1635t2267r1939b2327],
20	EMS	NNP	ORGANIZATION	EMS	conj_and	10	SENT_91	[p4l1965t2268r2139b2339],
21	,	,	O	,	_	0	SENT_91	[p4l1965t2268r2139b2339],
22	Eckhardt	NNP	PERSON	Eckhardt	dobj	9	SENT_91	[p4l7t2368r310b2429],
23	et	FW	O	et	nn	25	SENT_91	[p4l351t2376r408b2429],
24	al.	FW	O	al.	nn	25	SENT_91	[p4l449t2368r522b2428],
25	(	FW	O	(	dobj	9	SENT_91	[p4l569t2368r788b2445],
26	1998	CD	DATE	1998	num	27	SENT_91	[p4l569t2368r788b2445],
27	)	CD	NUMBER	)	nsubj	38	SENT_91	[p4l569t2368r788b2445],
28	demonstrated	VBD	O	demonstrate	_	0	SENT_91	[p4l832t2368r1282b2429],
29	that	IN	O	that	complm	33	SENT_91	[p4l1321t2368r1446b2428],
30	CYPZD6	NN	O	cypzd6	nn	31	SENT_91	[p4l1488t2369r1792b2429],
31	PMs	NNS	O	pm	nsubj	33	SENT_91	[p4l1835t2370r1986b2429],
32	can	MD	O	can	aux	33	SENT_91	[p4l2029t2388r2143b2429],
33	show	VB	O	show	ccomp	28	SENT_91	[p4l10t2470r184b2531],
34	codeine	NN	O	codeine	nn	36	SENT_91	[p4l210t2470r468b2531],
35	side	JJ	O	side	amod	36	SENT_91	[p4l496t2470r626b2531],
36	effects	NNS	O	effect	dobj	33	SENT_91	[p4l654t2471r870b2531],
37	but	CC	O	but	_	0	SENT_91	[p4l895t2470r1004b2531],
38	lack	VBP	O	lack	conj_but	28	SENT_91	[p4l1029t2470r1166b2531],
39	analgesic	JJ	O	analgesic	amod	40	SENT_91	[p4l1191t2470r1499b2548],
40	response	NN	O	response	dobj	38	SENT_91	[p4l1525t2490r1834b2548],
41	.	.	O	.	_	0	SENT_91	[p4l1525t2490r1834b2548],

1	The	DT	O	the	det	2	SENT_92	[p4l110t2572r236b2633],
2	patient	NN	O	patient	nsubj	5	SENT_92	[p4l287t2572r512b2650],
3	could	MD	O	could	aux	5	SENT_92	[p4l565t2572r839b2633],
4	n’t	RB	O	n’t	advmod	5	SENT_92	[p4l565t2572r839b2633],
5	tolerate	VB	O	tolerate	_	0	SENT_92	[p4l889t2572r1133b2633],
6	the	DT	O	the	det	7	SENT_92	[p4l1185t2572r1284b2633],
7	regimen	NN	O	regimen	dobj	5	SENT_92	[p4l1337t2572r1607b2650],
8	of	IN	O	of	_	0	SENT_92	[p4l1660t2572r1737b2633],
9	oxycodone	NN	O	oxycodone	prep_of	7	SENT_92	[p4l1780t2572r2142b2650],
10	combined	VBN	O	combine	partmod	9	SENT_92	[p4l9t2674r334b2735],
11	with	IN	O	with	_	0	SENT_92	[p4l358t2674r505b2735],
12	tramadol	NN	O	tramadol	nn	13	SENT_92	[p4l529t2674r822b2735],
13	prns	NNS	O	prn	prep_with	10	SENT_92	[p4l845t2693r987b2751],
14	during	IN	O	during	_	0	SENT_92	[p4l1015t2674r1228b2752],
15	her	PRP$	O	she	poss	17	SENT_92	[p4l1253t2674r1360b2735],
16	first	JJ	ORDINAL	first	amod	17	SENT_92	[p4l1386t2674r1514b2735],
17	admission	NN	O	admission	prep_during	10	SENT_92	[p4l1540t2674r1890b2747],
18	,	,	O	,	_	0	SENT_92	[p4l1540t2674r1890b2747],
19	having	VBG	O	have	xcomp	10	SENT_92	[p4l1918t2674r2143b2752],
20	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_92	[p4l10t2776r353b2854],
21	side	JJ	O	side	amod	22	SENT_92	[p4l396t2776r524b2837],
22	effects	NNS	O	effect	dobj	19	SENT_92	[p4l569t2777r798b2837],
23	.	.	O	.	_	0	SENT_92	[p4l569t2777r798b2837],

1	She	PRP	O	she	nsubj	2	SENT_93	[p4l849t2776r967b2837],
2	obtained	VBD	O	obtain	_	0	SENT_93	[p4l1011t2776r1295b2837],
3	no	DT	O	no	det	5	SENT_93	[p4l1334t2796r1416b2837],
4	pain	NN	O	pain	nn	5	SENT_93	[p4l1458t2776r1602b2854],
5	relief	NN	O	relief	dobj	2	SENT_93	[p4l1642t2776r1823b2837],
6	and	CC	O	and	_	0	SENT_93	[p4l1856t2776r1974b2837],
7	was	VBD	O	be	auxpass	8	SENT_93	[p4l2015t2796r2141b2837],
8	considered	VBN	O	consider	conj_and	2	SENT_93	[p4l9t2878r365b2939],
9	a	DT	O	a	det	11	SENT_93	[p4l388t2898r423b2939],
10	difﬁcult	JJ	O	difﬁcult	amod	11	SENT_93	[p4l447t2878r707b2939],
11	patient	NN	O	patient	dobj	8	SENT_93	[p4l728t2878r952b2956],
12	for	IN	O	for	_	0	SENT_93	[p4l977t2878r1071b2939],
13	not	RB	O	not	neg	14	SENT_93	[p4l1092t2887r1198b2939],
14	collaborating	VBG	O	collaborate	prepc_for	8	SENT_93	[p4l1222t2878r1652b2956],
15	with	IN	O	with	_	0	SENT_93	[p4l1676t2878r1823b2939],
16	her	PRP$	O	she	poss	17	SENT_93	[p4l1845t2878r1952b2939],
17	treatment	NN	O	treatment	prep_with	14	SENT_93	[p4l1973t2887r2142b2939, p4l7t2988r186b3041],
18	.	.	O	.	_	0	SENT_93	[p4l1973t2887r2142b2939, p4l7t2988r186b3041],

1	We	PRP	O	we	nsubj	3	SENT_94	[p4l232t2982r339b3041],
2	are	VBP	O	be	cop	3	SENT_94	[p4l382t3000r478b3041],
3	aware	JJ	O	aware	_	0	SENT_94	[p4l521t2999r713b3041],
4	of	IN	O	of	_	0	SENT_94	[p4l756t2980r833b3041],
5	no	DT	O	no	det	6	SENT_94	[p4l861t3000r943b3041],
6	studies	NNS	O	study	prep_of	3	SENT_94	[p4l988t2980r1211b3041],
7	on	IN	O	on	_	0	SENT_94	[p4l1254t3000r1336b3041],
8	oXycodone	NN	O	oxycodone	poss	11	SENT_94	[p4l1377t2980r1796b3058],
9	’s	POS	O	’s	_	0	SENT_94	[p4l1377t2980r1796b3058],
10	analgesic	JJ	O	analgesic	amod	11	SENT_94	[p4l1840t2980r2142b3058],
11	effects	NNS	O	effect	prep_on	6	SENT_94	[p4l9t3082r220b3142],
12	on	IN	O	on	_	0	SENT_94	[p4l242t3101r324b3142],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_94	[p4l343t3083r645b3143],
14	PMs	NNS	O	pm	prep_on	11	SENT_94	[p4l666t3084r835b3155],
15	,	,	O	,	_	0	SENT_94	[p4l666t3084r835b3155],
16	but	CC	O	but	prep	11	SENT_94	[p4l855t3082r962b3142],
17	Otton	NNP	PERSON	Otton	dep	16	SENT_94	[p4l982t3083r1168b3143],
18	et	FW	O	et	nn	20	SENT_94	[p4l1188t3090r1246b3142],
19	al.	FW	O	al.	nn	20	SENT_94	[p4l1264t3082r1335b3142],
20	(	FW	O	(	dep	17	SENT_94	[p4l1361t3082r1577b3159],
21	1993	CD	DATE	1993	num	22	SENT_94	[p4l1361t3082r1577b3159],
22	)	CD	NUMBER	)	dep	20	SENT_94	[p4l1361t3082r1577b3159],
23	described	VBN	O	describe	partmod	22	SENT_94	[p4l1598t3082r1912b3142],
24	loss	NN	O	loss	dobj	23	SENT_94	[p4l1931t3082r2056b3142],
25	of	IN	O	of	_	0	SENT_94	[p4l2077t3082r2154b3142],
26	oxycodone	NN	O	oxycodone	nn	28	SENT_94	[p4l9t3184r370b3262],
27	analgesic	JJ	O	analgesic	amod	28	SENT_94	[p4l413t3184r714b3262],
28	effects	NNS	O	effect	prep_of	24	SENT_94	[p4l758t3184r969b3245],
29	after	IN	O	after	_	0	SENT_94	[p4l1013t3184r1161b3245],
30	adding	VBG	O	add	prepc_after	23	SENT_94	[p4l1200t3184r1423b3262],
31	CYPZD6	NN	O	cypzd6	nn	32	SENT_94	[p4l1465t3185r1766b3245],
32	inhibitors	NNS	O	inhibitor	dobj	30	SENT_94	[p4l1810t3184r2138b3245],
33	.	.	O	.	_	0	SENT_94	[p4l1810t3184r2138b3245],

1	Conversely	RB	O	conversely	advmod	7	SENT_95	[p4l9t3286r394b3364],
2	,	,	O	,	_	0	SENT_95	[p4l9t3286r394b3364],
3	adding	VBG	O	add	csubj	7	SENT_95	[p4l441t3286r664b3364],
4	quinidine	NN	O	quinidine	dobj	3	SENT_95	[p4l708t3286r1016b3364],
5	did	VBD	O	do	aux	7	SENT_95	[p4l1060t3286r1164b3347],
6	not	RB	O	not	neg	7	SENT_95	[p4l1205t3295r1311b3347],
7	appear	VB	O	appear	_	0	SENT_95	[p4l1353t3306r1573b3364],
8	to	TO	O	to	aux	9	SENT_95	[p4l1612t3295r1674b3347],
9	change	VB	O	change	xcomp	7	SENT_95	[p4l1719t3286r1950b3364],
10	oxycodone	NN	O	oxycodone	nn	11	SENT_95	[p4l1994t3306r2142b3364, p4l9t3388r245b3449],
11	psychomotor	NN	O	psychomotor	dobj	9	SENT_95	[p4l260t3388r695b3466],
12	or	CC	O	or	_	0	SENT_95	[p4l710t3408r779b3449],
13	subjective	JJ	O	subjective	amod	14	SENT_95	[p4l795t3388r1124b3466],
14	effects	NNS	O	effect	nsubj	15	SENT_95	[p4l1142t3388r1354b3449],
15	(	VBP	O	(	conj_or	7	SENT_95	[p4l1373t3388r1746b3466],
16	Heiskanen	NNP	PERSON	Heiskanen	dobj	15	SENT_95	[p4l1373t3388r1746b3466],
17	et	FW	O	et	nn	18	SENT_95	[p4l1764t3397r1822b3449],
18	al.	FW	O	al.	nsubj	29	SENT_95	[p4l1837t3388r1932b3462],
19	,	,	O	,	_	0	SENT_95	[p4l1837t3388r1932b3462],
20	1998	CD	DATE	1998	num	21	SENT_95	[p4l1959t3389r2141b3466],
21	)	NN	O	)	appos	18	SENT_95	[p4l1959t3389r2141b3466],
22	but	CC	O	but	prep	21	SENT_95	[p4l6t3490r113b3551],
23	quinidine	NN	O	quinidine	dep	22	SENT_95	[p4l138t3490r447b3567],
24	may	MD	O	may	aux	29	SENT_95	[p4l472t3510r614b3568],
25	not	RB	O	not	neg	29	SENT_95	[p4l638t3498r744b3551],
26	be	VB	O	be	cop	29	SENT_95	[p4l767t3490r845b3551],
27	an	DT	O	a	det	29	SENT_95	[p4l872t3510r948b3550],
28	ideal	JJ	O	ideal	amod	29	SENT_95	[p4l974t3490r1129b3551],
29	drug	NN	O	drug	rcmod	16	SENT_95	[p4l1157t3490r1306b3568],
30	to	TO	O	to	aux	31	SENT_95	[p4l1330t3498r1392b3551],
31	block	VB	O	block	infmod	29	SENT_95	[p4l1417t3490r1602b3551],
32	CYPZD6	NN	O	cypzd6	dobj	31	SENT_95	[p4l1628t3491r1929b3551],
33	in	IN	O	in	_	0	SENT_95	[p4l1958t3490r2020b3550],
34	the	DT	O	the	det	35	SENT_95	[p4l2043t3490r2142b3551],
35	brain	NN	O	brain	prep_in	31	SENT_95	[p4l6t3592r191b3653],
36	.	.	O	.	_	0	SENT_95	[p4l6t3592r191b3653],

1	This	DT	O	this	det	3	SENT_96	[p4l237t3592r381b3653],
2	case	NN	O	case	nn	3	SENT_96	[p4l424t3612r562b3653],
3	report	NN	O	report	nsubj	4	SENT_96	[p4l603t3601r800b3670],
4	appears	VBZ	O	appear	_	0	SENT_96	[p4l841t3612r1087b3670],
5	to	TO	O	to	aux	6	SENT_96	[p4l1129t3601r1191b3653],
6	suggest	VB	O	suggest	xcomp	4	SENT_96	[p4l1236t3601r1482b3670],
7	that	IN	O	that	complm	14	SENT_96	[p4l1521t3592r1660b3666],
8	,	,	O	,	_	0	SENT_96	[p4l1521t3592r1660b3666],
9	like	IN	O	like	_	0	SENT_96	[p4l1706t3592r1826b3653],
10	codeine	NN	O	codeine	prep_like	14	SENT_96	[p4l1868t3592r2141b3666],
11	,	,	O	,	_	0	SENT_96	[p4l1868t3592r2141b3666],
12	oxycodone	NN	O	oxycodone	nsubj	14	SENT_96	[p4l9t3694r370b3772],
13	may	MD	O	may	aux	14	SENT_96	[p4l394t3714r537b3772],
14	need	VB	O	need	ccomp	6	SENT_96	[p4l559t3694r717b3755],
15	CYPZD6	NN	O	cypzd6	dobj	14	SENT_96	[p4l740t3696r1041b3755],
16	to	TO	O	to	aux	17	SENT_96	[p4l1067t3703r1129b3755],
17	provide	VB	O	provide	xcomp	14	SENT_96	[p4l1152t3694r1404b3772],
18	analgesic	JJ	O	analgesic	amod	19	SENT_96	[p4l1430t3694r1732b3772],
19	effects	NNS	O	effect	dobj	17	SENT_96	[p4l1758t3694r1988b3755],
20	.	.	O	.	_	0	SENT_96	[p4l1758t3694r1988b3755],

1	The	DT	O	the	det	2	SENT_97	[p4l2017t3694r2142b3755],
2	patient	NN	O	patient	nsubj	4	SENT_97	[p5l6t19r230b97],
3	was	VBD	O	be	aux	4	SENT_97	[p5l247t39r374b80],
4	taking	VBG	O	take	_	0	SENT_97	[p5l394t19r599b97],
5	some	DT	O	some	det	7	SENT_97	[p5l621t38r792b80],
6	other	JJ	O	other	amod	7	SENT_97	[p5l813t19r981b80],
7	medications	NNS	O	medication	dobj	4	SENT_97	[p5l997t19r1412b92],
8	,	,	O	,	_	0	SENT_97	[p5l997t19r1412b92],
9	which	WDT	O	which	nsubj	13	SENT_97	[p5l1433t19r1636b80],
10	arguably	RB	O	arguably	advmod	13	SENT_97	[p5l1656t19r1942b97],
11	could	MD	O	could	aux	13	SENT_97	[p5l1962t19r2144b80],
12	have	VB	O	have	aux	13	SENT_97	[p5l6t121r162b181],
13	contributed	VBN	O	contribute	rcmod	7	SENT_97	[p5l185t121r558b181],
14	to	TO	O	to	_	0	SENT_97	[p5l577t129r639b181],
15	the	DT	O	the	det	16	SENT_97	[p5l661t121r759b181],
16	lack	NN	O	lack	prep_to	13	SENT_97	[p5l782t121r919b181],
17	of	IN	O	of	_	0	SENT_97	[p5l939t121r1016b181],
18	response	NN	O	response	prep_of	16	SENT_97	[p5l1025t140r1313b198],
19	to	TO	O	to	_	0	SENT_97	[p5l1333t129r1395b181],
20	oxycodone	NN	O	oxycodone	prep_to	13	SENT_97	[p5l1419t121r1797b198],
21	.	.	O	.	_	0	SENT_97	[p5l1419t121r1797b198],

1	However	RB	O	however	advmod	7	SENT_98	[p5l1823t123r2140b194],
2	,	,	O	,	_	0	SENT_98	[p5l1823t123r2140b194],
3	none	NN	O	none	nsubj	7	SENT_98	[p5l7t242r167b284],
4	of	IN	O	of	_	0	SENT_98	[p5l203t223r280b284],
5	her	PRP$	O	she	poss	6	SENT_98	[p5l302t223r409b284],
6	medications	NNS	O	medication	prep_of	3	SENT_98	[p5l440t223r836b284],
7	(	VBP	O	(	_	0	SENT_98	[p5l873t223r1248b300],
8	nifedipine	NN	O	nifedipine	nn	19	SENT_98	[p5l873t223r1248b300],
9	,	,	O	,	_	0	SENT_98	[p5l873t223r1248b300],
10	doxazosin	NN	O	doxazosin	dep	19	SENT_98	[p5l1286t223r1637b296],
11	,	,	O	,	_	0	SENT_98	[p5l1286t223r1637b296],
12	enteric	JJ	O	enteric	amod	19	SENT_98	[p5l1676t223r1894b284],
13	coated	JJ	O	coated	amod	19	SENT_98	[p5l1931t223r2145b284],
14	aspirin	NN	O	aspirin	nn	19	SENT_98	[p5l9t325r246b403],
15	,	,	O	,	_	0	SENT_98	[p5l9t325r246b403],
16	hydrochlorothiazide	NN	O	hydrochlorothiazide	nn	19	SENT_98	[p5l297t325r960b403],
17	and	CC	O	and	_	0	SENT_98	[p5l1011t325r1129b386],
18	loratadine	NN	O	loratadine	nn	19	SENT_98	[p5l1178t325r1529b403],
19	)	NN	O	)	dobj	7	SENT_98	[p5l1178t325r1529b403],
20	appear	VBP	O	appear	cop	21	SENT_98	[p5l1581t345r1800b403],
21	likely	JJ	O	likely	rcmod	19	SENT_98	[p5l1847t325r2032b403],
22	to	TO	O	to	aux	23	SENT_98	[p5l2079t334r2142b386],
23	inhibit	VB	O	inhibit	xcomp	21	SENT_98	[p5l9t427r221b488],
24	CYP2D6	NN	O	cyp2d6	dobj	23	SENT_98	[p5l246t429r547b488],
25	in	IN	O	in	_	0	SENT_98	[p5l575t427r637b487],
26	a	DT	O	a	det	28	SENT_98	[p5l662t447r697b488],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_98	[p5l722t427r1066b505],
28	way	NN	O	way	prep_in	23	SENT_98	[p5l1087t447r1235b505],
29	.	.	O	.	_	0	SENT_98	[p5l1087t447r1235b505],

1	Hydrocodone	NN	O	hydrocodone	nsubjpass	3	SENT_99	[p5l109t529r559b607],
2	is	VBZ	O	be	auxpass	3	SENT_99	[p5l586t529r637b590],
3	metabolized	VBN	O	metabolize	_	0	SENT_99	[p5l662t529r1065b590],
4	by	IN	O	by	_	0	SENT_99	[p5l1088t529r1172b607],
5	CYP2D6	NN	O	cyp2d6	agent	3	SENT_99	[p5l1198t530r1499b590],
6	to	TO	O	to	_	0	SENT_99	[p5l1525t537r1587b590],
7	hydromorphone	NN	O	hydromorphone	nn	9	SENT_99	[p5l1613t529r2142b607],
8	(	CD	NUMBER	(	num	9	SENT_99	[p5l9t631r415b709],
9	Hutchinson	NNP	PERSON	Hutchinson	prep_to	3	SENT_99	[p5l9t631r415b709],
10	et	FW	O	et	nn	11	SENT_99	[p5l452t640r509b692],
11	al.	FW	O	al.	dep	9	SENT_99	[p5l545t631r639b705],
12	,	,	O	,	_	0	SENT_99	[p5l545t631r639b705],
13	2004	CD	DATE	2004	num	14	SENT_99	[p5l677t632r885b709],
14	)	NN	O	)	appos	9	SENT_99	[p5l677t632r885b709],
15	.	.	O	.	_	0	SENT_99	[p5l677t632r885b709],

1	We	PRP	O	we	nsubj	3	SENT_100	[p5l925t634r1032b692],
2	are	VBP	O	be	cop	3	SENT_100	[p5l1070t651r1166b692],
3	aware	JJ	O	aware	dep	30	SENT_100	[p5l1204t651r1397b692],
4	of	IN	O	of	_	0	SENT_100	[p5l1435t632r1511b692],
5	no	DT	O	no	det	6	SENT_100	[p5l1535t651r1617b692],
6	studies	NNS	O	study	prep_of	3	SENT_100	[p5l1656t631r1879b692],
7	on	IN	O	on	_	0	SENT_100	[p5l1918t651r1999b692],
8	hydrocodone	NN	O	hydrocodone	poss	11	SENT_100	[p5l2033t631r2141b709, p5l9t733r413b794],
9	’s	POS	O	’s	_	0	SENT_100	[p5l2033t631r2141b709, p5l9t733r413b794],
10	analgesic	JJ	O	analgesic	amod	11	SENT_100	[p5l432t733r734b811],
11	effects	NNS	O	effect	prep_on	6	SENT_100	[p5l753t733r965b794],
12	on	IN	O	on	_	0	SENT_100	[p5l984t753r1066b794],
13	CYP2D6	NN	O	cyp2d6	nn	14	SENT_100	[p5l1082t735r1384b794],
14	PMs	NNS	O	pm	prep_on	3	SENT_100	[p5l1402t736r1571b807],
15	,	,	O	,	_	0	SENT_100	[p5l1402t736r1571b807],
16	but	CC	O	but	_	0	SENT_100	[p5l1589t733r1696b794],
17	hydrocodone	NN	O	hydrocodone	nsubj	20	SENT_100	[p5l1710t733r2142b811],
18	by	IN	O	by	_	0	SENT_100	[p5l6t835r90b913],
19	itself	PRP	O	itself	prep_by	17	SENT_100	[p5l137t835r307b896],
20	appears	VBZ	O	appear	conj_but	3	SENT_100	[p5l344t855r591b913],
21	to	TO	O	to	aux	22	SENT_100	[p5l637t843r700b896],
22	have	VB	O	have	xcomp	20	SENT_100	[p5l747t835r901b896],
23	some	DT	O	some	det	25	SENT_100	[p5l951t854r1122b896],
24	agonist	NN	O	agonist	nn	25	SENT_100	[p5l1170t835r1406b913],
25	effects	NNS	O	effect	dobj	22	SENT_100	[p5l1452t835r1664b896],
26	on	IN	O	on	_	0	SENT_100	[p5l1713t854r1795b896],
27	u	NN	O	u	nn	29	SENT_100	[p5l1842t856r1884b911],
28	opioid	NN	O	opioid	nn	29	SENT_100	[p5l1934t835r2144b912],
29	receptors	NNS	O	receptor	prep_on	25	SENT_100	[p5l7t945r305b1014],
30	(	VBP	O	(	_	0	SENT_100	[p5l327t937r527b1014],
31	Chen	NNP	PERSON	Chen	dobj	30	SENT_100	[p5l327t937r527b1014],
32	et	FW	O	et	nn	33	SENT_100	[p5l546t945r604b997],
33	al.	FW	O	al.	nsubj	30	SENT_100	[p5l622t937r716b1010],
34	,	,	O	,	_	0	SENT_100	[p5l622t937r716b1010],
35	1991	CD	DATE	1991	num	36	SENT_100	[p5l747t937r945b1014],
36	)	NN	O	)	appos	33	SENT_100	[p5l747t937r945b1014],
37	.	.	O	.	_	0	SENT_100	[p5l747t937r945b1014],

1	Some	DT	O	some	det	3	SENT_101	[p5l973t938r1156b998],
2	animal	NN	O	animal	nn	3	SENT_101	[p5l1177t937r1399b997],
3	studies	NNS	O	study	nsubj	4	SENT_101	[p5l1419t937r1642b997],
4	supported	VBD	O	support	_	0	SENT_101	[p5l1665t937r1988b1014],
5	this	DT	O	this	dobj	4	SENT_101	[p5l2005t937r2140b1010],
6	,	,	O	,	_	0	SENT_101	[p5l2005t937r2140b1010],
7	suggesting	VBG	O	suggest	partmod	4	SENT_101	[p5l10t1039r359b1117],
8	that	IN	O	that	complm	9	SENT_101	[p5l385t1039r510b1099],
9	inhibiting	VBG	O	inhibit	dep	7	SENT_101	[p5l535t1039r853b1117],
10	the	DT	O	the	det	12	SENT_101	[p5l880t1039r978b1100],
11	CYP	NN	O	cyp	nn	12	SENT_101	[p5l1007t1040r1165b1100],
12	analog	NN	O	analog	dobj	9	SENT_101	[p5l1195t1039r1413b1117],
13	to	TO	O	to	_	0	SENT_101	[p5l1439t1047r1501b1100],
14	CYP2D6	NN	O	cyp2d6	prep_to	9	SENT_101	[p5l1531t1040r1832b1100],
15	does	VBZ	O	do	aux	17	SENT_101	[p5l1863t1039r2011b1100],
16	not	RB	O	not	neg	17	SENT_101	[p5l2037t1047r2144b1100],
17	decrease	VB	O	decrease	dep	9	SENT_101	[p5l9t1141r288b1202],
18	hydrocodone	NN	O	hydrocodone	nn	19	SENT_101	[p5l316t1141r748b1219],
19	analgesia	NN	O	analgesia	dobj	17	SENT_101	[p5l778t1141r1082b1219],
20	(	CD	NUMBER	(	num	19	SENT_101	[p5l1111t1141r1311b1219],
21	Lelas	NNP	O	Lelas	dep	17	SENT_101	[p5l1111t1141r1311b1219],
22	et	FW	O	et	nn	23	SENT_101	[p5l1342t1150r1399b1202],
23	al.	FW	O	al.	dep	21	SENT_101	[p5l1427t1141r1522b1215],
24	,	,	O	,	_	0	SENT_101	[p5l1427t1141r1522b1215],
25	1999	CD	DATE	1999	appos	23	SENT_101	[p5l1562t1143r1737b1215],
26	;	:	O	;	_	0	SENT_101	[p5l1562t1143r1737b1215],
27	Tomkins	NNP	ORGANIZATION	Tomkins	dep	23	SENT_101	[p5l1770t1141r2056b1202],
28	et	FW	O	et	nn	29	SENT_101	[p5l2087t1150r2145b1202],
29	al.	FW	O	al.	nsubj	9	SENT_101	[p5l9t1243r102b1317],
30	,	,	O	,	_	0	SENT_101	[p5l9t1243r102b1317],
31	1997	CD	DATE	1997	num	32	SENT_101	[p5l138t1244r338b1321],
32	)	NN	O	)	appos	29	SENT_101	[p5l138t1244r338b1321],
33	.	.	O	.	_	0	SENT_101	[p5l138t1244r338b1321],

1	Also	RB	O	also	advmod	5	SENT_102	[p5l365t1243r538b1317],
2	,	,	O	,	_	0	SENT_102	[p5l365t1243r538b1317],
3	human	JJ	O	human	amod	4	SENT_102	[p5l565t1243r791b1304],
4	studies	NNS	O	study	nsubj	5	SENT_102	[p5l817t1243r1040b1304],
5	propose	VBP	O	propose	_	0	SENT_102	[p5l1064t1263r1325b1321],
6	that	IN	O	that	complm	11	SENT_102	[p5l1350t1243r1473b1304],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_102	[p5l1497t1245r1798b1304],
8	inhibition	NN	O	inhibition	nsubj	11	SENT_102	[p5l1826t1243r2144b1304],
9	does	VBZ	O	do	aux	11	SENT_102	[p5l9t1345r157b1406],
10	not	RB	O	not	neg	11	SENT_102	[p5l178t1353r285b1406],
11	affect	VB	O	affect	ccomp	5	SENT_102	[p5l306t1345r490b1406],
12	hydrocodone	NN	O	hydrocodone	nn	13	SENT_102	[p5l509t1345r941b1423],
13	abuse	NN	O	abuse	nsubj	16	SENT_102	[p5l964t1345r1149b1406],
14	liability	NN	O	liability	nn	16	SENT_102	[p5l1173t1345r1424b1423],
15	(	CD	NUMBER	(	num	16	SENT_102	[p5l1448t1345r1711b1422],
16	Kaplan	NNP	PERSON	Kaplan	xcomp	11	SENT_102	[p5l1448t1345r1711b1422],
17	et	FW	O	et	nn	18	SENT_102	[p5l1733t1353r1790b1405],
18	al.	FW	O	al.	dep	16	SENT_102	[p5l1812t1345r1906b1418],
19	,	,	O	,	_	0	SENT_102	[p5l1812t1345r1906b1418],
20	1997	CD	DATE	1997	num	21	SENT_102	[p5l1939t1345r2139b1422],
21	)	NN	O	)	appos	16	SENT_102	[p5l1939t1345r2139b1422],
22	.	.	O	.	_	0	SENT_102	[p5l1939t1345r2139b1422],

1	Per	IN	O	per	amod	3	SENT_103	[p5l109t1450r221b1508],
2	the	DT	O	the	det	3	SENT_103	[p5l244t1447r344b1508],
3	literature	NN	O	literature	tmod	12	SENT_103	[p5l372t1447r669b1508],
4	and	CC	O	and	_	0	SENT_103	[p5l697t1447r816b1508],
5	our	PRP$	O	we	poss	6	SENT_103	[p5l843t1467r954b1508],
6	case	NN	O	case	tmod	12	SENT_103	[p5l979t1467r1137b1521],
7	,	,	O	,	_	0	SENT_103	[p5l979t1467r1137b1521],
8	the	DT	O	the	det	11	SENT_103	[p5l1167t1447r1267b1508],
9	very	RB	O	very	advmod	10	SENT_103	[p5l1293t1467r1442b1525],
10	limited	JJ	O	limited	amod	11	SENT_103	[p5l1468t1447r1702b1508],
11	data	NNS	O	datum	nsubj	12	SENT_103	[p5l1730t1447r1867b1508],
12	suggest	VBP	O	suggest	_	0	SENT_103	[p5l1894t1456r2144b1525],
13	that	IN	O	that	complm	19	SENT_103	[p5l7t1549r132b1610],
14	hydrocodone	NN	O	hydrocodone	nsubj	19	SENT_103	[p5l151t1549r591b1627],
15	may	MD	O	may	aux	19	SENT_103	[p5l613t1569r757b1627],
16	be	VB	O	be	cop	19	SENT_103	[p5l776t1549r854b1610],
17	a	DT	O	a	det	19	SENT_103	[p5l879t1569r914b1610],
18	better	JJR	O	better	amod	19	SENT_103	[p5l932t1549r1124b1610],
19	option	NN	O	option	ccomp	12	SENT_103	[p5l1144t1549r1358b1627],
20	for	IN	O	for	_	0	SENT_103	[p5l1380t1549r1476b1610],
21	CYP2D6	NN	O	cyp2d6	nn	22	SENT_103	[p5l1497t1551r1802b1610],
22	PMs	NNS	O	pm	prep_for	19	SENT_103	[p5l1825t1552r1976b1610],
23	than	IN	O	than	_	0	SENT_103	[p5l1999t1549r2143b1610],
24	codeine	NN	O	codeine	prep_than	22	SENT_103	[p5l9t1651r285b1724],
25	,	,	O	,	_	0	SENT_103	[p5l9t1651r285b1724],
26	and	CC	O	and	cc	22	SENT_103	[p5l330t1651r449b1712],
27	perhaps	RB	O	perhaps	advmod	22	SENT_103	[p5l487t1651r746b1728],
28	oxycodone	NN	O	oxycodone	dep	22	SENT_103	[p5l790t1651r1175b1729],
29	.	.	O	.	_	0	SENT_103	[p5l790t1651r1175b1729],

1	More	RBR	O	more	advmod	2	SENT_104	[p5l1220t1653r1399b1712],
2	importantly	RB	O	importantly	advmod	6	SENT_104	[p5l1441t1651r1843b1729],
3	,	,	O	,	_	0	SENT_104	[p5l1441t1651r1843b1729],
4	a	DT	O	a	det	5	SENT_104	[p5l1888t1671r1923b1711],
5	study	NN	O	study	nsubj	6	SENT_104	[p5l1964t1651r2143b1729],
6	needs	VBZ	O	need	dep	39	SENT_104	[p5l7t1753r195b1813],
7	to	TO	O	to	aux	8	SENT_104	[p5l235t1761r297b1813],
8	explore	VB	O	explore	xcomp	6	SENT_104	[p5l339t1753r586b1830],
9	whether	IN	O	whether	_	0	SENT_104	[p5l625t1753r897b1813],
10	patients	NNS	O	patient	prep_whether	8	SENT_104	[p5l931t1753r1190b1830],
11	with	IN	O	with	_	0	SENT_104	[p5l1230t1753r1378b1813],
12	unusual	JJ	O	unusual	amod	13	SENT_104	[p5l1415t1753r1677b1813],
13	responses	NNS	O	response	prep_with	10	SENT_104	[p5l1715t1772r2040b1830],
14	to	TO	O	to	_	0	SENT_104	[p5l2078t1761r2141b1813],
15	hydrocodone	NN	O	hydrocodone	prep_to	13	SENT_104	[p5l7t1855r465b1933],
16	,	,	O	,	_	0	SENT_104	[p5l7t1855r465b1933],
17	oxycodone	NN	O	oxycodone	prep_to	13	SENT_104	[p5l503t1855r889b1933],
18	,	,	O	,	_	0	SENT_104	[p5l503t1855r889b1933],
19	tramadol	NN	O	tramadol	prep_to	13	SENT_104	[p5l927t1855r1222b1916],
20	and	CC	O	and	_	0	SENT_104	[p5l1259t1855r1378b1916],
21	dihydrocodeine	NN	O	dihydrocodeine	prep_to	13	SENT_104	[p5l1413t1855r1934b1933],
22	overrepresent	JJ	O	overrepresent	amod	23	SENT_104	[p5l1970t1875r2142b1916, p5l7t1966r313b2035],
23	subjects	NNS	O	subject	dobj	8	SENT_104	[p5l357t1957r621b2035],
24	with	IN	O	with	_	0	SENT_104	[p5l665t1957r813b2018],
25	unusual	JJ	O	unusual	amod	38	SENT_104	[p5l854t1957r1116b2018],
26	CYP2D6	NN	O	cyp2d6	nn	28	SENT_104	[p5l1160t1959r1465b2018],
27	genetic	JJ	O	genetic	amod	28	SENT_104	[p5l1511t1957r1749b2035],
28	variations	NNS	O	variation	tmod	25	SENT_104	[p5l1792t1957r2139b2031],
29	,	,	O	,	_	0	SENT_104	[p5l1792t1957r2139b2031],
30	such	JJ	O	such	_	0	SENT_104	[p5l10t2059r160b2120],
31	as	IN	O	as	_	0	SENT_104	[p5l183t2079r247b2120],
32	CYP2D6	NN	O	cyp2d6	nn	33	SENT_104	[p5l272t2061r576b2120],
33	PMs	NNS	O	pm	prep_such_as	28	SENT_104	[p5l600t2062r751b2120],
34	or	CC	O	or	_	0	SENT_104	[p5l775t2079r844b2120],
35	even	RB	O	even	advmod	36	SENT_104	[p5l865t2079r1021b2120],
36	CYP2D6	NN	O	cyp2d6	conj_or	33	SENT_104	[p5l1043t2061r1347b2120],
37	ultrarapid	JJ	O	ultrarapid	amod	38	SENT_104	[p5l1370t2059r1696b2137],
38	metabolizers	NNS	O	metabolizer	prep_with	23	SENT_104	[p5l1716t2059r2141b2120],
39	(	VBP	O	(	_	0	SENT_104	[p5l9t2161r227b2238],
40	UMs	NNS	O	um	nsubj	44	SENT_104	[p5l9t2161r227b2238],
41	)	CD	NUMBER	)	number	42	SENT_104	[p5l9t2161r227b2238],
42	(	CD	NUMBER	(	num	44	SENT_104	[p5l254t2161r357b2238],
43	de	IN	O	de	amod	44	SENT_104	[p5l254t2161r357b2238],
44	Leon	NNP	O	Leon	xcomp	39	SENT_104	[p5l382t2163r554b2221],
45	et	FW	O	et	nn	46	SENT_104	[p5l578t2169r636b2221],
46	al.	FW	O	al.	nsubj	39	SENT_104	[p5l660t2161r755b2234],
47	,	,	O	,	_	0	SENT_104	[p5l660t2161r755b2234],
48	2003	CD	DATE	2003	appos	46	SENT_104	[p5l783t2162r969b2234],
49	;	:	O	;	_	0	SENT_104	[p5l783t2162r969b2234],
50	Gasche	NNP	O	Gasche	dep	48	SENT_104	[p5l999t2161r1242b2222],
51	et	FW	O	et	nn	52	SENT_104	[p5l1269t2169r1326b2221],
52	al.	FW	O	al.	dep	50	SENT_104	[p5l1350t2161r1445b2234],
53	,	,	O	,	_	0	SENT_104	[p5l1350t2161r1445b2234],
54	2004	CD	DATE	2004	num	55	SENT_104	[p5l1473t2161r1684b2238],
55	)	NN	O	)	appos	52	SENT_104	[p5l1473t2161r1684b2238],
56	.	.	O	.	_	0	SENT_104	[p5l1473t2161r1684b2238],

1	Next	RB	O	next	advmod	14	SENT_105	[p5l1711t2163r1893b2234],
2	,	,	O	,	_	0	SENT_105	[p5l1711t2163r1893b2234],
3	a	DT	O	a	det	6	SENT_105	[p5l1922t2181r1957b2221],
4	large	JJ	O	large	amod	6	SENT_105	[p5l1980t2161r2142b2239],
5	case-control	JJ	O	case-control	amod	6	SENT_105	[p5l9t2263r414b2324],
6	study	NN	O	study	nsubjpass	14	SENT_105	[p5l455t2263r634b2341],
7	in	IN	O	in	_	0	SENT_105	[p5l673t2264r736b2323],
8	patents	NNS	O	patent	prep_in	6	SENT_105	[p5l771t2272r1008b2341],
9	taking	VBG	O	take	partmod	8	SENT_105	[p5l1047t2263r1256b2341],
10	these	DT	O	these	det	11	SENT_105	[p5l1293t2263r1463b2324],
11	analgesics	NNS	O	analgesic	dobj	9	SENT_105	[p5l1504t2263r1844b2341],
12	may	MD	O	may	aux	14	SENT_105	[p5l1884t2283r2027b2341],
13	be	VB	O	be	auxpass	14	SENT_105	[p5l2064t2263r2142b2324],
14	needed	VBN	O	need	_	0	SENT_105	[p5l7t2365r262b2439],
15	,	,	O	,	_	0	SENT_105	[p5l7t2365r262b2439],
16	controlling	VBG	O	control	xcomp	14	SENT_105	[p5l313t2365r678b2443],
17	for	IN	O	for	_	0	SENT_105	[p5l726t2365r822b2426],
18	confounders	NNS	O	confounder	prep_for	16	SENT_105	[p5l868t2365r1279b2426],
19	(	CD	NUMBER	(	num	18	SENT_105	[p5l1329t2365r1432b2443],
20	de	IN	O	de	_	0	SENT_105	[p5l1329t2365r1432b2443],
21	Leon	NNP	O	Leon	prep_de	18	SENT_105	[p5l1479t2368r1650b2426],
22	et	FW	O	et	nn	23	SENT_105	[p5l1698t2374r1756b2426],
23	al.	FW	O	al.	dobj	16	SENT_105	[p5l1802t2365r1898b2439],
24	,	,	O	,	_	0	SENT_105	[p5l1802t2365r1898b2439],
25	2005	CD	DATE	2005	num	26	SENT_105	[p5l1948t2366r2141b2443],
26	)	NN	O	)	appos	23	SENT_105	[p5l1948t2366r2141b2443],
27	associated	VBN	O	associate	partmod	26	SENT_105	[p5l9t2467r350b2528],
28	with	IN	O	with	_	0	SENT_105	[p5l366t2467r514b2528],
29	lack	NN	O	lack	prep_with	27	SENT_105	[p5l532t2467r670b2528],
30	of	IN	O	of	_	0	SENT_105	[p5l687t2467r763b2528],
31	response	NN	O	response	prep_of	29	SENT_105	[p5l769t2487r1078b2544],
32	.	.	O	.	_	0	SENT_105	[p5l769t2487r1078b2544],

1	It	PRP	O	it	nsubj	5	SENT_106	[p5l1101t2469r1150b2527],
2	may	MD	O	may	aux	5	SENT_106	[p5l1165t2486r1309b2545],
3	be	VB	O	be	cop	5	SENT_106	[p5l1323t2467r1401b2528],
4	even	RB	O	even	advmod	5	SENT_106	[p5l1420t2487r1576b2528],
5	better	JJR	O	better	_	0	SENT_106	[p5l1591t2467r1783b2528],
6	to	TO	O	to	aux	7	SENT_106	[p5l1797t2475r1859b2528],
7	conduct	VB	O	conduct	xcomp	5	SENT_106	[p5l1879t2467r2144b2528],
8	a	DT	O	a	det	13	SENT_106	[p5l9t2588r44b2629],
9	double	JJ	O	double	amod	13	SENT_106	[p5l77t2569r506b2630],
10	—	NN	O	—	nn	13	SENT_106	[p5l77t2569r506b2630],
11	blind	JJ	O	blind	amod	12	SENT_106	[p5l77t2569r506b2630],
12	randomized	JJ	O	randomized	amod	13	SENT_106	[p5l538t2569r935b2629],
13	study	NN	O	study	dobj	7	SENT_106	[p5l971t2569r1150b2646],
14	using	VBG	O	use	xcomp	7	SENT_106	[p5l1182t2569r1364b2646],
15	CYP2D6	NN	O	cyp2d6	nn	16	SENT_106	[p5l1400t2570r1705b2630],
16	genotyping	NN	O	genotyping	dobj	14	SENT_106	[p5l1742t2569r2139b2646],
17	;	:	O	;	_	0	SENT_106	[p5l1742t2569r2139b2646],
18	unfortunately	RB	O	unfortunately	advmod	20	SENT_106	[p5l6t2671r459b2749],
19	there	EX	O	there	expl	20	SENT_106	[p5l480t2671r645b2732],
20	is	VBZ	O	be	parataxis	5	SENT_106	[p5l669t2671r720b2732],
21	limited	JJ	O	limited	amod	22	SENT_106	[p5l745t2671r980b2732],
22	experience	NN	O	experience	nsubj	20	SENT_106	[p5l1003t2671r1362b2748],
23	in	IN	O	in	_	0	SENT_106	[p5l1387t2671r1449b2731],
24	the	DT	O	the	det	26	SENT_106	[p5l1471t2671r1571b2732],
25	practical	JJ	O	practical	amod	26	SENT_106	[p5l1593t2671r1879b2748],
26	aspects	NNS	O	aspect	prep_in	22	SENT_106	[p5l1904t2679r2141b2748],
27	of	IN	O	of	_	0	SENT_106	[p5l9t2774r85b2834],
28	combining	VBG	O	combine	prepc_of	26	SENT_106	[p5l116t2773r473b2851],
29	well-controlled	JJ	O	well-controlled	amod	30	SENT_106	[p5l513t2773r1025b2834],
30	designs	NNS	O	design	dobj	28	SENT_106	[p5l1065t2773r1314b2851],
31	in	IN	O	in	_	0	SENT_106	[p5l1356t2773r1419b2833],
32	the	DT	O	the	det	34	SENT_106	[p5l1457t2773r1557b2834],
33	real	JJ	O	real	amod	34	SENT_106	[p5l1598t2773r1721b2834],
34	world	NN	O	world	prep_in	28	SENT_106	[p5l1760t2773r1956b2834],
35	with	IN	O	with	_	0	SENT_106	[p5l1994t2773r2143b2834],
36	CYP2D6	NN	O	cyp2d6	nn	37	SENT_106	[p5l9t2877r313b2936],
37	genotyping	NN	O	genotyping	prep_with	34	SENT_106	[p5l342t2875r736b2953],
38	.	.	O	.	_	0	SENT_106	[p5l342t2875r736b2953],

1	5	CD	NUMBER	5	_	0	SENT_107	[p5l9t3081r70b3139],
2	.	.	O	.	_	0	SENT_107	[p5l9t3081r70b3139],

1	Conclusions	NNS	O	conclusion	_	0	SENT_108	[p5l106t3080r536b3139],

1	This	DT	O	this	det	3	SENT_109	[p5l110t3282r257b3343],
2	CYP2D6	NN	O	cyp2d6	nn	3	SENT_109	[p5l318t3283r627b3343],
3	PM	NN	O	pm	nsubj	4	SENT_109	[p5l687t3284r807b3342],
4	had	VBD	O	have	_	0	SENT_109	[p5l864t3282r988b3343],
5	problems	NNS	O	problem	dobj	4	SENT_109	[p5l1043t3282r1360b3359],
6	with	IN	O	with	_	0	SENT_109	[p5l1419t3282r1570b3343],
7	several	JJ	O	several	amod	9	SENT_109	[p5l1630t3282r1867b3343],
8	opioid	JJ	O	opioid	amod	9	SENT_109	[p5l1926t3282r2144b3359],
9	analgesics	NNS	O	analgesic	prep_with	5	SENT_109	[p5l9t3384r348b3461],
10	and	CC	O	and	_	0	SENT_109	[p5l380t3384r499b3444],
11	knowing	VBG	O	know	csubj	15	SENT_109	[p5l526t3384r820b3461],
12	her	PRP$	O	she	poss	14	SENT_109	[p5l848t3384r956b3444],
13	CYP2D6	NN	O	cyp2d6	nn	14	SENT_109	[p5l984t3385r1289b3445],
14	genotype	NN	O	genotype	dobj	11	SENT_109	[p5l1320t3392r1626b3461],
15	helped	VBD	O	help	conj_and	4	SENT_109	[p5l1654t3384r1878b3461],
16	to	TO	O	to	aux	17	SENT_109	[p5l1905t3392r1967b3444],
17	treat	VB	O	treat	xcomp	15	SENT_109	[p5l1997t3392r2144b3444],
18	her	PRP	O	she	dobj	17	SENT_109	[p5l7t3485r124b3546],
19	.	.	O	.	_	0	SENT_109	[p5l7t3485r124b3546],

1	The	DT	O	the	det	2	SENT_110	[p5l153t3485r279b3546],
2	patient	NN	O	patient	nsubj	3	SENT_110	[p5l301t3485r530b3562],
3	had	VBD	O	have	_	0	SENT_110	[p5l551t3485r672b3546],
4	a	DT	O	a	det	8	SENT_110	[p5l696t3505r731b3545],
5	long	JJ	O	long	amod	8	SENT_110	[p5l753t3485r1213b3563],
6	—	NN	O	—	nn	8	SENT_110	[p5l753t3485r1213b3563],
7	standing	NN	O	standing	nn	8	SENT_110	[p5l753t3485r1213b3563],
8	intolerance	NN	O	intolerance	dobj	3	SENT_110	[p5l1237t3485r1605b3546],
9	to	TO	O	to	_	0	SENT_110	[p5l1628t3493r1690b3546],
10	codeine	NN	O	codeine	prep_to	8	SENT_110	[p5l1716t3485r1991b3546],
11	.	.	O	.	_	0	SENT_110	[p5l1716t3485r1991b3546],

1	She	PRP	O	she	_	0	SENT_111	[p5l2022t3485r2142b3546],

1	1358	CD	DATE	1358	num	3	SENT_112	[p5l181t3639r241b3662],
2	MT	NNP	O	MT	nn	3	SENT_112	[p5l541t3639r599b3662],
3	Susce	NNP	O	Susce	_	0	SENT_112	[p5l613t3639r688b3662],
4	et	FW	O	et	nn	5	SENT_112	[p5l700t3642r723b3662],
5	al.	FW	O	al.	dep	3	SENT_112	[p5l734t3638r763b3662],
6	/	:	O	/	punct	3	SENT_112	[p5l777t3638r791b3662],
7	Progress	NNP	O	Progress	dep	3	SENT_112	[p5l798t3639r914b3669],
8	in	IN	O	in	_	0	SENT_112	[p5l927t3640r950b3662],
9	Neuro-Psychopharmacology	NNP	ORGANIZATION	Neuro-Psychopharmacology	nn	12	SENT_112	[p5l962t3638r1340b3669],
10	&	CC	ORGANIZATION	&	_	0	SENT_112	[p5l1352t3639r1375b3662],
11	Biological	NNP	ORGANIZATION	Biological	nn	12	SENT_112	[p5l1387t3638r1525b3669],
12	Psychiatry	NNP	ORGANIZATION	Psychiatry	prep_in	7	SENT_112	[p5l1534t3638r1675b3669],
13	30	CD	NUMBER	30	num	12	SENT_112	[p5l1687t3639r1719b3662],
14	(	CD	NUMBER	(	num	15	SENT_112	[p5l1733t3638r1816b3669],
15	2006	CD	DATE	2006	dep	12	SENT_112	[p5l1733t3638r1816b3669],
16	)	CD	NUMBER	)	number	17	SENT_112	[p5l1733t3638r1816b3669],
17	13564358	CD	NUMBER	13564358	dep	15	SENT_112	[p5l1831t3639r1978b3662],

1	could	MD	O	could	aux	3	SENT_113	[p6l8t84r287b145],
2	n’t	RB	O	n’t	advmod	3	SENT_113	[p6l8t84r287b145],
3	tolerate	VB	O	tolerate	csubj	8	SENT_113	[p6l330t84r579b145],
4	the	DT	O	the	det	5	SENT_113	[p6l625t84r725b145],
5	regimen	NN	O	regimen	dobj	3	SENT_113	[p6l771t84r1046b162],
6	of	IN	O	of	_	0	SENT_113	[p6l1093t84r1170b145],
7	oxycodone	NN	O	oxycodone	prep_of	5	SENT_113	[p6l1206t84r1574b162],
8	combined	VBN	O	combine	_	0	SENT_113	[p6l1623t84r1952b145],
9	with	IN	O	with	_	0	SENT_113	[p6l1997t84r2146b145],
10	tramadol	NN	O	tramadol	nn	11	SENT_113	[p6l6t186r303b247],
11	pms	NNS	O	pm	prep_with	8	SENT_113	[p6l322t206r466b264],
12	during	IN	O	during	_	0	SENT_113	[p6l490t186r706b264],
13	her	PRP$	O	she	poss	15	SENT_113	[p6l727t186r835b247],
14	first	JJ	ORDINAL	first	amod	15	SENT_113	[p6l856t186r987b247],
15	admission	NN	O	admission	prep_during	8	SENT_113	[p6l1009t186r1365b260],
16	,	,	O	,	_	0	SENT_113	[p6l1009t186r1365b260],
17	having	VBG	O	have	xcomp	8	SENT_113	[p6l1388t186r1617b264],
18	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_113	[p6l1641t186r1992b264],
19	side	JJ	O	side	amod	20	SENT_113	[p6l2015t186r2145b247],
20	effects	NNS	O	effect	dobj	17	SENT_113	[p6l8t288r243b349],
21	.	.	O	.	_	0	SENT_113	[p6l8t288r243b349],

1	She	PRP	O	she	nsubj	2	SENT_114	[p6l273t288r393b349],
2	seemed	VBD	O	seem	_	0	SENT_114	[p6l418t288r667b349],
3	to	TO	O	to	aux	4	SENT_114	[p6l687t296r749b349],
4	have	VB	O	have	xcomp	2	SENT_114	[p6l773t288r930b349],
5	a	DT	O	a	det	7	SENT_114	[p6l954t308r989b348],
6	better	JJR	O	better	amod	7	SENT_114	[p6l1008t288r1200b349],
7	response	NN	O	response	dobj	4	SENT_114	[p6l1219t308r1512b366],
8	to	TO	O	to	_	0	SENT_114	[p6l1534t296r1596b349],
9	hydrocodone	NN	O	hydrocodone	prep_to	4	SENT_114	[p6l1619t288r2059b366],
10	in	IN	O	in	_	0	SENT_114	[p6l2083t288r2146b348],
11	her	PRP$	O	she	poss	13	SENT_114	[p6l6t390r114b451],
12	second	JJ	ORDINAL	second	amod	13	SENT_114	[p6l154t390r385b451],
13	admission	NN	O	admission	prep_in	9	SENT_114	[p6l425t390r780b451],
14	.	.	O	.	_	0	SENT_114	[p6l425t390r780b451],

1	Large	JJ	O	large	amod	2	SENT_115	[p6l824t392r1016b468],
2	case	NN	O	case	nsubj	25	SENT_115	[p6l1058t390r1464b451],
3	—	CD	NUMBER	—	num	6	SENT_115	[p6l1058t390r1464b451],
4	control	NN	O	control	nn	6	SENT_115	[p6l1058t390r1464b451],
5	naturalistic	JJ	O	naturalistic	amod	6	SENT_115	[p6l1503t390r1872b451],
6	studies	NNS	O	study	nsubjpass	18	SENT_115	[p6l1916t390r2143b451],
7	followed	VBN	O	follow	partmod	6	SENT_115	[p6l8t492r305b553],
8	by	IN	O	by	_	0	SENT_115	[p6l341t492r426b570],
9	randomized	VBN	O	randomize	agent	7	SENT_115	[p6l464t492r862b553],
10	trials	NNS	O	trial	dobj	9	SENT_115	[p6l898t492r1061b553],
11	in	IN	O	in	_	0	SENT_115	[p6l1104t492r1166b552],
12	patents	NNS	O	patent	prep_in	10	SENT_115	[p6l1203t501r1439b570],
13	taking	VBG	O	take	partmod	12	SENT_115	[p6l1479t492r1688b570],
14	opioid	JJ	O	opioid	amod	15	SENT_115	[p6l1729t492r1942b570],
15	analgesics	NNS	O	analgesic	dobj	13	SENT_115	[p6l1982t492r2144b553, p6l8t594r209b672],
16	may	MD	O	may	aux	18	SENT_115	[p6l247t614r391b672],
17	be	VB	O	be	auxpass	18	SENT_115	[p6l428t594r506b655],
18	needed	VBN	O	need	rcmod	2	SENT_115	[p6l544t594r783b655],
19	to	TO	O	to	aux	21	SENT_115	[p6l819t603r881b655],
20	definitively	RB	O	definitively	advmod	21	SENT_115	[p6l923t594r1307b672],
21	establish	VB	O	establish	xcomp	18	SENT_115	[p6l1346t594r1637b655],
22	that	DT	O	that	det	24	SENT_115	[p6l1674t594r1800b655],
23	CYP2D6	NN	O	cyp2d6	nn	24	SENT_115	[p6l1838t596r2143b655],
24	genotyping	NN	O	genotyping	dobj	21	SENT_115	[p6l8t696r385b774],
25	has	VBZ	O	have	_	0	SENT_115	[p6l417t696r527b757],
26	clinical	JJ	O	clinical	amod	27	SENT_115	[p6l563t696r805b757],
27	relevance	NN	O	relevance	dobj	25	SENT_115	[p6l838t696r1157b757],
28	in	IN	O	in	_	0	SENT_115	[p6l1192t696r1255b756],
29	the	DT	O	the	det	30	SENT_115	[p6l1286t696r1386b757],
30	use	NN	O	use	prep_in	27	SENT_115	[p6l1418t716r1529b757],
31	of	IN	O	of	_	0	SENT_115	[p6l1564t696r1641b757],
32	several	JJ	O	several	amod	34	SENT_115	[p6l1666t696r1898b757],
33	opioid	JJ	O	opioid	amod	34	SENT_115	[p6l1933t696r2146b773],
34	analgesics	NNS	O	analgesic	prep_of	30	SENT_115	[p6l8t798r366b875],
35	.	.	O	.	_	0	SENT_115	[p6l8t798r366b875],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_116	[p6l9t1002r706b1078],

1	This	DT	O	this	det	2	SENT_117	[p6l110t1204r255b1265],
2	patient	NN	O	patient	nsubjpass	4	SENT_117	[p6l279t1204r509b1281],
3	was	VBD	O	be	auxpass	4	SENT_117	[p6l531t1224r660b1265],
4	genotyped	VBN	O	genotype	_	0	SENT_117	[p6l687t1204r1038b1282],
5	with	IN	O	with	_	0	SENT_117	[p6l1060t1204r1209b1265],
6	no	DT	O	no	det	8	SENT_117	[p6l1233t1223r1315b1265],
7	external	JJ	O	external	amod	8	SENT_117	[p6l1343t1204r1609b1265],
8	support	NN	O	support	prep_with	4	SENT_117	[p6l1637t1212r1902b1281],
9	.	.	O	.	_	0	SENT_117	[p6l1637t1212r1902b1281],

1	Roche	NNP	ORGANIZATION	Roche	nn	3	SENT_118	[p6l1931t1204r2144b1265],
2	Molecular	JJ	ORGANIZATION	molecular	amod	3	SENT_118	[p6l7t1306r353b1367],
3	Systems	NNPS	ORGANIZATION	Systems	nsubj	6	SENT_118	[p6l373t1308r666b1384],
4	,	,	ORGANIZATION	,	_	0	SENT_118	[p6l373t1308r666b1384],
5	Inc.	NNP	ORGANIZATION	Inc.	appos	3	SENT_118	[p6l690t1309r810b1367],
6	markets	VBZ	O	market	_	0	SENT_118	[p6l834t1306r1097b1367],
7	the	DT	O	the	det	11	SENT_118	[p6l1117t1306r1218b1367],
8	FDA-approved	JJ	MISC	fda-approved	amod	11	SENT_118	[p6l1238t1306r1749b1384],
9	AmpliChip	NN	MISC	amplichip	nn	11	SENT_118	[p6l1767t1306r2144b1384],
10	CYP450	NN	MISC	cyp450	nn	11	SENT_118	[p6l8t1410r295b1469],
11	microarray	NN	O	microarray	dobj	6	SENT_118	[p6l317t1408r684b1486],
12	detecting	VBG	O	detect	partmod	11	SENT_118	[p6l705t1408r1008b1486],
13	the	DT	O	the	det	14	SENT_118	[p6l1029t1408r1130b1469],
14	CYP2D6	NN	O	cyp2d6	dobj	12	SENT_118	[p6l1153t1410r1457b1469],
15	and	CC	O	and	_	0	SENT_118	[p6l1482t1408r1601b1469],
16	CYP2Cl9	NN	O	cyp2cl9	nn	18	SENT_118	[p6l1622t1410r1965b1469],
17	gene	NN	O	gene	nn	18	SENT_118	[p6l1989t1428r2144b1486],
18	variations	NNS	O	variation	dobj	12	SENT_118	[p6l6t1510r334b1571],
19	using	VBG	O	use	xcomp	12	SENT_118	[p6l356t1510r538b1588],
20	a	DT	O	a	det	21	SENT_118	[p6l563t1530r598b1570],
21	technology	NN	O	technology	dobj	19	SENT_118	[p6l617t1510r992b1588],
22	developed	VBN	O	develop	partmod	21	SENT_118	[p6l1015t1510r1360b1587],
23	by	IN	O	by	_	0	SENT_118	[p6l1379t1510r1464b1588],
24	Affymetrix	NNP	ORGANIZATION	Affymetrix	agent	22	SENT_118	[p6l1484t1510r1876b1588],
25	.	.	O	.	_	0	SENT_118	[p6l1484t1510r1876b1588],

1	Jose	NNP	PERSON	Jose	nn	3	SENT_119	[p6l1903t1512r2045b1571],
2	de	NNP	PERSON	de	nn	3	SENT_119	[p6l2069t1510r2144b1571],
3	Leon	NNP	PERSON	Leon	nsubj	8	SENT_119	[p6l7t1614r196b1685],
4	,	,	O	,	_	0	SENT_119	[p6l7t1614r196b1685],
5	M.D.	NNP	O	M.D.	appos	3	SENT_119	[p6l229t1614r424b1685],
6	,	,	O	,	_	0	SENT_119	[p6l229t1614r424b1685],
7	has	VBZ	O	have	aux	8	SENT_119	[p6l457t1612r566b1672],
8	lectured	VBN	O	lecture	_	0	SENT_119	[p6l599t1612r867b1673],
9	once	RB	DATE	once	advmod	10	SENT_119	[p6l898t1631r1053b1672],
10	supported	VBN	O	support	dep	8	SENT_119	[p6l1086t1612r1416b1689],
11	by	IN	O	by	_	0	SENT_119	[p6l1444t1612r1528b1689],
12	Roche	NNP	PERSON	Roche	prep_by	10	SENT_119	[p6l1558t1612r2147b1672],
13	.	.	O	.	_	0	SENT_119	[p6l1558t1612r2147b1672],

1	—	NN	O	—	_	0	SENT_120	[p6l1558t1612r2147b1672],
2	.	.	O	.	_	0	SENT_120	[p6l1558t1612r2147b1672],

1	Molecular	JJ	O	molecular	amod	2	SENT_121	[p6l1558t1612r2147b1672],
2	Systems	NNPS	O	Systems	_	0	SENT_121	[p6l10t1715r303b1792],
3	,	,	O	,	_	0	SENT_121	[p6l10t1715r303b1792],
4	Inc.	NNP	ORGANIZATION	Inc.	appos	2	SENT_121	[p6l341t1716r461b1775],
5	.	.	O	.	_	0	SENT_121	[p6l341t1716r461b1775],

1	He	PRP	O	he	nsubj	4	SENT_122	[p6l500t1716r596b1775],
2	has	VBZ	O	have	aux	4	SENT_122	[p6l630t1714r739b1775],
3	also	RB	O	also	advmod	4	SENT_122	[p6l776t1714r906b1775],
4	received	VBN	O	receive	_	0	SENT_122	[p6l941t1714r1225b1775],
5	support	NN	O	support	dobj	4	SENT_122	[p6l1261t1722r1511b1791],
6	for	IN	O	for	_	0	SENT_122	[p6l1544t1714r1640b1775],
7	his	PRP$	O	he	poss	8	SENT_122	[p6l1671t1714r1766b1775],
8	laboratory	NN	O	laboratory	prep_for	5	SENT_122	[p6l1803t1714r2146b1792],
9	and	CC	O	and	_	0	SENT_122	[p6l8t1816r128b1877],
10	research-initiated	JJ	O	research-initiated	amod	11	SENT_122	[p6l164t1816r744b1877],
11	grants	NNS	O	grant	prep_for	5	SENT_122	[p6l782t1825r983b1894],
12	from	IN	O	from	_	0	SENT_122	[p6l1024t1816r1184b1877],
13	Roche	NNP	LOCATION	Roche	prep_from	4	SENT_122	[p6l1220t1816r1810b1877],
14	.	.	O	.	_	0	SENT_122	[p6l1220t1816r1810b1877],

1	—	NN	O	—	_	0	SENT_123	[p6l1220t1816r1810b1877],
2	.	.	O	.	_	0	SENT_123	[p6l1220t1816r1810b1877],

1	Molecular	JJ	O	molecular	amod	2	SENT_124	[p6l1220t1816r1810b1877],
2	Systems	NNPS	O	Systems	nsubj	10	SENT_124	[p6l1849t1818r2142b1894],
3	,	,	O	,	_	0	SENT_124	[p6l1849t1818r2142b1894],
4	Inc.	NNP	ORGANIZATION	Inc.	appos	2	SENT_124	[p6l7t1921r151b1992],
5	,	,	O	,	_	0	SENT_124	[p6l7t1921r151b1992],
6	but	CC	O	but	prep	2	SENT_124	[p6l172t1918r281b1979],
7	he	PRP	O	he	dep	6	SENT_124	[p6l298t1918r376b1979],
8	has	VBZ	O	have	aux	10	SENT_124	[p6l395t1918r505b1979],
9	not	RB	O	not	neg	10	SENT_124	[p6l525t1926r633b1979],
10	received	VBN	O	receive	_	0	SENT_124	[p6l650t1918r933b1979],
11	any	DT	O	any	det	13	SENT_124	[p6l954t1938r1073b1996],
12	consultant	NN	O	consultant	nn	13	SENT_124	[p6l1093t1918r1438b1979],
13	payments	NNS	O	payment	dobj	10	SENT_124	[p6l1453t1926r1793b1996],
14	.	.	O	.	_	0	SENT_124	[p6l1453t1926r1793b1996],

1	He	PRP	O	he	nsubj	2	SENT_125	[p6l1817t1921r1913b1979],
2	has	VBZ	O	have	_	0	SENT_125	[p6l1932t1918r2042b1979],
3	no	DT	O	no	det	6	SENT_125	[p6l2062t1938r2143b1979],
4	other	JJ	O	other	amod	6	SENT_125	[p6l8t2020r179b2081],
5	financial	JJ	O	financial	amod	6	SENT_125	[p6l216t2020r505b2081],
6	arrangements	NNS	O	arrangement	dobj	2	SENT_125	[p6l543t2028r992b2098],
7	with	IN	O	with	_	0	SENT_125	[p6l1029t2020r1178b2081],
8	Roche	NNP	ORGANIZATION	Roche	nn	10	SENT_125	[p6l1214t2020r1428b2081],
9	Molecular	JJ	ORGANIZATION	molecular	amod	10	SENT_125	[p6l1465t2020r1811b2081],
10	Systems	NNPS	ORGANIZATION	Systems	prep_with	6	SENT_125	[p6l1849t2021r2142b2098],
11	,	,	ORGANIZATION	,	_	0	SENT_125	[p6l1849t2021r2142b2098],
12	Inc.	NNP	ORGANIZATION	Inc.	appos	10	SENT_125	[p6l7t2125r128b2183],
13	.	.	O	.	_	0	SENT_125	[p6l7t2125r128b2183],

1	He	PRP	O	he	nsubj	2	SENT_126	[p6l161t2125r256b2183],
2	has	VBZ	O	have	_	0	SENT_126	[p6l284t2122r393b2183],
3	no	DT	O	no	det	4	SENT_126	[p6l422t2142r504b2183],
4	stocks	NNS	O	stock	dobj	2	SENT_126	[p6l536t2122r741b2183],
5	from	IN	O	from	_	0	SENT_126	[p6l771t2123r931b2183],
6	Roche	NNP	LOCATION	Roche	prep_from	4	SENT_126	[p6l959t2122r1172b2183],
7	or	CC	O	or	_	0	SENT_126	[p6l1202t2142r1271b2183],
8	Affymetrix	NNP	O	Affymetrix	prep_from	4	SENT_126	[p6l1295t2123r1686b2200],
9	.	.	O	.	_	0	SENT_126	[p6l1295t2123r1686b2200],

1	References	NNS	O	reference	_	0	SENT_127	[p6l7t2327r394b2386],

1	Chen	NNP	ORGANIZATION	Chen	nn	2	SENT_128	[p6l8t2524r148b2572],
2	ZR	NNP	ORGANIZATION	ZR	_	0	SENT_128	[p6l179t2526r278b2582],
3	,	,	O	,	_	0	SENT_128	[p6l179t2526r278b2582],
4	Irvine	NNP	ORGANIZATION	Irvine	nn	5	SENT_128	[p6l312t2524r470b2572],
5	RJ	NN	ORGANIZATION	rj	appos	2	SENT_128	[p6l501t2526r586b2582],
6	,	,	O	,	_	0	SENT_128	[p6l501t2526r586b2582],
7	Somogyi	NNP	ORGANIZATION	Somogyi	nn	8	SENT_128	[p6l623t2524r862b2585],
8	AA	NNP	ORGANIZATION	AA	appos	2	SENT_128	[p6l892t2525r1003b2582],
9	,	,	O	,	_	0	SENT_128	[p6l892t2525r1003b2582],
10	Bochner	NNP	PERSON	Bochner	nn	13	SENT_128	[p6l1037t2524r1266b2572],
11	F.	NNP	O	F.	nn	13	SENT_128	[p6l1295t2526r1339b2572],
12	u-receptor	NN	O	u-receptor	nn	13	SENT_128	[p6l1376t2530r1655b2585],
13	binding	NN	O	binding	appos	2	SENT_128	[p6l1682t2524r1888b2585],
14	of	IN	O	of	_	0	SENT_128	[p6l1921t2524r1983b2572],
15	some	DT	O	some	det	18	SENT_128	[p6l2008t2539r2146b2572],
16	commonly	RB	O	commonly	advmod	17	SENT_128	[p6l109t2607r395b2669],
17	used	VBN	O	use	amod	18	SENT_128	[p6l416t2607r540b2655],
18	opioids	NNS	O	opioid	prep_of	13	SENT_128	[p6l562t2607r756b2669],
19	and	CC	O	and	_	0	SENT_128	[p6l781t2607r876b2655],
20	their	PRP$	O	they	poss	21	SENT_128	[p6l897t2607r1020b2655],
21	metabolites	NNS	O	metabolite	prep_of	13	SENT_128	[p6l1039t2607r1360b2655],
22	.	.	O	.	_	0	SENT_128	[p6l1039t2607r1360b2655],

1	Life	NNP	O	Life	nn	3	SENT_129	[p6l1386t2607r1494b2655],
2	Sci	NNP	O	Sci	nn	3	SENT_129	[p6l1520t2607r1600b2655],
3	l99l	NN	O	l99l	_	0	SENT_129	[p6l1630t2608r2118b2665],
4	;	:	O	;	_	0	SENT_129	[p6l1630t2608r2118b2665],
5	48:2165	CD	NUMBER	48:2165	number	6	SENT_129	[p6l1630t2608r2118b2665],
6	—	CD	NUMBER	—	num	7	SENT_129	[p6l1630t2608r2118b2665],
7	7l	NN	O	7l	dep	3	SENT_129	[p6l1630t2608r2118b2665],
8	.	.	O	.	_	0	SENT_129	[p6l1630t2608r2118b2665],

1	de	IN	PERSON	de	amod	3	SENT_130	[p6l7t2689r68b2737],
2	Leon	NNP	PERSON	Leon	nn	3	SENT_130	[p6l88t2691r226b2737],
3	J	NNP	PERSON	J	_	0	SENT_130	[p6l244t2691r283b2747],
4	,	,	O	,	_	0	SENT_130	[p6l244t2691r283b2747],
5	Dinsmore	NNP	PERSON	Dinsmore	nn	6	SENT_130	[p6l305t2689r568b2737],
6	L	NNP	O	L	appos	3	SENT_130	[p6l588t2691r642b2747],
7	,	,	O	,	_	0	SENT_130	[p6l588t2691r642b2747],
8	Wedlund	NNP	PERSON	Wedlund	nn	9	SENT_130	[p6l664t2689r906b2738],
9	PJ	NNP	PERSON	PJ	appos	6	SENT_130	[p6l924t2691r999b2737],
10	.	.	O	.	_	0	SENT_130	[p6l924t2691r999b2737],

1	Adverse	JJ	O	adverse	amod	3	SENT_131	[p6l1022t2689r1244b2737],
2	drug	NN	O	drug	nn	3	SENT_131	[p6l1266t2689r1386b2751],
3	reactions	NNS	O	reaction	_	0	SENT_131	[p6l1405t2689r1644b2737],
4	to	TO	O	to	_	0	SENT_131	[p6l1665t2696r1714b2737],
5	oxycodone	NN	O	oxycodone	prep_to	3	SENT_131	[p6l1736t2689r2030b2751],
6	and	CC	O	and	_	0	SENT_131	[p6l2051t2689r2147b2737],
7	hydrocodone	NN	O	hydrocodone	conj_and	5	SENT_131	[p6l108t2772r458b2834],
8	in	IN	O	in	_	0	SENT_131	[p6l490t2772r541b2820],
9	CYPZD6	NN	O	cypzd6	nn	11	SENT_131	[p6l572t2773r815b2820],
10	ultrarapid	NN	O	ultrarapid	nn	11	SENT_131	[p6l845t2772r1106b2834],
11	metabolizers	NNS	O	metabolizer	prep_in	3	SENT_131	[p6l1135t2772r1474b2820],
12	(	CD	NUMBER	(	num	13	SENT_131	[p6l1507t2772r1697b2833],
13	letter	NN	O	letter	dep	3	SENT_131	[p6l1507t2772r1697b2833],
14	)	CD	NUMBER	)	dep	13	SENT_131	[p6l1507t2772r1697b2833],
15	.	.	O	.	_	0	SENT_131	[p6l1507t2772r1697b2833],

1	J	NNP	O	J	nn	3	SENT_132	[p6l1732t2774r1757b2820],
2	Clin	NNP	O	Clin	nn	3	SENT_132	[p6l1787t2772r1901b2820],
3	Psychopharrnacol	NNP	O	Psychopharrnacol	_	0	SENT_132	[p6l1931t2772r2145b2834, p6l107t2856r390b2918],
4	2003	CD	DATE	2003	num	3	SENT_132	[p6l412t2857r839b2914],
5	;	:	O	;	_	0	SENT_132	[p6l412t2857r839b2914],
6	23:420	CD	NUMBER	23:420	number	7	SENT_132	[p6l412t2857r839b2914],
7	—	CD	NUMBER	—	num	8	SENT_132	[p6l412t2857r839b2914],
8	l.	NN	O	l.	dep	3	SENT_132	[p6l412t2857r839b2914],

1	de	IN	PERSON	de	_	0	SENT_133	[p6l7t2939r68b2987],
2	Leon	NNP	PERSON	Leon	nn	3	SENT_133	[p6l99t2941r237b2987],
3	J	NNP	PERSON	J	dep	1	SENT_133	[p6l267t2941r306b2997],
4	,	,	O	,	_	0	SENT_133	[p6l267t2941r306b2997],
5	Susce	NNP	O	Susce	nn	6	SENT_133	[p6l343t2940r494b2987],
6	MT	NNP	O	MT	appos	3	SENT_133	[p6l526t2941r635b2997],
7	,	,	O	,	_	0	SENT_133	[p6l526t2941r635b2997],
8	Pan	NNP	O	Pan	nn	9	SENT_133	[p6l668t2941r769b2987],
9	RM	NN	O	rm	appos	3	SENT_133	[p6l798t2941r917b2997],
10	,	,	O	,	_	0	SENT_133	[p6l798t2941r917b2997],
11	Fairchild	NNP	O	Fairchild	nn	12	SENT_133	[p6l950t2939r1191b2987],
12	M	NNP	O	M	appos	3	SENT_133	[p6l1221t2941r1294b2997],
13	,	,	O	,	_	0	SENT_133	[p6l1221t2941r1294b2997],
14	Koch	NNP	PERSON	Koch	nn	15	SENT_133	[p6l1327t2939r1473b2987],
15	WH	NNP	PERSON	WH	appos	3	SENT_133	[p6l1502t2941r1628b2997],
16	,	,	O	,	_	0	SENT_133	[p6l1502t2941r1628b2997],
17	Wedlund	NNP	PERSON	Wedlund	nn	18	SENT_133	[p6l1661t2939r1903b2987],
18	PJ	NNP	PERSON	PJ	appos	3	SENT_133	[p6l1933t2941r2008b2987],
19	.	.	O	.	_	0	SENT_133	[p6l1933t2941r2008b2987],

1	The	DT	O	the	det	2	SENT_134	[p6l2043t2939r2145b2987],
2	CYPZD6	NN	O	cypzd6	nsubjpass	8	SENT_134	[p6l110t3022r353b3069],
3	poor	JJ	O	poor	amod	5	SENT_134	[p6l379t3037r505b3083],
4	metabolizer	NN	O	metabolizer	nn	5	SENT_134	[p6l528t3021r845b3069],
5	phenotype	NN	O	phenotype	dep	2	SENT_134	[p6l867t3021r1148b3083],
6	may	MD	O	may	aux	8	SENT_134	[p6l1174t3037r1289b3083],
7	be	VB	O	be	auxpass	8	SENT_134	[p6l1313t3021r1375b3069],
8	associated	VBN	O	associate	_	0	SENT_134	[p6l1404t3021r1677b3069],
9	with	IN	O	with	_	0	SENT_134	[p6l1701t3021r1820b3069],
10	risperidone	NN	O	risperidone	prep_with	8	SENT_134	[p6l1845t3021r2146b3083],
11	adverse	JJ	O	adverse	amod	13	SENT_134	[p6l110t3105r311b3153],
12	drug	NN	O	drug	nn	13	SENT_134	[p6l349t3105r469b3167],
13	reactions	NNS	O	reaction	tmod	8	SENT_134	[p6l505t3105r744b3153],
14	and	CC	O	and	_	0	SENT_134	[p6l783t3105r878b3153],
15	discontinuation	NN	O	discontinuation	conj_and	13	SENT_134	[p6l915t3105r1339b3153],
16	.	.	O	.	_	0	SENT_134	[p6l915t3105r1339b3153],

1	J	NNP	O	J	nn	3	SENT_135	[p6l1379t3107r1404b3153],
2	Clin	NNP	O	Clin	nn	3	SENT_135	[p6l1441t3105r1554b3153],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_135	[p6l1589t3105r1872b3167],
4	2005	CD	DATE	2005	num	3	SENT_135	[p6l1907t3106r2038b3153],
5	;	:	O	;	_	0	SENT_135	[p6l2047t3106r2142b3163],
6	66	CD	NUMBER	66	num	8	SENT_135	[p6l2047t3106r2142b3163],
7	:	:	O	:	_	0	SENT_135	[p6l2047t3106r2142b3163],
8	15-27	CD	DATE	15-27	dep	3	SENT_135	[p6l115t3190r296b3237],
9	.	.	O	.	_	0	SENT_135	[p6l115t3190r296b3237],

1	Desmeules	NNS	O	desmeule	nn	2	SENT_136	[p6l6t3271r299b3319],
2	J	NN	O	j	_	0	SENT_136	[p6l322t3273r360b3329],
3	,	,	O	,	_	0	SENT_136	[p6l322t3273r360b3329],
4	Gascon	NNP	PERSON	Gascon	nn	5	SENT_136	[p6l386t3272r586b3319],
5	MP	NNP	O	MP	appos	2	SENT_136	[p6l608t3273r711b3329],
6	,	,	O	,	_	0	SENT_136	[p6l608t3273r711b3329],
7	Dayer	NNP	O	Dayer	nn	8	SENT_136	[p6l736t3273r900b3333],
8	P	NN	O	p	appos	2	SENT_136	[p6l920t3273r963b3329],
9	,	,	O	,	_	0	SENT_136	[p6l920t3273r963b3329],
10	Magistris	NNP	O	Magistris	nn	12	SENT_136	[p6l988t3271r1238b3333],
11	M.	NNP	O	M.	nn	12	SENT_136	[p6l1262t3273r1333b3319],
12	Impact	NNP	O	Impact	appos	2	SENT_136	[p6l1360t3273r1545b3333],
13	of	IN	O	of	_	0	SENT_136	[p6l1566t3271r1628b3319],
14	environmental	JJ	O	environmental	amod	17	SENT_136	[p6l1643t3271r2028b3319],
15	and	CC	O	and	_	0	SENT_136	[p6l2051t3271r2147b3319],
16	genetic	JJ	O	genetic	conj_and	14	SENT_136	[p6l109t3354r300b3416],
17	factors	NNS	O	factor	prep_of	12	SENT_136	[p6l323t3354r501b3403],
18	on	IN	O	on	_	0	SENT_136	[p6l525t3370r591b3403],
19	codeine	NN	O	codeine	nn	20	SENT_136	[p6l613t3354r819b3403],
20	analgesia	NN	O	analgesia	prep_on	12	SENT_136	[p6l843t3354r1102b3416],
21	.	.	O	.	_	0	SENT_136	[p6l843t3354r1102b3416],

1	Eur	NNP	O	Eur	nn	5	SENT_137	[p6l1128t3356r1225b3403],
2	J	NNP	O	J	nn	5	SENT_137	[p6l1245t3356r1270b3403],
3	Clin	NNP	O	Clin	nn	5	SENT_137	[p6l1293t3354r1406b3403],
4	Pharrnacol	NNP	O	Pharrnacol	nn	5	SENT_137	[p6l1427t3354r1713b3403],
5	l991	NN	O	l991	_	0	SENT_137	[p6l1742t3356r2128b3412],
6	;	:	O	;	_	0	SENT_137	[p6l1742t3356r2128b3412],
7	4l	NN	O	4l	dep	5	SENT_137	[p6l1742t3356r2128b3412],
8	:23	CD	NUMBER	:23	num	7	SENT_137	[p6l1742t3356r2128b3412],
9	—	NN	O	—	dep	7	SENT_137	[p6l1742t3356r2128b3412],
10	6	CD	NUMBER	6	num	9	SENT_137	[p6l1742t3356r2128b3412],
11	.	.	O	.	_	0	SENT_137	[p6l1742t3356r2128b3412],

1	Eckhardt	NNP	PERSON	Eckhardt	nn	2	SENT_138	[p6l7t3438r249b3486],
2	K	NNP	PERSON	K	_	0	SENT_138	[p6l277t3440r339b3496],
3	,	,	O	,	_	0	SENT_138	[p6l277t3440r339b3496],
4	Li	NNP	PERSON	Li	nn	5	SENT_138	[p6l373t3438r431b3485],
5	S	NNP	PERSON	S	appos	2	SENT_138	[p6l464t3439r512b3496],
6	,	,	O	,	_	0	SENT_138	[p6l464t3439r512b3496],
7	Ammon	NNP	PERSON	Ammon	nn	8	SENT_138	[p6l544t3439r766b3486],
8	S	NNP	O	S	appos	2	SENT_138	[p6l799t3439r846b3496],
9	,	,	O	,	_	0	SENT_138	[p6l799t3439r846b3496],
10	Schanzle	NNP	PERSON	Schanzle	nn	11	SENT_138	[p6l882t3438r1120b3486],
11	G	NNP	PERSON	G	appos	2	SENT_138	[p6l1152t3439r1212b3496],
12	,	,	O	,	_	0	SENT_138	[p6l1152t3439r1212b3496],
13	Mikus	NNP	PERSON	Mikus	nn	14	SENT_138	[p6l1245t3438r1415b3486],
14	G	NNP	PERSON	G	appos	2	SENT_138	[p6l1449t3439r1509b3496],
15	,	,	O	,	_	0	SENT_138	[p6l1449t3439r1509b3496],
16	Eichelbaum	NNP	PERSON	Eichelbaum	nn	19	SENT_138	[p6l1543t3438r1862b3486],
17	M.	NNP	PERSON	M.	nn	19	SENT_138	[p6l1892t3440r1964b3486],
18	Same	JJ	PERSON	same	amod	19	SENT_138	[p6l2001t3439r2145b3486],
19	incidence	NN	O	incidence	appos	2	SENT_138	[p6l109t3520r364b3568],
20	of	IN	O	of	_	0	SENT_138	[p6l382t3520r444b3568],
21	adverse	JJ	O	adverse	amod	23	SENT_138	[p6l454t3520r656b3568],
22	drug	NN	O	drug	nn	23	SENT_138	[p6l674t3520r795b3582],
23	events	NNS	O	event	prep_of	19	SENT_138	[p6l814t3527r981b3568],
24	after	IN	O	after	_	0	SENT_138	[p6l1001t3520r1122b3568],
25	codeine	NN	O	codeine	nn	26	SENT_138	[p6l1139t3520r1345b3568],
26	administration	NN	O	administration	prep_after	23	SENT_138	[p6l1363t3520r1748b3568],
27	irrespective	RB	O	irrespective	_	0	SENT_138	[p6l1765t3520r2074b3582],
28	of	IN	O	of	_	0	SENT_138	[p6l2093t3520r2154b3568],
29	the	DT	O	the	det	32	SENT_138	[p6l108t3603r189b3652],
30	genetically	RB	O	genetically	advmod	31	SENT_138	[p6l237t3603r538b3665],
31	determined	VBN	O	determine	amod	32	SENT_138	[p6l585t3603r892b3652],
32	differences	NNS	O	difference	prep_irrespective_of	23	SENT_138	[p6l938t3603r1238b3652],
33	in	IN	O	in	_	0	SENT_138	[p6l1287t3603r1338b3651],
34	morphine	NN	O	morphine	nn	35	SENT_138	[p6l1383t3603r1645b3665],
35	formation	NN	O	formation	prep_in	32	SENT_138	[p6l1693t3603r1975b3652],
36	.	.	O	.	_	0	SENT_138	[p6l1693t3603r1975b3652],

1	Pain	NN	O	pain	nn	2	SENT_139	[p6l2025t3603r2146b3651],
2	l998	NN	O	l998	_	0	SENT_139	[p6l115t3689r536b3743],
3	;	:	O	;	_	0	SENT_139	[p6l115t3689r536b3743],
4	76:27	CD	NUMBER	76:27	number	5	SENT_139	[p6l115t3689r536b3743],
5	—	CD	NUMBER	—	dep	2	SENT_139	[p6l115t3689r536b3743],
6	33	CD	NUMBER	33	dep	5	SENT_139	[p6l115t3689r536b3743],
7	.	.	O	.	_	0	SENT_139	[p6l115t3689r536b3743],

1	Gasche	NNP	O	Gasche	nn	2	SENT_140	[p7l7t21r202b69],
2	Y	NN	O	y	_	0	SENT_140	[p7l231t23r284b79],
3	,	,	O	,	_	0	SENT_140	[p7l231t23r284b79],
4	Daali	NNP	PERSON	Daali	nn	5	SENT_140	[p7l316t21r460b69],
5	Y	NN	PERSON	y	appos	2	SENT_140	[p7l489t23r542b79],
6	,	,	O	,	_	0	SENT_140	[p7l489t23r542b79],
7	Fathi	NNP	PERSON	Fathi	nn	8	SENT_140	[p7l574t21r710b69],
8	M	NNP	PERSON	M	appos	5	SENT_140	[p7l740t23r813b79],
9	,	,	O	,	_	0	SENT_140	[p7l740t23r813b79],
10	Chiappe	NNP	PERSON	Chiappe	nn	11	SENT_140	[p7l846t21r1067b82],
11	A	NNP	O	A	appos	5	SENT_140	[p7l1096t22r1158b79],
12	,	,	O	,	_	0	SENT_140	[p7l1096t22r1158b79],
13	Cottini	NNP	PERSON	Cottini	nn	14	SENT_140	[p7l1192t21r1375b69],
14	S	NNP	O	S	appos	5	SENT_140	[p7l1408t22r1455b79],
15	,	,	O	,	_	0	SENT_140	[p7l1408t22r1455b79],
16	Dayer	NNP	O	Dayer	nn	17	SENT_140	[p7l1487t23r1652b82],
17	P	NN	O	p	appos	5	SENT_140	[p7l1678t23r1722b79],
18	,	,	O	,	_	0	SENT_140	[p7l1678t23r1722b79],
19	et	FW	O	et	nn	20	SENT_140	[p7l1755t28r1801b69],
20	al.	FW	O	al.	appos	5	SENT_140	[p7l1831t21r1889b69],
21	.	.	O	.	_	0	SENT_140	[p7l1831t21r1889b69],

1	Codeine	NNP	O	Codeine	nn	2	SENT_141	[p7l1924t21r2145b69],
2	intoxication	NN	O	intoxication	nsubj	3	SENT_141	[p7l109t104r428b152],
3	associated	VBN	O	associate	_	0	SENT_141	[p7l447t104r721b152],
4	with	IN	O	with	_	0	SENT_141	[p7l739t104r858b152],
5	ultrarapid	JJ	O	ultrarapid	amod	7	SENT_141	[p7l876t104r1136b166],
6	CYPZD6	NN	O	cypzd6	nn	7	SENT_141	[p7l1156t105r1399b152],
7	metabolism	NN	O	metabolism	prep_with	3	SENT_141	[p7l1420t104r1745b152],
8	.	.	O	.	_	0	SENT_141	[p7l1420t104r1745b152],

1	N	NN	O	n	nn	3	SENT_142	[p7l1766t106r1815b152],
2	Engl	NNP	O	Engl	nn	3	SENT_142	[p7l1835t104r1961b166],
3	J	NNP	O	J	_	0	SENT_142	[p7l1979t106r2005b152],
4	Med	VBD	O	med	partmod	3	SENT_142	[p7l2023t104r2146b152],
5	2004	CD	DATE	2004	dobj	4	SENT_142	[p7l108t188r324b245],
6	;	:	O	;	_	0	SENT_142	[p7l108t188r324b245],
7	35	CD	NUMBER	35	number	8	SENT_142	[p7l108t188r324b245],
8	1	CD	NUMBER	1	dep	3	SENT_142	[p7l337t188r355b234],
9	22827-3	CD	NUMBER	22827-3	num	10	SENT_142	[p7l368t188r585b235],
10	l.	NN	O	l.	dep	8	SENT_142	[p7l599t188r637b235],

1	Heiskanen	NNP	PERSON	Heiskanen	nn	2	SENT_143	[p7l6t269r290b317],
2	T	NN	O	t	_	0	SENT_143	[p7l327t271r374b327],
3	,	,	O	,	_	0	SENT_143	[p7l327t271r374b327],
4	Olkkola	JJ	ORGANIZATION	olkkola	amod	5	SENT_143	[p7l415t269r631b317],
5	KT	NN	ORGANIZATION	kt	appos	2	SENT_143	[p7l667t271r764b327],
6	,	,	O	,	_	0	SENT_143	[p7l667t271r764b327],
7	Kalso	NNP	PERSON	Kalso	nn	9	SENT_143	[p7l804t269r958b317],
8	E.	NNP	O	E.	nn	9	SENT_143	[p7l998t271r1050b317],
9	Effects	NNS	O	effect	appos	2	SENT_143	[p7l1091t269r1276b317],
10	of	IN	O	of	_	0	SENT_143	[p7l1316t269r1377b317],
11	blocking	VBG	O	block	prepc_of	9	SENT_143	[p7l1405t269r1640b331],
12	CYP2D6	NN	O	cyp2d6	dobj	11	SENT_143	[p7l1679t270r1923b317],
13	on	IN	O	on	_	0	SENT_143	[p7l1962t285r2028b317],
14	the	DT	O	the	det	15	SENT_143	[p7l2065t269r2145b317],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_143	[p7l106t353r578b414],
16	and	CC	O	and	_	0	SENT_143	[p7l611t353r707b401],
17	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	15	SENT_143	[p7l735t353r1257b414],
18	of	IN	O	of	_	0	SENT_143	[p7l1289t353r1351b401],
19	oxycodone	NN	O	oxycodone	prep_of	15	SENT_143	[p7l1374t353r1681b414],
20	.	.	O	.	_	0	SENT_143	[p7l1374t353r1681b414],

1	Clin	NNP	O	Clin	nn	4	SENT_144	[p7l1716t353r1830b401],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_144	[p7l1860t353r2146b401],
3	Ther	NNP	O	Ther	nn	4	SENT_144	[p7l108t436r235b484],
4	l998	NN	O	l998	_	0	SENT_144	[p7l262t437r714b494],
5	;	:	O	;	_	0	SENT_144	[p7l262t437r714b494],
6	64:603	CD	NUMBER	64:603	number	7	SENT_144	[p7l262t437r714b494],
7	—	CD	NUMBER	—	num	8	SENT_144	[p7l262t437r714b494],
8	ll	NN	O	ll	dep	4	SENT_144	[p7l262t437r714b494],
9	.	.	O	.	_	0	SENT_144	[p7l262t437r714b494],

1	Hutchinson	NNP	PERSON	Hutchinson	nn	2	SENT_145	[p7l6t518r315b566],
2	MR	NN	PERSON	mr	_	0	SENT_145	[p7l330t520r449b576],
3	,	,	O	,	_	0	SENT_145	[p7l330t520r449b576],
4	Menelaou	NNP	O	Menelaou	nn	5	SENT_145	[p7l466t518r735b566],
5	A	NNP	O	A	appos	2	SENT_145	[p7l749t519r811b576],
6	,	,	O	,	_	0	SENT_145	[p7l749t519r811b576],
7	Foster	NNP	O	Foster	nn	8	SENT_145	[p7l829t520r997b566],
8	DJ	NNP	O	DJ	appos	2	SENT_145	[p7l1010t520r1098b576],
9	,	,	O	,	_	0	SENT_145	[p7l1010t520r1098b576],
10	Coller	NNP	PERSON	Coller	nn	12	SENT_145	[p7l1117t518r1283b566],
11	J	NNP	PERSON	J	nn	12	SENT_145	[p7l1297t520r1322b566],
12	K	NNP	PERSON	K	appos	2	SENT_145	[p7l1323t520r1384b576],
13	,	,	O	,	_	0	SENT_145	[p7l1323t520r1384b576],
14	Somogyi	NNP	O	Somogyi	nn	15	SENT_145	[p7l1406t518r1644b580],
15	AA	NNP	O	AA	appos	2	SENT_145	[p7l1659t519r1769b566],
16	.	.	O	.	_	0	SENT_145	[p7l1659t519r1769b566],

1	CYP2D6	NN	O	cyp2d6	nn	4	SENT_146	[p7l1789t519r2033b566],
2	and	CC	O	and	_	0	SENT_146	[p7l2051t518r2147b566],
3	CYP3A4	NN	O	cyp3a4	nn	4	SENT_146	[p7l109t603r353b650],
4	involvement	NN	O	involvement	_	0	SENT_146	[p7l374t602r709b650],
5	in	IN	O	in	_	0	SENT_146	[p7l727t602r778b649],
6	the	DT	O	the	det	9	SENT_146	[p7l796t602r876b650],
7	primary	JJ	O	primary	amod	9	SENT_146	[p7l894t602r1106b663],
8	oxidative	JJ	O	oxidative	amod	9	SENT_146	[p7l1125t602r1372b650],
9	metabolism	NN	O	metabolism	prep_in	4	SENT_146	[p7l1391t602r1704b650],
10	of	IN	O	of	_	0	SENT_146	[p7l1722t602r1784b650],
11	hydrocodone	NN	O	hydrocodone	prep_of	9	SENT_146	[p7l1794t602r2145b663],
12	by	IN	O	by	_	0	SENT_146	[p7l106t685r174b747],
13	human	JJ	O	human	amod	15	SENT_146	[p7l196t685r379b733],
14	liver	NN	O	liver	nn	15	SENT_146	[p7l401t685r523b733],
15	microsomes	NNS	O	microsome	prep_by	4	SENT_146	[p7l542t685r878b733],
16	.	.	O	.	_	0	SENT_146	[p7l542t685r878b733],

1	Br	NN	O	br	nn	3	SENT_147	[p7l904t687r971b732],
2	J	NN	O	j	nn	3	SENT_147	[p7l991t687r1017b733],
3	Clin	NN	O	clin	_	0	SENT_147	[p7l1039t685r1153b733],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_147	[p7l1174t685r1459b733],
5	2004	CD	DATE	2004	num	4	SENT_147	[p7l1481t686r1943b743],
6	;	:	O	;	_	0	SENT_147	[p7l1481t686r1943b743],
7	57:287	CD	NUMBER	57:287	number	8	SENT_147	[p7l1481t686r1943b743],
8	—	CD	NUMBER	—	dep	3	SENT_147	[p7l1481t686r1943b743],
9	97	CD	NUMBER	97	dep	8	SENT_147	[p7l1481t686r1943b743],
10	.	.	O	.	_	0	SENT_147	[p7l1481t686r1943b743],

1	Kaplan	NNP	PERSON	Kaplan	nn	2	SENT_148	[p7l6t767r200b829],
2	HL	NNS	O	hl	nsubj	31	SENT_148	[p7l218t769r320b825],
3	,	,	O	,	_	0	SENT_148	[p7l218t769r320b825],
4	Busto	NNP	O	Busto	nn	5	SENT_148	[p7l342t769r497b815],
5	UE	NNP	O	UE	appos	2	SENT_148	[p7l517t769r620b825],
6	,	,	O	,	_	0	SENT_148	[p7l517t769r620b825],
7	Baylon	NNP	O	Baylon	nn	8	SENT_148	[p7l642t767r836b829],
8	GJ	NNP	O	GJ	appos	2	SENT_148	[p7l856t768r942b825],
9	,	,	O	,	_	0	SENT_148	[p7l856t768r942b825],
10	Cheung	NNP	ORGANIZATION	Cheung	nn	11	SENT_148	[p7l966t767r1173b829],
11	SW	NNP	ORGANIZATION	SW	appos	2	SENT_148	[p7l1196t768r1301b825],
12	,	,	O	,	_	0	SENT_148	[p7l1196t768r1301b825],
13	Otton	NNP	PERSON	Otton	nn	14	SENT_148	[p7l1324t768r1475b815],
14	SV	NNP	O	SV	appos	2	SENT_148	[p7l1496t768r1584b825],
15	,	,	O	,	_	0	SENT_148	[p7l1496t768r1584b825],
16	Somer	NNP	PERSON	Somer	nn	18	SENT_148	[p7l1609t768r1782b815],
17	G.	NNP	O	G.	nn	18	SENT_148	[p7l1800t768r1859b815],
18	Inhibition	NN	O	inhibition	appos	2	SENT_148	[p7l1882t767r2146b815],
19	of	IN	O	of	_	0	SENT_148	[p7l109t850r170b899],
20	cytochrome	NN	O	cytochrome	nn	23	SENT_148	[p7l191t850r505b912],
21	P450	NN	O	p450	nn	23	SENT_148	[p7l533t852r669b898],
22	2D6	NN	O	2d6	nn	23	SENT_148	[p7l698t852r811b898],
23	metabolism	NN	O	metabolism	prep_of	18	SENT_148	[p7l839t850r1152b899],
24	of	IN	O	of	_	0	SENT_148	[p7l1180t850r1241b899],
25	hydrocodone	NN	O	hydrocodone	prep_of	23	SENT_148	[p7l1259t850r1611b912],
26	to	TO	O	to	_	0	SENT_148	[p7l1638t857r1688b899],
27	hydromorphone	NN	O	hydromorphone	prep_to	25	SENT_148	[p7l1716t850r2145b912],
28	does	VBZ	O	do	aux	31	SENT_148	[p7l109t934r231b982],
29	not	RB	O	not	neg	31	SENT_148	[p7l278t941r366b982],
30	importantly	RB	O	importantly	advmod	31	SENT_148	[p7l413t934r732b996],
31	affect	VB	O	affect	_	0	SENT_148	[p7l780t934r933b982],
32	abuse	NN	O	abuse	nn	33	SENT_148	[p7l979t934r1133b982],
33	liability	NN	O	liability	dobj	31	SENT_148	[p7l1181t934r1403b996],
34	.	.	O	.	_	0	SENT_148	[p7l1181t934r1403b996],

1	J	NNP	O	J	nn	4	SENT_149	[p7l1453t936r1478b982],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_149	[p7l1523t934r1816b982],
3	Exp	NNP	O	Exp	nn	4	SENT_149	[p7l1863t936r1970b996],
4	Ther	NNP	O	Ther	_	0	SENT_149	[p7l2019t934r2148b982],
5	1997	CD	DATE	1997	num	4	SENT_149	[p7l115t1017r569b1074],
6	;	:	O	;	_	0	SENT_149	[p7l115t1017r569b1074],
7	28l	CD	NUMBER	28l	num	9	SENT_149	[p7l115t1017r569b1074],
8	:	:	O	:	_	0	SENT_149	[p7l115t1017r569b1074],
9	l03	CD	NUMBER	l03	dep	4	SENT_149	[p7l115t1017r569b1074],
10	—	CD	NUMBER	—	number	11	SENT_149	[p7l115t1017r569b1074],
11	8	CD	NUMBER	8	dep	9	SENT_149	[p7l115t1017r569b1074],
12	.	.	O	.	_	0	SENT_149	[p7l115t1017r569b1074],

1	Lelas	NNP	O	Lelas	nn	2	SENT_150	[p7l6t1099r148b1147],
2	S	NNP	O	S	_	0	SENT_150	[p7l174t1100r221b1157],
3	,	,	O	,	_	0	SENT_150	[p7l174t1100r221b1157],
4	Wegert	NNP	O	Wegert	nn	5	SENT_150	[p7l245t1101r437b1161],
5	S	NNP	O	S	appos	2	SENT_150	[p7l460t1100r508b1157],
6	,	,	O	,	_	0	SENT_150	[p7l460t1100r508b1157],
7	Otton	NNP	PERSON	Otton	nn	8	SENT_150	[p7l533t1100r684b1147],
8	SV	NNP	O	SV	appos	2	SENT_150	[p7l708t1100r795b1157],
9	,	,	O	,	_	0	SENT_150	[p7l708t1100r795b1157],
10	Sellers	NNP	ORGANIZATION	Sellers	nn	11	SENT_150	[p7l822t1099r998b1147],
11	EM	NNP	ORGANIZATION	EM	appos	2	SENT_150	[p7l1021t1101r1135b1157],
12	,	,	O	,	_	0	SENT_150	[p7l1021t1101r1135b1157],
13	France	NNP	LOCATION	France	nn	14	SENT_150	[p7l1159t1101r1339b1147],
14	CP	NNP	O	CP	appos	2	SENT_150	[p7l1363t1100r1448b1147],
15	.	.	O	.	_	0	SENT_150	[p7l1363t1100r1448b1147],

1	Inhibitors	NNS	O	inhibitor	nsubj	6	SENT_151	[p7l1474t1099r1731b1147],
2	of	IN	O	of	_	0	SENT_151	[p7l1756t1099r1817b1147],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_151	[p7l1831t1099r2145b1161],
4	P450	NN	O	p450	prep_of	1	SENT_151	[p7l107t1184r244b1230],
5	differentially	RB	O	differentially	advmod	6	SENT_151	[p7l291t1182r637b1244],
6	modify	VB	O	modify	_	0	SENT_151	[p7l681t1182r875b1244],
7	discriminative-stimulus	JJ	O	discriminative-stimulus	amod	10	SENT_151	[p7l921t1182r1549b1231],
8	and	CC	O	and	_	0	SENT_151	[p7l1597t1182r1693b1231],
9	antinociceptive	JJ	O	antinociceptive	amod	10	SENT_151	[p7l1737t1182r2144b1244],
10	effects	NNS	O	effect	dobj	6	SENT_151	[p7l109t1265r282b1313],
11	of	IN	O	of	_	0	SENT_151	[p7l323t1265r385b1313],
12	hydrocodone	NN	O	hydrocodone	prep_of	10	SENT_151	[p7l415t1265r766b1327],
13	and	CC	O	and	_	0	SENT_151	[p7l807t1265r903b1313],
14	hydromorphone	NN	O	hydromorphone	conj_and	12	SENT_151	[p7l941t1265r1370b1327],
15	in	IN	O	in	_	0	SENT_151	[p7l1411t1265r1461b1313],
16	rhesus	NN	O	rhesus	nn	17	SENT_151	[p7l1500t1265r1670b1313],
17	monkeys	NNS	O	monkey	prep_in	6	SENT_151	[p7l1710t1265r1965b1327],
18	.	.	O	.	_	0	SENT_151	[p7l1710t1265r1965b1327],

1	Drug	NN	O	drug	nn	3	SENT_152	[p7l2009t1267r2145b1327],
2	Alcohol	NNP	O	Alcohol	nn	3	SENT_152	[p7l107t1348r323b1396],
3	Depend	NNP	O	Depend	_	0	SENT_152	[p7l345t1348r555b1410],
4	l999	NN	O	l999	dep	3	SENT_152	[p7l582t1349r1037b1406],
5	;	:	O	;	_	0	SENT_152	[p7l582t1349r1037b1406],
6	54:239	CD	NUMBER	54:239	number	7	SENT_152	[p7l582t1349r1037b1406],
7	—	CD	NUMBER	—	dep	3	SENT_152	[p7l582t1349r1037b1406],
8	49	CD	NUMBER	49	dep	7	SENT_152	[p7l582t1349r1037b1406],
9	.	.	O	.	_	0	SENT_152	[p7l582t1349r1037b1406],

1	Lotsch	JJ	PERSON	lotsch	amod	2	SENT_153	[p7l6t1431r188b1480],
2	J	NN	PERSON	j	_	0	SENT_153	[p7l208t1433r247b1489],
3	,	,	O	,	_	0	SENT_153	[p7l208t1433r247b1489],
4	Starke	NNP	PERSON	Starke	nn	5	SENT_153	[p7l273t1431r439b1480],
5	C	NNP	O	C	appos	2	SENT_153	[p7l461t1432r518b1489],
6	,	,	O	,	_	0	SENT_153	[p7l461t1432r518b1489],
7	Liefhold	NNP	O	Liefhold	nn	8	SENT_153	[p7l541t1431r772b1480],
8	J	NNP	O	J	appos	2	SENT_153	[p7l791t1433r830b1489],
9	,	,	O	,	_	0	SENT_153	[p7l791t1433r830b1489],
10	Geisslinger	NNP	O	Geisslinger	nn	13	SENT_153	[p7l854t1431r1158b1493],
11	G.	NNP	O	G.	nn	13	SENT_153	[p7l1178t1432r1237b1480],
12	Genetic	NNP	O	Genetic	nn	13	SENT_153	[p7l1262t1431r1467b1480],
13	predictors	NNS	O	predictor	appos	2	SENT_153	[p7l1487t1431r1754b1493],
14	of	IN	O	of	_	0	SENT_153	[p7l1776t1431r1838b1479],
15	the	DT	O	the	det	17	SENT_153	[p7l1849t1431r1929b1479],
16	clinical	JJ	O	clinical	amod	17	SENT_153	[p7l1952t1431r2145b1479],
17	response	NN	O	response	prep_of	13	SENT_153	[p7l107t1530r341b1576],
18	to	TO	O	to	_	0	SENT_153	[p7l366t1521r416b1562],
19	opioid	JJ	O	opioid	amod	20	SENT_153	[p7l443t1514r614b1576],
20	analgesics	NNS	O	analgesic	prep_to	17	SENT_153	[p7l638t1514r925b1576],
21	:	:	O	:	_	0	SENT_153	[p7l638t1514r925b1576],
22	clinical	JJ	O	clinical	amod	23	SENT_153	[p7l955t1514r1149b1562],
23	utility	NN	O	utility	dep	2	SENT_153	[p7l1172t1514r1332b1576],
24	and	CC	O	and	_	0	SENT_153	[p7l1358t1514r1453b1562],
25	future	JJ	DATE	future	amod	26	SENT_153	[p7l1478t1514r1634b1562],
26	perspectives	NNS	O	perspective	conj_and	23	SENT_153	[p7l1659t1514r2003b1576],
27	.	.	O	.	_	0	SENT_153	[p7l1659t1514r2003b1576],

1	Clin	NNP	O	Clin	nn	2	SENT_154	[p7l2033t1514r2146b1562],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_154	[p7l107t1597r510b1645],
3	2004	CD	DATE	2004	num	2	SENT_154	[p7l531t1598r1060b1655],
4	;	:	O	;	_	0	SENT_154	[p7l531t1598r1060b1655],
5	43:983	CD	NUMBER	43:983	number	6	SENT_154	[p7l531t1598r1060b1655],
6	—	CD	NUMBER	—	num	7	SENT_154	[p7l531t1598r1060b1655],
7	l0l3	NN	O	l0l3	dep	2	SENT_154	[p7l531t1598r1060b1655],
8	.	.	O	.	_	0	SENT_154	[p7l531t1598r1060b1655],

1	Otton	NNP	PERSON	Otton	nn	2	SENT_155	[p7l7t1682r158b1729],
2	SV	NNP	O	SV	_	0	SENT_155	[p7l180t1682r267b1739],
3	,	,	O	,	_	0	SENT_155	[p7l180t1682r267b1739],
4	Wu	NNP	O	Wu	nn	5	SENT_155	[p7l287t1682r383b1729],
5	D	NNP	O	D	appos	2	SENT_155	[p7l401t1682r462b1739],
6	,	,	O	,	_	0	SENT_155	[p7l401t1682r462b1739],
7	J	NNP	O	J	nsubj	8	SENT_155	[p7l484t1682r509b1729],
8	offe	VBD	O	offe	dep	2	SENT_155	[p7l511t1680r614b1729],
9	RT	NN	O	rt	dobj	8	SENT_155	[p7l633t1682r724b1738],
10	,	,	O	,	_	0	SENT_155	[p7l633t1682r724b1738],
11	Cheung	NNP	ORGANIZATION	Cheung	nn	12	SENT_155	[p7l746t1680r954b1742],
12	SW	NNP	ORGANIZATION	SW	appos	2	SENT_155	[p7l976t1681r1081b1738],
13	,	,	O	,	_	0	SENT_155	[p7l976t1681r1081b1738],
14	Sellers	NNP	O	Sellers	nn	15	SENT_155	[p7l1105t1680r1280b1729],
15	EM	NNP	O	EM	appos	2	SENT_155	[p7l1300t1682r1413b1728],
16	.	.	O	.	_	0	SENT_155	[p7l1300t1682r1413b1728],

1	Inhibition	NN	O	inhibition	_	0	SENT_156	[p7l1436t1680r1700b1728],
2	by	IN	O	by	_	0	SENT_156	[p7l1716t1680r1784b1742],
3	ﬂuoxetine	NN	O	ﬂuoxetine	prep_by	1	SENT_156	[p7l1804t1680r2072b1729],
4	of	IN	O	of	_	0	SENT_156	[p7l2092t1680r2154b1729],
5	cytochrome	NN	O	cytochrome	nn	8	SENT_156	[p7l109t1764r423b1825],
6	P450	NN	O	p450	nn	8	SENT_156	[p7l445t1765r581b1812],
7	2D6	NN	O	2d6	nn	8	SENT_156	[p7l605t1765r718b1812],
8	activity	NN	O	activity	prep_of	1	SENT_156	[p7l743t1764r949b1825],
9	.	.	O	.	_	0	SENT_156	[p7l743t1764r949b1825],

1	Clin	NNP	O	Clin	nn	4	SENT_157	[p7l976t1764r1090b1812],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_157	[p7l1111t1764r1397b1812],
3	Ther	NNP	O	Ther	nn	4	SENT_157	[p7l1419t1764r1545b1812],
4	l993	NN	O	l993	_	0	SENT_157	[p7l1572t1765r1993b1822],
5	;	:	O	;	_	0	SENT_157	[p7l1572t1765r1993b1822],
6	53:40	CD	NUMBER	53:40	num	7	SENT_157	[p7l1572t1765r1993b1822],
7	l	NN	O	l	dep	4	SENT_157	[p7l1572t1765r1993b1822],
8	—	CD	NUMBER	—	number	9	SENT_157	[p7l1572t1765r1993b1822],
9	9	CD	NUMBER	9	dep	7	SENT_157	[p7l1572t1765r1993b1822],
10	.	.	O	.	_	0	SENT_157	[p7l1572t1765r1993b1822],

1	Persson	NNP	PERSON	Persson	nn	2	SENT_158	[p7l6t1848r215b1894],
2	K	NNP	PERSON	K	dep	22	SENT_158	[p7l239t1848r300b1904],
3	,	,	O	,	_	0	SENT_158	[p7l239t1848r300b1904],
4	Sjostrom	NNP	PERSON	Sjostrom	nn	5	SENT_158	[p7l332t1846r571b1908],
5	S	NNP	PERSON	S	appos	2	SENT_158	[p7l597t1847r645b1904],
6	,	,	O	,	_	0	SENT_158	[p7l597t1847r645b1904],
7	Sigurdardottir	NNP	PERSON	Sigurdardottir	nn	11	SENT_158	[p7l676t1846r1050b1908],
8	I	PRP	O	I	dep	11	SENT_158	[p7l1073t1848r1107b1904],
9	,	,	O	,	_	0	SENT_158	[p7l1073t1848r1107b1904],
10	Molnar	NNP	PERSON	Molnar	dep	11	SENT_158	[p7l1135t1846r1334b1894],
11	V	NNP	O	V	appos	2	SENT_158	[p7l1356t1848r1410b1904],
12	,	,	O	,	_	0	SENT_158	[p7l1356t1848r1410b1904],
13	Hammarlund-Udenaes	NNP	O	Hammarlund-Udenaes	nn	14	SENT_158	[p7l1438t1846r2044b1894],
14	M	NNP	O	M	appos	2	SENT_158	[p7l2070t1848r2143b1904],
15	,	,	O	,	_	0	SENT_158	[p7l2070t1848r2143b1904],
16	Rane	NNP	PERSON	Rane	nn	19	SENT_158	[p7l107t1931r244b1978],
17	A.	NNP	O	A.	nn	19	SENT_158	[p7l266t1931r327b1977],
18	Patient-controlled	JJ	O	patient-controlled	amod	19	SENT_158	[p7l353t1929r832b1978],
19	analgesia	NN	O	analgesia	appos	2	SENT_158	[p7l854t1929r1102b1991],
20	(	CD	NUMBER	(	num	22	SENT_158	[p7l1124t1930r1295b1991],
21	PCA	NN	ORGANIZATION	pca	nn	22	SENT_158	[p7l1124t1930r1295b1991],
22	)	NN	O	)	_	0	SENT_158	[p7l1124t1930r1295b1991],
23	with	IN	O	with	_	0	SENT_158	[p7l1318t1929r1437b1978],
24	codeine	NN	O	codeine	prep_with	22	SENT_158	[p7l1459t1929r1665b1978],
25	for	IN	O	for	_	0	SENT_158	[p7l1688t1929r1765b1978],
26	postoperative	JJ	O	postoperative	amod	28	SENT_158	[p7l1784t1929r2145b1991],
27	pain	NN	O	pain	nn	28	SENT_158	[p7l106t2013r226b2074],
28	relief	NN	O	relief	prep_for	24	SENT_158	[p7l271t2013r424b2061],
29	in	IN	O	in	_	0	SENT_158	[p7l463t2013r514b2060],
30	extensive	JJ	O	extensive	amod	31	SENT_158	[p7l562t2013r820b2061],
31	metabolisers	NNS	O	metaboliser	prep_in	28	SENT_158	[p7l867t2013r1214b2061],
32	and	CC	O	and	_	0	SENT_158	[p7l1263t2013r1360b2061],
33	one	CD	NUMBER	one	num	35	SENT_158	[p7l1407t2028r1503b2061],
34	poor	JJ	O	poor	amod	35	SENT_158	[p7l1549t2028r1678b2074],
35	metaboliser	NN	O	metaboliser	conj_and	22	SENT_158	[p7l1722t2012r2045b2061],
36	of	IN	O	of	_	0	SENT_158	[p7l2091t2013r2153b2061],
37	dextromethorphan	NN	O	dextromethorphan	prep_of	35	SENT_158	[p7l109t2096r612b2157],
38	.	.	O	.	_	0	SENT_158	[p7l109t2096r612b2157],

1	Br	NN	PERSON	br	nn	5	SENT_159	[p7l638t2098r706b2143],
2	J	NN	PERSON	j	nn	5	SENT_159	[p7l726t2098r751b2144],
3	Clin	NN	PERSON	clin	nn	5	SENT_159	[p7l773t2096r887b2144],
4	Pharmacol	NN	PERSON	pharmacol	nn	5	SENT_159	[p7l908t2096r1193b2144],
5	l995	NN	O	l995	_	0	SENT_159	[p7l1222t2097r1643b2154],
6	;	:	O	;	_	0	SENT_159	[p7l1222t2097r1643b2154],
7	39	CD	NUMBER	39	num	9	SENT_159	[p7l1222t2097r1643b2154],
8	:	:	O	:	_	0	SENT_159	[p7l1222t2097r1643b2154],
9	l82	CD	NUMBER	l82	dep	5	SENT_159	[p7l1222t2097r1643b2154],
10	—	CD	NUMBER	—	number	11	SENT_159	[p7l1222t2097r1643b2154],
11	6	CD	NUMBER	6	dep	9	SENT_159	[p7l1222t2097r1643b2154],
12	.	.	O	.	_	0	SENT_159	[p7l1222t2097r1643b2154],

1	Poulsen	NNP	PERSON	Poulsen	nn	2	SENT_160	[p7l6t2178r219b2227],
2	L	NNP	PERSON	L	_	0	SENT_160	[p7l249t2180r303b2236],
3	,	,	O	,	_	0	SENT_160	[p7l249t2180r303b2236],
4	Brosen	NNP	PERSON	Brosen	nn	5	SENT_160	[p7l337t2180r527b2227],
5	K	NNP	PERSON	K	appos	2	SENT_160	[p7l558t2180r620b2237],
6	,	,	O	,	_	0	SENT_160	[p7l558t2180r620b2237],
7	Arendt-Nielsen	NNP	PERSON	Arendt-Nielsen	nn	8	SENT_160	[p7l654t2178r1066b2227],
8	L	NNP	O	L	appos	5	SENT_160	[p7l1097t2180r1151b2237],
9	,	,	O	,	_	0	SENT_160	[p7l1097t2180r1151b2237],
10	Gram	NNP	ORGANIZATION	Gram	nn	11	SENT_160	[p7l1186t2180r1337b2227],
11	LF	NNP	ORGANIZATION	LF	appos	5	SENT_160	[p7l1368t2180r1454b2237],
12	,	,	O	,	_	0	SENT_160	[p7l1368t2180r1454b2237],
13	Elbaek	NNP	ORGANIZATION	Elbaek	nn	14	SENT_160	[p7l1488t2178r1674b2227],
14	K	NNP	ORGANIZATION	K	appos	5	SENT_160	[p7l1705t2180r1766b2237],
15	,	,	O	,	_	0	SENT_160	[p7l1705t2180r1766b2237],
16	Sindrup	NNP	O	Sindrup	nn	17	SENT_160	[p7l1803t2178r2011b2240],
17	SH	NNP	O	SH	appos	5	SENT_160	[p7l2047t2179r2142b2227],
18	.	.	O	.	_	0	SENT_160	[p7l2047t2179r2142b2227],

1	Codeine	NNP	O	Codeine	_	0	SENT_161	[p7l109t2262r331b2310],
2	and	CC	O	and	_	0	SENT_161	[p7l365t2262r460b2310],
3	morphine	NN	O	morphine	conj_and	1	SENT_161	[p7l492t2262r747b2323],
4	in	IN	O	in	_	0	SENT_161	[p7l782t2262r832b2309],
5	extensive	JJ	O	extensive	amod	8	SENT_161	[p7l865t2262r1115b2310],
6	and	CC	O	and	_	0	SENT_161	[p7l1149t2262r1245b2310],
7	poor	JJ	O	poor	conj_and	5	SENT_161	[p7l1275t2277r1401b2323],
8	metabolisers	NNS	O	metaboliser	prep_in	3	SENT_161	[p7l1431t2262r1766b2310],
9	of	IN	O	of	_	0	SENT_161	[p7l1801t2262r1863b2310],
10	sparteine	NN	O	sparteine	prep_of	8	SENT_161	[p7l1889t2262r2142b2323],
11	:	:	O	:	_	0	SENT_161	[p7l1889t2262r2142b2323],
12	pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_161	[p7l106t2345r594b2406],
13	,	,	O	,	_	0	SENT_161	[p7l106t2345r594b2406],
14	analgesic	JJ	O	analgesic	amod	15	SENT_161	[p7l621t2345r867b2406],
15	effects	NNS	O	effect	conj_and	12	SENT_161	[p7l893t2345r1065b2393],
16	and	CC	O	and	_	0	SENT_161	[p7l1091t2345r1187b2393],
17	side	JJ	O	side	amod	18	SENT_161	[p7l1212t2344r1315b2393],
18	effects	NNS	O	effect	dep	1	SENT_161	[p7l1341t2345r1528b2393],
19	.	.	O	.	_	0	SENT_161	[p7l1341t2345r1528b2393],

1	Eur	NNP	O	Eur	nn	5	SENT_162	[p7l1555t2347r1653b2393],
2	J	NNP	O	J	nn	5	SENT_162	[p7l1674t2347r1700b2393],
3	Clin	NNP	O	Clin	nn	5	SENT_162	[p7l1724t2345r1837b2393],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_162	[p7l1860t2345r2146b2393],
5	l996	NN	O	l996	_	0	SENT_162	[p7l115t2429r569b2486],
6	;	:	O	;	_	0	SENT_162	[p7l115t2429r569b2486],
7	5l	NN	O	5l	dep	5	SENT_162	[p7l115t2429r569b2486],
8	:289	CD	NUMBER	:289	num	7	SENT_162	[p7l115t2429r569b2486],
9	—	CD	NUMBER	—	number	10	SENT_162	[p7l115t2429r569b2486],
10	95	CD	NUMBER	95	dep	7	SENT_162	[p7l115t2429r569b2486],
11	.	.	O	.	_	0	SENT_162	[p7l115t2429r569b2486],

1	Poulsen	NNP	PERSON	Poulsen	nn	2	SENT_163	[p7l6t2510r219b2559],
2	L	NNP	PERSON	L	_	0	SENT_163	[p7l245t2512r299b2568],
3	,	,	O	,	_	0	SENT_163	[p7l245t2512r299b2568],
4	Riishede	NNP	PERSON	Riishede	nn	5	SENT_163	[p7l327t2510r561b2559],
5	L	NNP	PERSON	L	appos	2	SENT_163	[p7l588t2512r642b2568],
6	,	,	O	,	_	0	SENT_163	[p7l588t2512r642b2568],
7	Brosen	NNP	PERSON	Brosen	nn	8	SENT_163	[p7l671t2512r861b2559],
8	K	NNP	PERSON	K	appos	2	SENT_163	[p7l887t2512r949b2569],
9	,	,	O	,	_	0	SENT_163	[p7l887t2512r949b2569],
10	Clemens	NNP	PERSON	Clemens	nn	11	SENT_163	[p7l980t2510r1211b2559],
11	S	NNP	O	S	appos	2	SENT_163	[p7l1241t2512r1289b2569],
12	,	,	O	,	_	0	SENT_163	[p7l1241t2512r1289b2569],
13	Sindrup	NNP	O	Sindrup	nn	14	SENT_163	[p7l1321t2510r1529b2572],
14	SH	NNP	O	SH	appos	2	SENT_163	[p7l1560t2511r1655b2559],
15	.	.	O	.	_	0	SENT_163	[p7l1560t2511r1655b2559],

1	Codeine	NNP	O	Codeine	_	0	SENT_164	[p7l1686t2510r1908b2559],
2	in	IN	O	in	_	0	SENT_164	[p7l1936t2510r1986b2558],
3	postoperative	JJ	O	postoperative	amod	4	SENT_164	[p7l2012t2517r2145b2572, p7l109t2594r355b2655],
4	pain	NN	O	pain	prep_in	1	SENT_164	[p7l379t2594r509b2655],
5	:	:	O	:	_	0	SENT_164	[p7l379t2594r509b2655],
6	a	DT	O	a	det	7	SENT_164	[p7l539t2609r567b2641],
7	study	NN	O	study	dep	1	SENT_164	[p7l592t2594r736b2655],
8	of	IN	O	of	_	0	SENT_164	[p7l761t2594r822b2642],
9	the	DT	O	the	det	10	SENT_164	[p7l838t2594r918b2642],
10	inﬂuence	NN	O	inﬂuence	prep_of	7	SENT_164	[p7l944t2594r1190b2642],
11	of	IN	O	of	_	0	SENT_164	[p7l1216t2594r1278b2642],
12	sparteine	NN	O	sparteine	nn	13	SENT_164	[p7l1296t2594r1534b2655],
13	phenotype	NN	O	phenotype	prep_of	10	SENT_164	[p7l1557t2594r1838b2655],
14	and	CC	O	and	_	0	SENT_164	[p7l1864t2594r1960b2642],
15	serum	NN	O	serum	nn	16	SENT_164	[p7l1985t2609r2147b2642],
16	concentrations	NNS	O	concentration	prep_of	10	SENT_164	[p7l109t2677r501b2725],
17	of	IN	O	of	_	0	SENT_164	[p7l549t2677r610b2725],
18	morphine	NN	O	morphine	prep_of	7	SENT_164	[p7l647t2677r906b2738],
19	and	CC	O	and	_	0	SENT_164	[p7l952t2677r1049b2725],
20	morphine-6-glucuronide	NN	O	morphine-6-glucuronide	conj_and	18	SENT_164	[p7l1093t2677r1770b2738],
21	.	.	O	.	_	0	SENT_164	[p7l1093t2677r1770b2738],

1	Eur	NNP	O	Eur	nn	5	SENT_165	[p7l1819t2679r1917b2725],
2	J	NNP	O	J	nn	5	SENT_165	[p7l1960t2679r1985b2725],
3	Clin	NNP	O	Clin	nn	5	SENT_165	[p7l2031t2677r2146b2725],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_165	[p7l108t2759r393b2808],
5	l998	NN	O	l998	_	0	SENT_165	[p7l422t2761r842b2817],
6	;	:	O	;	_	0	SENT_165	[p7l422t2761r842b2817],
7	54:45	CD	NUMBER	54:45	num	8	SENT_165	[p7l422t2761r842b2817],
8	l	NN	O	l	dep	5	SENT_165	[p7l422t2761r842b2817],
9	—	CD	NUMBER	—	number	10	SENT_165	[p7l422t2761r842b2817],
10	4	CD	NUMBER	4	dep	8	SENT_165	[p7l422t2761r842b2817],
11	.	.	O	.	_	0	SENT_165	[p7l422t2761r842b2817],

1	Sindrup	JJ	O	sindrup	amod	2	SENT_166	[p7l9t2843r217b2904],
2	SH	NN	O	sh	_	0	SENT_166	[p7l241t2844r337b2901],
3	,	,	O	,	_	0	SENT_166	[p7l241t2844r337b2901],
4	Brosen	NNP	PERSON	Brosen	nn	5	SENT_166	[p7l360t2845r550b2891],
5	K	NNP	PERSON	K	appos	2	SENT_166	[p7l569t2845r631b2901],
6	,	,	O	,	_	0	SENT_166	[p7l569t2845r631b2901],
7	Bjeriing	NNP	O	Bjeriing	nn	8	SENT_166	[p7l653t2843r872b2904],
8	P	NN	O	p	appos	5	SENT_166	[p7l892t2845r935b2901],
9	,	,	O	,	_	0	SENT_166	[p7l892t2845r935b2901],
10	Arendt-Nielsen	JJ	PERSON	arendt-nielsen	amod	11	SENT_166	[p7l958t2843r1370b2891],
11	L	NN	PERSON	l	appos	5	SENT_166	[p7l1390t2845r1444b2901],
12	,	,	O	,	_	0	SENT_166	[p7l1390t2845r1444b2901],
13	Larsen	NNP	PERSON	Larsen	nn	14	SENT_166	[p7l1467t2845r1648b2891],
14	U	NNP	PERSON	U	appos	5	SENT_166	[p7l1667t2845r1729b2901],
15	,	,	O	,	_	0	SENT_166	[p7l1667t2845r1729b2901],
16	Angelo	NNP	O	Angelo	nn	17	SENT_166	[p7l1751t2843r1947b2904],
17	HR	NNP	DURATION	HR	appos	5	SENT_166	[p7l1969t2845r2076b2901],
18	,	,	O	,	_	0	SENT_166	[p7l1969t2845r2076b2901],
19	et	FW	O	et	nn	20	SENT_166	[p7l2101t2849r2147b2891],
20	al.	FW	O	al.	appos	5	SENT_166	[p7l109t2926r167b2974],
21	.	.	O	.	_	0	SENT_166	[p7l109t2926r167b2974],

1	Codeine	NNP	O	Codeine	nsubj	2	SENT_167	[p7l213t2926r435b2974],
2	increases	VBZ	O	increase	_	0	SENT_167	[p7l476t2926r717b2974],
3	pain	NN	O	pain	nn	4	SENT_167	[p7l757t2926r874b2987],
4	threshold	NN	O	threshold	dobj	2	SENT_167	[p7l913t2926r1162b2974],
5	to	TO	O	to	_	0	SENT_167	[p7l1201t2933r1251b2974],
6	copper	NN	O	copper	nn	9	SENT_167	[p7l1294t2941r1477b2987],
7	vapor	NN	O	vapor	nn	9	SENT_167	[p7l1513t2941r1668b2987],
8	laser	NN	O	laser	nn	9	SENT_167	[p7l1707t2926r1832b2974],
9	stimuli	NNS	O	stimulus	prep_to	2	SENT_167	[p7l1872t2926r2054b2974],
10	in	IN	O	in	_	0	SENT_167	[p7l2096t2926r2146b2973],
11	extensive	JJ	O	extensive	amod	15	SENT_167	[p7l109t3009r359b3057],
12	but	CC	O	but	_	0	SENT_167	[p7l394t3009r481b3057],
13	not	RB	O	not	_	0	SENT_167	[p7l515t3016r601b3057],
14	poor	JJ	O	poor	amod	15	SENT_167	[p7l634t3025r759b3071],
15	metabolizers	NNS	O	metabolizer	prep_in	9	SENT_167	[p7l793t3009r1132b3057],
16	of	IN	O	of	_	0	SENT_167	[p7l1169t3009r1231b3057],
17	sparteine	NN	O	sparteine	prep_of	15	SENT_167	[p7l1260t3009r1511b3071],
18	.	.	O	.	_	0	SENT_167	[p7l1260t3009r1511b3071],

1	Clin	NNP	O	Clin	nn	4	SENT_168	[p7l1552t3009r1665b3057],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_168	[p7l1700t3009r1985b3057],
3	Ther	NNP	O	Ther	nn	4	SENT_168	[p7l2022t3009r2148b3057],
4	l990	NN	O	l990	_	0	SENT_168	[p7l115t3093r569b3150],
5	;	:	O	;	_	0	SENT_168	[p7l115t3093r569b3150],
6	48:686	CD	NUMBER	48:686	number	7	SENT_168	[p7l115t3093r569b3150],
7	—	CD	NUMBER	—	dep	4	SENT_168	[p7l115t3093r569b3150],
8	93	CD	NUMBER	93	dep	7	SENT_168	[p7l115t3093r569b3150],
9	.	.	O	.	_	0	SENT_168	[p7l115t3093r569b3150],

1	Tomkins	NNP	ORGANIZATION	Tomkins	nn	2	SENT_169	[p7l7t3175r239b3223],
2	DM	NN	ORGANIZATION	dm	_	0	SENT_169	[p7l255t3177r378b3233],
3	,	,	O	,	_	0	SENT_169	[p7l255t3177r378b3233],
4	Otton	NNP	PERSON	Otton	nn	5	SENT_169	[p7l397t3176r548b3223],
5	SV	NNP	O	SV	appos	2	SENT_169	[p7l567t3176r654b3233],
6	,	,	O	,	_	0	SENT_169	[p7l567t3176r654b3233],
7	J	NNP	O	J	nn	9	SENT_169	[p7l673t3177r699b3223],
8	oharchi	NNS	O	oharchus	nn	9	SENT_169	[p7l701t3175r899b3223],
9	N	NN	O	n	appos	5	SENT_169	[p7l913t3177r977b3233],
10	,	,	O	,	_	0	SENT_169	[p7l913t3177r977b3233],
11	Li	NNP	LOCATION	Li	nn	12	SENT_169	[p7l995t3175r1053b3222],
12	NY	NNP	LOCATION	NY	appos	5	SENT_169	[p7l1067t3177r1171b3233],
13	,	,	O	,	_	0	SENT_169	[p7l1067t3177r1171b3233],
14	Balster	NNP	PERSON	Balster	nn	15	SENT_169	[p7l1190t3175r1380b3223],
15	RF	NNP	O	RF	appos	5	SENT_169	[p7l1394t3177r1484b3233],
16	,	,	O	,	_	0	SENT_169	[p7l1394t3177r1484b3233],
17	Tyndale	NNP	ORGANIZATION	Tyndale	nn	18	SENT_169	[p7l1504t3175r1717b3236],
18	RF	NNP	O	RF	appos	5	SENT_169	[p7l1733t3177r1824b3233],
19	,	,	O	,	_	0	SENT_169	[p7l1733t3177r1824b3233],
20	et	FW	O	et	nn	21	SENT_169	[p7l1844t3182r1890b3223],
21	al.	FW	O	al.	appos	5	SENT_169	[p7l1907t3175r1965b3223],
22	.	.	O	.	_	0	SENT_169	[p7l1907t3175r1965b3223],

1	Effect	NN	O	effect	_	0	SENT_170	[p7l1986t3175r2147b3223],
2	of	IN	O	of	_	0	SENT_170	[p7l109t3258r171b3306],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_170	[p7l193t3258r507b3319],
4	P450	NN	O	p450	nn	6	SENT_170	[p7l537t3259r674b3306],
5	2Dl	NN	O	2dl	nn	6	SENT_170	[p7l706t3259r813b3305],
6	inhibition	NN	O	inhibition	prep_of	1	SENT_170	[p7l851t3258r1111b3306],
7	on	IN	O	on	_	0	SENT_170	[p7l1141t3273r1207b3306],
8	hydrocodone	NN	O	hydrocodone	nn	9	SENT_170	[p7l1236t3258r1586b3319],
9	metabolism	NN	O	metabolism	prep_on	1	SENT_170	[p7l1617t3258r1930b3306],
10	and	CC	O	and	_	0	SENT_170	[p7l1960t3258r2055b3306],
11	its	PRP$	O	its	poss	13	SENT_170	[p7l2085t3258r2144b3306],
12	behavioral	JJ	O	behavioral	amod	13	SENT_170	[p7l107t3341r390b3389],
13	consequences	NNS	O	consequence	prep_on	1	SENT_170	[p7l410t3357r776b3403],
14	in	IN	O	in	_	0	SENT_170	[p7l797t3341r847b3388],
15	rats	NNS	O	rat	prep_in	1	SENT_170	[p7l865t3348r973b3389],
16	.	.	O	.	_	0	SENT_170	[p7l865t3348r973b3389],

1	J	NNP	O	J	nn	5	SENT_171	[p7l995t3343r1021b3389],
2	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_171	[p7l1039t3341r1324b3389],
3	Exp	NNP	O	Exp	nn	5	SENT_171	[p7l1343t3343r1449b3403],
4	Ther	NNP	O	Ther	nn	5	SENT_171	[p7l1469t3341r1596b3389],
5	l997	NN	O	l997	_	0	SENT_171	[p7l1620t3342r2142b3399],
6	;	:	O	;	_	0	SENT_171	[p7l1620t3342r2142b3399],
7	280	CD	NUMBER	280	num	9	SENT_171	[p7l1620t3342r2142b3399],
8	:	:	O	:	_	0	SENT_171	[p7l1620t3342r2142b3399],
9	l374	CD	NUMBER	l374	dep	5	SENT_171	[p7l1620t3342r2142b3399],
10	—	CD	NUMBER	—	number	11	SENT_171	[p7l1620t3342r2142b3399],
11	82	CD	NUMBER	82	dep	9	SENT_171	[p7l1620t3342r2142b3399],
12	.	.	O	.	_	0	SENT_171	[p7l1620t3342r2142b3399],

